Back to Browse Journals » OncoTargets and Therapy

OncoTargets and Therapy


Journal Articles:

- 1,856 records -

Validation of a novel prognostic scoring system using inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma

Hirahara N, Fujii Y, Yamamoto T, Hyakudomi R, Hirayama T, Taniura T, Ishitobi K, Tajima Y

OncoTargets and Therapy 2017, 10:363-370

Published Date: 13 January 2017

Advances in antiangiogenic treatment of small-cell lung cancer

Lu H, Jiang Z

OncoTargets and Therapy 2017, 10:353-359

Published Date: 12 January 2017

Chidamide in the treatment of peripheral T-cell lymphoma

Chan TS, Tse E, Kwong YL

OncoTargets and Therapy 2017, 10:347-352

Published Date: 12 January 2017

Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy

Chen J, Liu L, Xu J

OncoTargets and Therapy 2017, 10:339-345

Published Date: 11 January 2017

Radiosynthesis and pharmacokinetics of [18F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice

Yang Z, Liu J, Huang Q, Zhang Z, Zhang J, Pan Y, Yang Y, Cheng D

OncoTargets and Therapy 2017, 10:329-338

Published Date: 11 January 2017

Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis

Yin SC, Li Z, Huang JY, Miao ZF, Zhang JY, Lu CY, Xu H, Xu HM

OncoTargets and Therapy 2017, 10:319-327

Published Date: 10 January 2017

Expression of phosphatase of regenerating liver-3 is associated with prognosis of Wilms’ tumor

Sun F, Li W, Wang L, Jiao C

OncoTargets and Therapy 2017, 10:311-317

Published Date: 10 January 2017

Association of MTHFR C677T and A1298C polymorphisms with oral cancer susceptibility: evidence from a meta-analysis

Jiang S, Xu J, Zhuo Z, Hua Z

OncoTargets and Therapy 2017, 10:303-310

Published Date: 10 January 2017

Clinical outcomes of patients with metachronous second primary lung adenocarcinomas

Zhao H, Yang H, Han K, Xu J, Yao F, Zhao Y, Fan L, Gu H, Shen Z

OncoTargets and Therapy 2017, 10:295-302

Published Date: 10 January 2017

Correlation of SASH1 expression and ultrasonographic features in breast cancer

Gong X, Wu J, Wu J, Liu J, Gu H, Shen H

OncoTargets and Therapy 2017, 10:271-276

Published Date: 10 January 2017

Strategies of temozolomide in future glioblastoma treatment

Lee CY

OncoTargets and Therapy 2017, 10:265-270

Published Date: 9 January 2017

RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis

Shou FY, Xu F, Li G, Zhao ZH, Mao Y, Yang FF, Wang HM, Guo HY

OncoTargets and Therapy 2017, 10:247-257

Published Date: 9 January 2017

Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection

Fan L, Yang H, Yao F, Zhao Y, Gu H, Han K, Zhao H

OncoTargets and Therapy 2017, 10:239-245

Published Date: 6 January 2017

VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma

Nadiminti K, Singh Abbi KK, Mott SL, Dozeman L, Tricot A, Schultz A, Behrends S, Zhan F, Tricot G

OncoTargets and Therapy 2017, 10:217-226

Published Date: 6 January 2017

Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer

Gao H, Song X, Kang T, Yan B, Feng L, Gao L, Ai L, Liu X, Yu J, Li H

OncoTargets and Therapy 2017, 10:205-216

Published Date: 5 January 2017

Multivoxel magnetic resonance spectroscopy identifies enriched foci of cancer stem-like cells in high-grade gliomas

He T, Qiu T, Wang X, Gui H, Wang X, Hu Q, Xia H, Qi G, Wu J, Ma H

OncoTargets and Therapy 2017, 10:195-203

Published Date: 4 January 2017

The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer

Dong J, Zhang Z, Gu T, Xu SF, Dong LX, Li X, Fu BH, Fu ZZ

OncoTargets and Therapy 2017, 10:185-194

Published Date: 29 December 2016

Pediatric papillary thyroid cancer: current management challenges

Verburg FA, Van Santen HM, Luster M

OncoTargets and Therapy 2017, 10:165-175

Published Date: 28 December 2016

Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings

Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M

OncoTargets and Therapy 2017, 10:153-163

Published Date: 28 December 2016

Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma

Zhang Q, Cao J, Xue K, Liu X, Ji D, Guo Y, Hong X

OncoTargets and Therapy 2017, 10:145-151

Published Date: 22 December 2016

Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells

Kwak TW, Park SB, Kim HJ, Jeong YI, Kang DH

OncoTargets and Therapy 2017, 10:137-144

Published Date: 22 December 2016

High expression of long noncoding RNA HULC is a poor predictor of prognosis and regulates cell proliferation in glioma

Yan H, Tian R, Zhang M, Wu J, Ding M, He J

OncoTargets and Therapy 2017, 10:113-120

Published Date: 21 December 2016

Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological study

Wang Y, Meng F, Liu Y, Chen X

OncoTargets and Therapy 2017, 10:95-100

Published Date: 20 December 2016

Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China

Tang H, Wu Y, Qin Y, Wang H, Wang L, Guan X, Luo S, Wang Q

OncoTargets and Therapy 2017, 10:85-94

Published Date: 20 December 2016

RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src

Zhang X, Song Y, Song N, Zhang Y, Zhang L, Wang Y, Wang Z, Qu X, Liu Y

OncoTargets and Therapy 2017, 10:73-83

Published Date: 5 January 2017

Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review

He W, Zou C, Tian ZK, Tan WY, Shen WX, Chen JH, Liu LP, Xu RL

OncoTargets and Therapy 2017, 10:67-72

Published Date: 20 December 2016

Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma

Cheng Y, Xing SG, Jia WD, Huang M, Bian NN

OncoTargets and Therapy 2017, 10:47-54

Published Date: 19 December 2016

Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP

Lei R, Xue M, Zhang L, Lin ZQ

OncoTargets and Therapy 2017, 10:35-46

Published Date: 19 December 2016

Atypical aleukemic presentation of large granular lymphocytic leukemia: a case report

Bagacean C, Tempescul A, Patiu M, Fetica B, Bumbea H, Zdrenghea M

OncoTargets and Therapy 2017, 10:31-34

Published Date: 19 December 2016

Potential role of immunotherapy in advanced non-small-cell lung cancer

de Mello RA, Veloso AF, Esrom Catarina P, Nadine S, Antoniou G

OncoTargets and Therapy 2017, 10:21-30

Published Date: 16 December 2016

J-pouch versus Roux-en-Y reconstruction after gastrectomy: functional assessment and quality of life (randomized trial)

Zonca P, Maly T, Ihnat P, Peteja M, Kraft O, Kuca K

OncoTargets and Therapy 2017, 10:13-19

Published Date: 16 December 2016

Association between TLR-9 polymorphisms and colon cancer susceptibility in Saudi Arabian female patients

Semlali A, Parine NR, Al Amri A, Azzi A, Arafah M, Kohailan M, Shaik JP, Almadi MA, Aljebreen AM, Alharbi O, Ali Azzam N, Rouabhia M, Alanazi MS

OncoTargets and Therapy 2017, 10:1-11

Published Date: 16 December 2016

Non-secretory multiple myeloma: from biology to clinical management

Dupuis MM, Tuchman SA

OncoTargets and Therapy 2016, 9:7583-7590

Published Date: 15 December 2016

Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives

Mulet-Margalef N, Garcia-del-Muro X

OncoTargets and Therapy 2016, 9:7573-7582

Published Date: 15 December 2016

Lipopolysaccharide-induced α-catenin downregulation enhances the motility of human colorectal cancer cells in an NF-κB signaling-dependent manner

Cheng G, Yang S, Zhang G, Xu Y, Liu X, Sun W, Zhu L

OncoTargets and Therapy 2016, 9:7563-7571

Published Date: 14 December 2016

Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role

Cochetti G, Poli G, Guelfi G, Boni A, Egidi MG, Mearini E

OncoTargets and Therapy 2016, 9:7545-7553

Published Date: 13 December 2016

The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning

Zhu J, Simon A, Haigron P, Lafond C, Acosta O, Shu H, Castelli J, Li B, De Crevoisier R

OncoTargets and Therapy 2016, 9:7537-7544

Published Date: 12 December 2016

A pilot study employing hepatic intra-arterial irinotecan injection of drug-eluting beads as salvage therapy in liver metastatic colorectal cancer patients without extrahepatic involvement: the first southern Italy experience

Ranieri G, Niccoli Asabella A, Altini C, Fazio V, Caporusso L, Marech I, Vinciarelli G, Macina F, de Ceglia D, Fanelli M, Ammendola M, Rubini G, Gadaleta CD

OncoTargets and Therapy 2016, 9:7527-7535

Published Date: 12 December 2016

β-Elemene treatment of glioblastoma: a single-center retrospective study

Ma C, Zhou W, Yan Z, Qu M, Bu X

OncoTargets and Therapy 2016, 9:7521-7526

Published Date: 12 December 2016

Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells

Souza e Silva V, Chinen LTD, Abdallah EA, Damascena A, Paludo J, Chojniak R, Dettino ALA, Mello CAL, Alves VS, Fanelli MF

OncoTargets and Therapy 2016, 9:7503-7513

Published Date: 13 December 2016

Overexpression and clinical significance of MYC-associated zinc finger protein in pancreatic carcinoma

Zhu X, Luo W, Liang W, Tang F, Bei C, Ren Y, Qin L, Tan C, Zhang Y, Tan S

OncoTargets and Therapy 2016, 9:7493-7501

Published Date: 12 December 2016

Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells

Ye T, Su J, Huang C, Yu D, Dai S, Huang X, Chen B, Zhou M

OncoTargets and Therapy 2016, 9:7481-7492

Published Date: 12 December 2016

Biomarkers in pancreatic adenocarcinoma: current perspectives

Swords DS, Firpo MA, Scaife CL, Mulvihill SJ

OncoTargets and Therapy 2016, 9:7459-7467

Published Date: 9 December 2016

Comparison of the clinical features and hematopoietic stem cell transplantation outcomes of mediastinal malignant germ cell tumors with nonmediastinal extragonadal placements

Ocal N, Yildiz B, Karadurmus N, Dogan D, Ozaydin S, Ocal R, Ozturk M, Arpaci F, Bilgic H

OncoTargets and Therapy 2016, 9:7445-7450

Published Date: 9 December 2016

Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population

Yan WY, Hu J, Xie L, Cheng L, Yang M, Li L, Shi J, Liu BR, Qian X

OncoTargets and Therapy 2016, 9:7415-7424

Published Date: 8 December 2016

Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis

Shi H, Wang X, Wang J, Pan J, Liu J, Ye B

OncoTargets and Therapy 2016, 9:7409-7414

Published Date: 8 December 2016

Identification of feature genes for smoking-related lung adenocarcinoma based on gene expression profile data

Liu Y, Ni R, Zhang H, Miao L, Wang J, Jia W, Wang Y

OncoTargets and Therapy 2016, 9:7397-7407

Published Date: 7 December 2016

Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran

Dolatkhah R, Somi MH, Asvadi Kermani I, Bonyadi M, Sepehri B, Boostani K, Azadbakht S, Fotouhi N, Farassati F, Dastgiri S

OncoTargets and Therapy 2016, 9:7385-7395

Published Date: 7 December 2016

Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway

Kang Y, Hu W, Bai E, Zheng H, Liu Z, Wu J, Jin R, Zhao C, Liang G

OncoTargets and Therapy 2016, 9:7373-7384

Published Date: 5 December 2016

Mutations in hepatitis B virus small S genes predict postoperative survival in hepatocellular carcinoma

Peng L, Yang G, Wu C, Wang WS, Wu J, Guo Z

OncoTargets and Therapy 2016, 9:7367-7372

Published Date: 2 December 2016

Next-generation sequencing: advances and applications in cancer diagnosis

Serratì S, De Summa S, Pilato B, Petriella D, Lacalamita R, Tommasi S, Pinto R

OncoTargets and Therapy 2016, 9:7355-7365

Published Date: 2 December 2016

Structure–activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches

Lakhlili W, Yasri A, Ibrahimi A

OncoTargets and Therapy 2016, 9:7345-7353

Published Date: 2 December 2016

History and progression of Fat cadherins in health and disease

Zhang X, Liu J, Liang X, Chen J, Hong J, Li L, He Q, Cai X

OncoTargets and Therapy 2016, 9:7337-7343

Published Date: 1 December 2016

Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel

Khosravian P, Shafiee Ardestani M, Khoobi M, Ostad SN, Dorkoosh FA, Akbari Javar H, Amanlou M

OncoTargets and Therapy 2016, 9:7315-7330

Published Date: 1 December 2016

Long-term benefit of sunitinib in patients with metastatic renal cell carcinoma in Latin America: retrospective analysis of patient clinical characteristics

Smaletz O, Chacón M, de Oliveira Koch L, de Carvalho Rocha DR, Cardoso FC

OncoTargets and Therapy 2016, 9:7309-7314

Published Date: 30 November 2016

Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1

Zhang J, Fu J, Pan Y, Zhang X, Shen L

OncoTargets and Therapy 2016, 9:7297-7307

Published Date: 1 December 2016

CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer

Yang K, Gao K, Hu G, Wen Y, Lin C, Li X

OncoTargets and Therapy 2016, 9:7285-7295

Published Date: 30 November 2016

Androgen deprivation therapy as backbone therapy in the management of prostate cancer

Merseburger AS, Alcaraz A, von Klot CA

OncoTargets and Therapy 2016, 9:7263-7274

Published Date: 29 November 2016

Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression

Xue F, Liu YH, Zhang HW, Wen Y, Yan L, Tang Q, Xiao EH, Zhang DY

OncoTargets and Therapy 2016, 9:7253-7261

Published Date: 28 November 2016

Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives

Davidson M, Starling N

OncoTargets and Therapy 2016, 9:7235-7245

Published Date: 25 November 2016

E2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol

Hu YX, He HL, Lu J, Wang Y, Xiao PF, Li JQ, Li J, Sun YN, Lv H, Fan JJ, Yao YH, Chai YH, Hu SY

OncoTargets and Therapy 2016, 9:7219-7225

Published Date: 22 November 2016

Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time

Baek N, Seo OW, Kim M, Hulme J, An SSA

OncoTargets and Therapy 2016, 9:7207-7218

Published Date: 22 November 2016

High expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma

Na N, Si T, Huang Z, Miao B, Hong L, Li H, Qiu J, Qiu J

OncoTargets and Therapy 2016, 9:7199-7205

Published Date: 22 November 2016

Effect of smoking on the genetic makeup of toll-like receptors 2 and 6

Kohailan M, Alanazi M, Rouabhia M, Alamri A, Parine NR, Alhadheq A, Basavarajappa S, Abdullah Al-Kheraif AA, Semlali A

OncoTargets and Therapy 2016, 9:7187-7198

Published Date: 21 November 2016

The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma

Wang J, Wang SZ, Song XM, Zeng WJ, Wang SY, Chen F, Ding H

OncoTargets and Therapy 2016, 9:7177-7185

Published Date: 21 November 2016

Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity

Liang P, Huang C, Liang S, Li Y, Huang S, Lian Z, Liu J, Tang Y, Lu H

OncoTargets and Therapy 2016, 9:7169-7175

Published Date: 18 November 2016

Next-generation sequence detects ARAP3 as a novel oncogene in papillary thyroid carcinoma

Wang QX, Chen ED, Cai YF, Zhou YL, Zheng ZC, Wang YH, Jin YX, Jin WX, Zhang XH, Wang OC

OncoTargets and Therapy 2016, 9:7161-7167

Published Date: 18 November 2016

BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy

Chowdhary M, Patel KR, Danish HH, Lawson DH, Khan MK

OncoTargets and Therapy 2016, 9:7149-7159

Published Date: 12 December 2016

Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus

Wu F, Lu H, Zhu S, Li Z, Zou L, Bai T, Chen J, Yang T, Liang S

OncoTargets and Therapy 2016, 9:7141-7147

Published Date: 1 December 2016

Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells

Xie L, Zhao T, Cai J, Su Y, Wang Z, Dong W

OncoTargets and Therapy 2016, 9:7115-7122

Published Date: 17 November 2016

Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases

Zeng ZM, Luo FF, Zou LX, He RQ, Pan DH, Chen X, Xie TT, Li YQ, Peng ZG, Chen G

OncoTargets and Therapy 2016, 9:7105-7114

Published Date: 17 November 2016

Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial

Harrington KJ, Andtbacka RHI, Collichio F, Downey G, Chen L, Szabo Z, Kaufman HL

OncoTargets and Therapy 2016, 9:7081-7093

Published Date: 16 November 2016

Lrig1 is a positive prognostic marker in hepatocellular carcinoma

Yang B, Dai C, Tan RM, Zhang B, Meng X, Ye J, Wang XQ, Wei L, He F, Chen ZS

OncoTargets and Therapy 2016, 9:7071-7079

Published Date: 15 November 2016

MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1

Xu D, Chen XF, He QY, Luo CQ

OncoTargets and Therapy 2016, 9:7047-7057

Published Date: 15 November 2016

Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer

Yang F, Lv S, Lv L, Liu Y, Dong S, Yao Z, Dai X, Zhang X, Wang O

OncoTargets and Therapy 2016, 9:7039-7045

Published Date: 15 November 2016

ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma

Chen L, Liu MM, Liu H, Lu D, Zhao XD, Yang XJ

OncoTargets and Therapy 2016, 9:7019-7028

Published Date: 14 November 2016

CT-diagnosed severe skull base bone destruction predicts distant bone metastasis in early N-stage nasopharyngeal carcinoma

Yi W, Liu ZG, Li X, Tang J, Jiang CB, Hu JY, Tu ZW, Wang H, Niu DL, Xia YF

OncoTargets and Therapy 2016, 9:7011-7017

Published Date: 14 November 2016

MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1

Hu ZL, Cui YH, Zhou YH, Zhou KY, Qiao XQ, Li CQ, Wang S

OncoTargets and Therapy 2016, 9:6999-7009

Published Date: 14 November 2016

The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis

Zhai R, Tang F, Gong JH, Zhang J, Lei B, Li B, Wei YC, Liang XS, Tang B, He SQ

OncoTargets and Therapy 2016, 9:6987-6998

Published Date: 24 November 2016

Role of p14ARF and p15INK4B promoter methylation in patients with lung cancer: a systematic meta-analysis

Yang X, Yang L, Dai W, Ye B

OncoTargets and Therapy 2016, 9:6977-6985

Published Date: 11 November 2016

Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis

Su X, Jiang X, Wang W, Wang H, Xu X, Lin A, Teng X, Wu H, Teng L

OncoTargets and Therapy 2016, 9:6965-6976

Published Date: 11 November 2016

Comparison of internal target volumes defined on 3-dimensional, 4-dimensonal, and cone-beam CT images of non-small-cell lung cancer

Li F, Li J, Ma Z, Zhang Y, Xing J, Qi H, Shang D

OncoTargets and Therapy 2016, 9:6945-6951

Published Date: 17 November 2016

Paxillin functions as an oncogene in human gliomas by promoting cell migration and invasion

Chen B, Xia L, Xu C, Xiao F, Wang Y

OncoTargets and Therapy 2016, 9:6935-6943

Published Date: 9 November 2016

Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells

Pileczki V, Pop L, Braicu C, Budisan L, Bolba Morar G, del C Monroig-Bosque P, Sandulescu RV, Berindan-Neagoe I

OncoTargets and Therapy 2016, 9:6921-6933

Published Date: 11 November 2016

A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma

Zhao YY, Liu L, Zhou T, Zhou NN, Yang YP, Hou X, Li Y, Zhao HY, Huang Y, Zhang L

OncoTargets and Therapy 2016, 9:6915-6920

Published Date: 8 November 2016

miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial–mesenchymal transition

Zhang XG, Zhang T, Yang K, Zhang MH, Wang KM

OncoTargets and Therapy 2016, 9:6909-6914

Published Date: 8 November 2016

Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection

Zhong JH, Ke Y, Zhu SL, Wang L, Luo CP, Gong WF, You XM, Ma L, Xiang BD, Li LQ

OncoTargets and Therapy 2016, 9:6897-6907

Published Date: 10 November 2016

Genetic variation rs7930 in the miR-4273-5p target site is associated with a risk of colorectal cancer

Lee AR, Park J, Jung KJ, Jee SH, Kim-Yoon SJ

OncoTargets and Therapy 2016, 9:6885-6895

Published Date: 7 November 2016

Hürthle cell carcinoma: current perspectives

Ahmadi S, Stang M, Jiang XS, Sosa JA

OncoTargets and Therapy 2016, 9:6873-6884

Published Date: 7 November 2016

NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells

Zhong Y, Shen S, Zhou Y, Mao F, Lin Y, Guan J, Xu Y, Zhang S, Liu X, Sun Q

OncoTargets and Therapy 2016, 9:6865-6871

Published Date: 7 November 2016

FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma

El-Hamamsy M, Ghali RR, Saad AS, Shaheen SM, Salem AM

OncoTargets and Therapy 2016, 9:6857-6863

Published Date: 7 November 2016

Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma

Jeannot V, Busser B, Vanwonterghem L, Michallet S, Ferroudj S, Cokol M, Coll JL, Ozturk M, Hurbin A

OncoTargets and Therapy 2016, 9:6843-6855

Published Date: 9 November 2016

Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma

Xu Y, Guo Q, Lin J, Chen B, Wen J, Lu T, Xu Y, Zhang M, Pan J, Lin S

OncoTargets and Therapy 2016, 9:6835-6841

Published Date: 4 November 2016

Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management

Wu S, Mo M, Wang Y, Zhang N, Li J, Di G, Shao Z, Wu J, Liu G

OncoTargets and Therapy 2016, 9:6829-6834

Published Date: 4 November 2016

Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening

Iovanescu D, Frandes M, Lungeanu D, Burlea A, Miutescu BP, Miutescu E

OncoTargets and Therapy 2016, 9:6819-6828

Published Date: 4 November 2016

Differentiation between adrenal adenomas and nonadenomas using dynamic contrast-enhanced computed tomography

Wang XF, Li KG, Sun HR, Zhao JL, Zheng LF, Zhang ZL, Bai RJ, Zhang GX

OncoTargets and Therapy 2016, 9:6809-6817

Published Date: 3 November 2016

Association of TIMP-2-418G/C and TIMP-2-303G/A with gastric cancer: a meta-analysis

Yang Y, Xiong Y, Li J, Wu C, Jiang J

OncoTargets and Therapy 2016, 9:6801-6808

Published Date: 3 November 2016

Total versus subtotal gastrectomy for distal gastric cancer: meta-analysis of randomized clinical trials

Kong L, Yang N, Shi L, Zhao G, Wang M, Zhang Y

OncoTargets and Therapy 2016, 9:6795-6800

Published Date: 7 November 2016

Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking

Coppola C, Riccio G, Barbieri A, Monti MG, Piscopo G, Rea D, Arra C, Maurea C, De Lorenzo C, Maurea N

OncoTargets and Therapy 2016, 9:6785-6794

Published Date: 2 November 2016

Cervical nodal necrosis is an independent survival predictor in nasopharyngeal carcinoma: an observational cohort study

Luo Y, Ren J, Zhou P, Gao Y, Yang G, Lang J

OncoTargets and Therapy 2016, 9:6775-6783

Published Date: 1 November 2016

Minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysis

Lv L, Hu WD, Ren YC, Wei XX

OncoTargets and Therapy 2016, 9:6751-6762

Published Date: 31 October 2016

Positive expression of KIF20A indicates poor prognosis of glioma patients

Duan J, Huang W, Shi H

OncoTargets and Therapy 2016, 9:6741-6749

Published Date: 2 November 2016

A current perspective on stereotactic body radiation therapy for pancreatic cancer

Hong JC, Czito BG, Willett CG, Palta M

OncoTargets and Therapy 2016, 9:6733-6739

Published Date: 31 October 2016

Effect of VEGF-C siRNA and endostatin on ring formation and proliferation of esophageal squamous cell carcinoma lymphatic endothelial cells

Zheng YP, Sun MM, Chen JY, He LL, Zhao N, Chen KS

OncoTargets and Therapy 2016, 9:6727-6732

Published Date: 31 October 2016

High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma

Zhang L, Xiu DR, Zhan J, He XK, Guo LM, Wang JL, Tao M, Fu W, Zhang HQ

OncoTargets and Therapy 2016, 9:6719-6726

Published Date: 31 October 2016

Elevated HABP1 protein expression correlates with progression and poor survival in patients with gastric cancer

Gao H, Yao Q, Lan X, Li S, Wu J, Zeng G, Xue Y

OncoTargets and Therapy 2016, 9:6711-6718

Published Date: 31 October 2016

Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis

Chen Z, Shao Y, Wang K, Cao W, Xiong Y, Wu R, Luo S, Xu X, He X

OncoTargets and Therapy 2016, 9:6701-6710

Published Date: 28 October 2016

Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients

Kurtz JE, Soubeyran P, Michallet M, Luporsi E, Albrand H

OncoTargets and Therapy 2016, 9:6689-6693

Published Date: 28 October 2016

Association between prognostic survival of human colorectal carcinoma and ZNRF3 expression

Yu N, Zhu H, Tao Y, Huang Y, Song X, Zhou Y, Li Y, Pei Q, Tan Q, Pei H

OncoTargets and Therapy 2016, 9:6679-6687

Published Date: 28 October 2016

Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis

Artene S, Turcu-Stiolica A, Hartley R, Ciurea ME, Daianu O, Brindusa C, Alexandru O, Tataranu LG, Purcaru SO, Dricu A

OncoTargets and Therapy 2016, 9:6669-6677

Published Date: 4 November 2016

SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer

Komiya K, Nakamura T, Nakashima C, Takahashi K, Umeguchi H, Watanabe N, Sato A, Takeda Y, Kimura S, Sueoka-Aragane N

OncoTargets and Therapy 2016, 9:6663-6668

Published Date: 27 October 2016

The medicinal fungus Antrodia cinnamomea regulates DNA repair and enhances the radiosensitivity of human esophageal cancer cells

Liu YM, Liu YK, Wang LW, Huang YC, Huang PI, Tsai TH, Chen YJ

OncoTargets and Therapy 2016, 9:6651-6661

Published Date: 27 October 2016

Investigation of cyclin D1 rs9344 G>A polymorphism in colorectal cancer: a meta-analysis involving 13,642 subjects

Qiu H, Cheng C, Wang Y, Kang M, Tang W, Chen S, Gu H, Liu C, Chen Y

OncoTargets and Therapy 2016, 9:6641-6650

Published Date: 27 October 2016

MLL1 promotes cervical carcinoma cell tumorigenesis and metastasis through interaction with β-catenin

Qiang R, Cai N, Wang X, Wang L, Cui K, Wang X, Li X

OncoTargets and Therapy 2016, 9:6631-6640

Published Date: 28 October 2016

BCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancer

Zhao H, Wang WL, Zhao QH, Hu GM, Deng KH, Liu YL

OncoTargets and Therapy 2016, 9:6619-6629

Published Date: 26 October 2016

Effective treatment with icotinib in lung adenocarcinoma with EGFR and ALK co-alterations and brain metastasis

Ye CY, Wang J, Zheng S, Chai Y

OncoTargets and Therapy 2016, 9:6605-6608

Published Date: 26 October 2016

The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer

Liu YY, Tu L, Wang L, Long J, Wang J, Wang Y, Luo F, Cao D

OncoTargets and Therapy 2016, 9:6581-6595

Published Date: 25 October 2016

Dysfunction of microRNA-32 regulates ubiquitin ligase FBXW7 in multiple myeloma disease

Hua J, Ding T, Yang L

OncoTargets and Therapy 2016, 9:6573-6579

Published Date: 25 October 2016

Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study

Cai CF, Sun JY, He Z, Lin HX, Liu FR, Wang Y

OncoTargets and Therapy 2016, 9:6569-6572

Published Date: 25 October 2016

Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy in Saudi Arabia

Maklad AM, Bayoumi Y, Senosy Hassan MA, Elawadi AA, AlHussain H, Elyamany A, Aldhahri SF, Al-Qahtani KH, AlQahtani M, Tunio MA

OncoTargets and Therapy 2016, 9:6561-6567

Published Date: 25 October 2016

Cell-free DNA as a diagnostic marker for cancer: current insights

Salvi S, Gurioli G, De Giorgi U, Conteduca V, Tedaldi G, Calistri D, Casadio V

OncoTargets and Therapy 2016, 9:6549-6559

Published Date: 25 October 2016

Novel therapeutic strategies for patients with triple-negative breast cancer

Zhang JF, Liu J, Wang Y, Zhang B

OncoTargets and Therapy 2016, 9:6519-6528

Published Date: 21 October 2016

Snake venom causes apoptosis by increasing the reactive oxygen species in colorectal and breast cancer cell lines

Al-Asmari AK, Riyasdeen A, Al-Shahrani MH, Islam M

OncoTargets and Therapy 2016, 9:6485-6498

Published Date: 20 October 2016

The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China

Xu J, Ding G, Zhang X, Jin B, Lou Y, Zhang Y, Wang H, Wu D, Han B

OncoTargets and Therapy 2016, 9:6479-6484

Published Date: 20 October 2016

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

Lorusso L, Pieruzzi L, Biagini A, Sabini E, Valerio L, Giani C, Passannanti P, Pontillo-Contillo B, Battaglia V, Mazzeo S, Molinaro E, Elisei R

OncoTargets and Therapy 2016, 9:6467-6477

Published Date: 20 October 2016

Dephosphorylated cofilin expression is associated with poor prognosis in cases of human breast cancer: a tissue microarray analysis

Maimaiti Y, Liu ZM, Tan J, Abudureyimu K, Huang BX, Liu CP, Guo YW, Wang CW, Nie X, Zhou J, Huang T

OncoTargets and Therapy 2016, 9:6461-6466

Published Date: 19 October 2016

Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER database

Lin MQ, Li YP, Wu SG, Sun JY, Lin HX, Zhang SY, He ZY

OncoTargets and Therapy 2016, 9:6435-6444

Published Date: 19 October 2016

Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma

Mürtz P, Penner AH, Pfeiffer AK, Sprinkart AM, Pieper CC, König R, Block W, Schild HH, Willinek WA, Kukuk GM

OncoTargets and Therapy 2016, 9:6425-6433

Published Date: 19 October 2016

Biomarker and competing endogenous RNA potential of tumor-specific long noncoding RNA in chromophobe renal cell carcinoma

He HT, Xu M, Kuang Y, Han XY, Wang MQ, Yang Q

OncoTargets and Therapy 2016, 9:6399-6406

Published Date: 18 October 2016

Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma

Sun P, Zhang F, Chen C, Ren C, Bi XW, Yang H, An X, Wang FH, Jiang WQ

OncoTargets and Therapy 2016, 9:6389-6397

Published Date: 17 October 2016

Synergistic suppression effect on tumor growth of ovarian cancer by combining cisplatin with a manganese superoxide dismutase-armed oncolytic adenovirus

Wang S, Shu J, Chen L, Chen X, Zhao J, Li S, Mou X, Tong X

OncoTargets and Therapy 2016, 9:6381-6388

Published Date: 17 October 2016

Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice

Passaro A, Lazzari C, Karachaliou N, Spitaleri G, Pochesci A, Catania C, Rosell R, de Marinis F

OncoTargets and Therapy 2016, 9:6361-6376

Published Date: 17 October 2016

Cancer: fundamentals behind pH targeting and the double-edged approach

Koltai T

OncoTargets and Therapy 2016, 9:6343-6360

Published Date: 17 October 2016

Rare frequency of gene variation and survival analysis in thymic epithelial tumors

Song Z, Yu X, Zhang Y

OncoTargets and Therapy 2016, 9:6337-6342

Published Date: 14 October 2016

hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy

Muratori L, Petroni G, Antonuzzo L, Boni L, Iorio J, Lastraioli E, Bartoli G, Messerini L, Di Costanzo F, Arcangeli A

OncoTargets and Therapy 2016, 9:6325-6332

Published Date: 14 October 2016

18F-fludrodeoxyglucose maximal standardized uptake value and metabolic tumor burden are associated with major chemotherapy-related tumor markers in NSCLC patients

Bai L, Guo CH, Wang JS, Liu X, Li Y, Li M, Guo YM, Duan XY

OncoTargets and Therapy 2016, 9:6315-6324

Published Date: 14 October 2016

Prognostic value of endocan expression in cancers: evidence from meta-analysis

Huang X, Chen C, Wang X, Zhang JY, Ren BH, Ma DW, Xia L, Xu XY, Xu L

OncoTargets and Therapy 2016, 9:6297-6304

Published Date: 13 October 2016

Primary adenoid cystic carcinoma of the trachea with thyroid invasion: a case report and literature review

Qi D, Feng L, Li J, Liu B, Zhang Q

OncoTargets and Therapy 2016, 9:6291-6296

Published Date: 13 October 2016

Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation

Gong ZJ, Guo W, Sun YF, Zhang X, Qiu SJ, Zhou J, Fan J, Yang XR

OncoTargets and Therapy 2016, 9:6281-6290

Published Date: 13 October 2016

CT-detected solitary thyroid calcification: an important imaging feature for papillary carcinoma

Yang T, Huang Y, Jing X, Gai X, Li W

OncoTargets and Therapy 2016, 9:6273-6279

Published Date: 13 October 2016

Locally advanced rectal cancer: management challenges

Kokelaar RF, Evans MD, Davies M, Harris DA, Beynon J

OncoTargets and Therapy 2016, 9:6265-6272

Published Date: 13 October 2016

Epidermal growth factor receptor and B7-H3 expression in esophageal squamous tissues correlate to patient prognosis

Song J, Shi W, Zhang Y, Sun M, Liang X, Zheng S

OncoTargets and Therapy 2016, 9:6257-6263

Published Date: 12 October 2016

Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas

De Vita A, Mercatali L, Recine F, Pieri F, Riva N, Bongiovanni A, Liverani C, Spadazzi C, Miserocchi G, Amadori D, Ibrahim T

OncoTargets and Therapy 2016, 9:6233-6246

Published Date: 11 October 2016

Differential expression of two activating transcription factor 5 isoforms in papillary thyroid carcinoma

Vicari L, La Rosa C, Forte S, Calabrese G, Colarossi C, Aiello E, Salluzzo S, Memeo L

OncoTargets and Therapy 2016, 9:6225-6231

Published Date: 11 October 2016

Influence of MDM2 polymorphisms on squamous cell carcinoma susceptibility: a meta-analysis

Yu H, Li H, Zhang J, Liu G

OncoTargets and Therapy 2016, 9:6211-6224

Published Date: 11 October 2016

miR-203 facilitates tumor growth and metastasis by targeting fibroblast growth factor 2 in breast cancer

He S, Zhang G, Dong H, Ma M, Sun Q

OncoTargets and Therapy 2016, 9:6203-6210

Published Date: 11 October 2016

Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells

Liu L, Wang ZH, Han J, Tang C, Chen N, Lin Z, Peng PJ

OncoTargets and Therapy 2016, 9:6195-6201

Published Date: 11 October 2016

Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma

Zhu S, Miao CW, Wang ZT, Peng L, Li B

OncoTargets and Therapy 2016, 9:6187-6193

Published Date: 13 October 2016

Invasive atypical thymic carcinoid: three case reports and literature review

Zhu S, Wang Z, Liu W, Zong S, Li B

OncoTargets and Therapy 2016, 9:6171-6176

Published Date: 11 October 2016

miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52

Chen H, Xu H, Meng YG, Zhang Y, Chen JY, Wei XN

OncoTargets and Therapy 2016, 9:6151-6160

Published Date: 11 October 2016

Chemotherapy combined with high-dose extended-field radiotherapy for stage I extranodal nasal-type natural killer/T-cell lymphoma

Luo J, Cao C, Zhu Y, Liu P, Liu L, Lu K, Zhang N, Zhou N

OncoTargets and Therapy 2016, 9:6147-6150

Published Date: 11 October 2016

Prognostic value of microRNA-126 and CRK expression in gastric cancer

Yue S, Shi H, Han J, Zhang T, Zhu W, Zhang D

OncoTargets and Therapy 2016, 9:6127-6135

Published Date: 11 October 2016

Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas

Auezova R, Ryskeldiev N, Doskaliyev A, Kuanyshev Y, Zhetpisbaev B, Aldiyarova N, Ivanova N, Akshulakov S, Auezova L

OncoTargets and Therapy 2016, 9:6111-6117

Published Date: 11 October 2016

Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer

He J, Jin Y, Chen Y, Yao HB, Xia YJ, Ma YY, Wang W, Shao QS

OncoTargets and Therapy 2016, 9:6099-6109

Published Date: 7 October 2016

Primary breast diffuse large B-cell lymphoma in the era of rituximab

Zhang N, Cao C, Zhu Y, Liu P, Liu L, Lu K, Luo J, Zhou N

OncoTargets and Therapy 2016, 9:6093-6097

Published Date: 7 October 2016

Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors

Fan Y, Ma K, Wang C, Ning J, Hu Y, Dong D, Dong X, Geng Q, Li E, Wu Y

OncoTargets and Therapy 2016, 9:6075-6082

Published Date: 6 October 2016

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

Van Der Steen N, Caparello C, Rolfo C, Pauwels P, Peters GJ, Giovannetti E

OncoTargets and Therapy 2016, 9:6065-6074

Published Date: 6 October 2016

Relationships between MGMT promoter methylation and gastric cancer: a meta-analysis

Yu D, Cao T, Han YD, Huang FS

OncoTargets and Therapy 2016, 9:6049-6057

Published Date: 5 October 2016

miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway

Shen B, Yu S, Zhang Y, Yuan Y, Li X, Zhong J, Feng J

OncoTargets and Therapy 2016, 9:6009-6019

Published Date: 3 October 2016

Infliximab enhances the therapeutic effects of 5-fluorouracil resulting in tumor regression in colon cancer

Liu F, Ai F, Tian L, Liu S, Zhao L, Wang X

OncoTargets and Therapy 2016, 9:5999-6008

Published Date: 3 October 2016

CX-5461 induces autophagy and inhibits tumor growth via mammalian target of rapamycin-related signaling pathways in osteosarcoma

Li L, Li Y, Zhao J, Fan S, Wang L, Li X

OncoTargets and Therapy 2016, 9:5985-5997

Published Date: 29 September 2016

Association analysis of DACT1 genetic variants and gastric cancer risk in a Chinese Han population: a case–control study

Huang C, Wang YN, Fan H, Ma X, Tang R, Huan XK, Zhu Y, Xu ZK, Xu H, Yang L

OncoTargets and Therapy 2016, 9:5975-5983

Published Date: 29 September 2016

Expression of OVOL2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma

Fu H, Qi L, Chen L, He Y, Zhang N, Guo H

OncoTargets and Therapy 2016, 9:5963-5973

Published Date: 29 September 2016

Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma

Wei GB, Lu YY, Liao RW, Chen QS, Zhang KQ

OncoTargets and Therapy 2016, 9:5955-5961

Published Date: 28 September 2016

BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects

Abedin SM, Boddy CS, Munshi HG

OncoTargets and Therapy 2016, 9:5943-5953

Published Date: 28 September 2016

MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches

Markowitz J, Abrams Z, Jacob NK, Zhang X, Hassani JN, Latchana N, Wei L, Regan KE, Brooks TR, Uppati SR, Levine KM, Bekaii-Saab T, Kendra KL, Lesinski GB, Howard JH, Olencki T, Payne PR, Carson WE III

OncoTargets and Therapy 2016, 9:5931-5941

Published Date: 29 September 2016

The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study

Jia YX, Li TF, Zhang DD, Fan ZM, Fan HJ, Yan J, Chen LJ, Tang H, Qin YR, Li XY

OncoTargets and Therapy 2016, 9:5919-5929

Published Date: 27 September 2016

Combination of cold atmospheric plasma and iron nanoparticles in breast cancer: gene expression and apoptosis study

Jalili A, Irani S, Mirfakhraie R

OncoTargets and Therapy 2016, 9:5911-5917

Published Date: 28 September 2016

Complications of ultrasound-guided percutaneous microwave ablation of renal cell carcinoma

Dong XJ, Li X, Yu J, Yu MA, Yu XL, Liang P

OncoTargets and Therapy 2016, 9:5903-5909

Published Date: 26 September 2016

Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study

Wang Y, Sun XR, Feng WM, Bao Y, Zheng YY

OncoTargets and Therapy 2016, 9:5897-5902

Published Date: 26 September 2016

Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification

Ren T, Lin SD, Wang ZF, Shang AJ

OncoTargets and Therapy 2016, 9:5883-5895

Published Date: 27 September 2016

Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy

Wang L, Bi XW, Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ

OncoTargets and Therapy 2016, 9:5875-5881

Published Date: 26 September 2016

The efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials

Huang J, Zhang Y, Sheng J, Zhang H, Fang W, Zhan J, Zhou T, Chen Y, Liu L, Zhang L

OncoTargets and Therapy 2016, 9:5867-5874

Published Date: 23 September 2016

Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date

Vachhani P, Chen H

OncoTargets and Therapy 2016, 9:5855-5866

Published Date: 23 September 2016

Nanoradiopharmaceuticals for breast cancer imaging: development, characterization, and imaging in inducted animals

Sarcinelli MA, Albernaz MS, Szwed M, Iscaife A, Leite KRM, Junqueira MS, Bernardes ES, da Silva EO, Tavares MIB, Santos-Oliveira R

OncoTargets and Therapy 2016, 9:5847-5854

Published Date: 23 September 2016

Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma

Barrios CH, Herchenhorn D, Chacón M, Cabrera-Galeana P, Sajben P, Zhang K

OncoTargets and Therapy 2016, 9:5839-5845

Published Date: 23 September 2016

An evaluation of the diagnostic efficacy of fine needle aspiration biopsy in patients operated for a thyroid nodular goiter

Janczak D, Pawlowski W, Dorobisz T, Janczak D, Dorobisz K, Leśniak M, Ziomek A, Chabowski M

OncoTargets and Therapy 2016, 9:5819-5823

Published Date: 22 September 2016

Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors

Yıldız Y, Sokmensuer C, Yalcin S

OncoTargets and Therapy 2016, 9:5809-5817

Published Date: 22 September 2016

Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer

Xing J, Luo Y, Wang X, Gao M, Sun M, Ding X, Fan T, Yu J

OncoTargets and Therapy 2016, 9:5803-5808

Published Date: 22 September 2016

A clear cell adenocarcinoma of the gallbladder with hepatoid differentiation: case report and review of literature

Zhang C, Zhang W, Mu D, Shi X, Zhao L

OncoTargets and Therapy 2016, 9:5797-5802

Published Date: 22 September 2016

Prognostic value of decreased microRNA-133a in solid cancers: a meta-analysis

Xiao J, Zou Y, Lu X, Xie B, Yu Q, He B, He B, Chen Q

OncoTargets and Therapy 2016, 9:5771-5779

Published Date: 21 September 2016

Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer

Wang X, Teng F, Kong L, Yu J

OncoTargets and Therapy 2016, 9:5761-5770

Published Date: 20 September 2016

The expression of NEDD9 and E-cadherin correlates with metastasis and poor prognosis in triple-negative breast cancer patients

Li P, Sun T, Yuan Q, Pan G, Zhang J, Sun D

OncoTargets and Therapy 2016, 9:5751-5759

Published Date: 19 September 2016

The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer

Jiang HC, Chen CS, Sun QM, Wu J, Qiu LJ, Gao CE, Liu WQ, Yang J, Jun N, Dong J

OncoTargets and Therapy 2016, 9:5737-5750

Published Date: 26 September 2016

Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study

Chen XR, Liang JZ, Ma SX, Fang WF, Zhou NN, Liao H, Li DL, Chen LK

OncoTargets and Therapy 2016, 9:5729-5736

Published Date: 19 September 2016

Proton beam therapy: clinical utility and current status in prostate cancer

Yamoah K, Johnstone PA

OncoTargets and Therapy 2016, 9:5721-5727

Published Date: 16 September 2016

A negative regulation loop of long noncoding RNA HOTAIR and p53 in non-small-cell lung cancer

Zhai N, Xia Y, Yin R, Liu J, Gao F

OncoTargets and Therapy 2016, 9:5713-5720

Published Date: 16 September 2016

Identifying module biomarkers from gastric cancer by differential correlation network

Liu X, Chang X

OncoTargets and Therapy 2016, 9:5701-5711

Published Date: 19 September 2016

MicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinoma

Lin K, Xu T, He BS, Pan YQ, Sun HL, Peng HX, Hu XX, Wang SK

OncoTargets and Therapy 2016, 9:5679-5692

Published Date: 15 September 2016

Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma

Doan HQ, Silapunt S, Migden MR

OncoTargets and Therapy 2016, 9:5671-5678

Published Date: 14 September 2016

Primary gastric anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma

Tian C, Zhang Y

OncoTargets and Therapy 2016, 9:5659-5661

Published Date: 13 September 2016

A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass

Takatori E, Shoji T, Takada A, Nagasawa T, Omi H, Kagabu M, Honda T, Miura F, Takeuchi S, Sugiyama T

OncoTargets and Therapy 2016, 9:5651-5657

Published Date: 13 September 2016

The association of PTEN hypermethylation and breast cancer: a meta-analysis

Luo S, Chen J, Mo X

OncoTargets and Therapy 2016, 9:5643-5650

Published Date: 12 September 2016

Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms

Ko SH, Baeg MK, Bae WJ, Kim P, Choi MG

OncoTargets and Therapy 2016, 9:5611-5617

Published Date: 9 September 2016

Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients

Suner A, Buyukhatipoglu H, Aktas G, Kus T, Ulaslı M, Oztuzcu S, Kalender ME, Sevinc A, Kul S, Camci C

OncoTargets and Therapy 2016, 9:5603-5609

Published Date: 9 September 2016

Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma

Wang J, Liu F, Ao P, Li X, Zheng H, Wu D, Zhang N, She J, Yuan J, Wu X

OncoTargets and Therapy 2016, 9:5597-5602

Published Date: 9 September 2016

Proton therapy for early stage prostate cancer: is there a case?

Chan TY, Tan PW, Tang JI

OncoTargets and Therapy 2016, 9:5577-5586

Published Date: 9 September 2016

The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis

Wei BJ, Yao MY, Xing CY, Wang W, Yao J, Hong Y, Liu Y, Fu PF

OncoTargets and Therapy 2016, 9:5567-5575

Published Date: 8 September 2016

Accelerated partial breast irradiation in an Asian population: dosimetric findings and preliminary results of a multicatheter interstitial program

Koh YV, Tan PW, Buhari SA, Iau P, Chan CW, Shen L, Tan SH, Tang JI

OncoTargets and Therapy 2016, 9:5561-5566

Published Date: 8 September 2016

Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer

Xian Y, Zhang S, Wang X, Qin J, Wang W, Wu H

OncoTargets and Therapy 2016, 9:5553-5560

Published Date: 7 September 2016

Novel chlorambucil-conjugated anionic linear-globular PEG-based second-generation dendrimer: in vitro/in vivo improved anticancer activity

Assadi A, Najafabadi VS, Shandiz SAS, Boroujeni AS, Ashrafi S, Vaziri AZ, Ghoreishi SM, Aghasadeghi MR, Ebrahimi SES, Pirali-Hamedani M, Ardestani MS

OncoTargets and Therapy 2016, 9:5531-5543

Published Date: 7 September 2016

Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980–2013): an analysis of population-based data in relation to socio-economic changes

Banas T, Juszczyk G, Pitynski K, Nieweglowska D, Ludwin A, Czerw A

OncoTargets and Therapy 2016, 9:5521-5530

Published Date: 7 September 2016

Polymorphisms in the XPC gene and gastric cancer susceptibility in a Southern Chinese population

Hua RX, Zhuo ZJ, Shen GP, Zhu J, Zhang SD, Xue WQ, Li XZ, Zhang PF, He J, Jia WH

OncoTargets and Therapy 2016, 9:5513-5519

Published Date: 7 September 2016

Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report

Garcia-Recio M, Martinez-Serra J, Bento L, Ramos R, Gines J, Daumal J, Sampol A, Gutierrez A

OncoTargets and Therapy 2016, 9:5507-5511

Published Date: 7 September 2016

Sunitinib: the antiangiogenic effects and beyond

Hao Z, Sadek I

OncoTargets and Therapy 2016, 9:5495-5505

Published Date: 8 September 2016

Osimertinib making a breakthrough in lung cancer targeted therapy

Zhang H

OncoTargets and Therapy 2016, 9:5489-5493

Published Date: 6 September 2016

Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancers

Jin CY, Zhang XY, Sun M, Zhang YF, Zhang GX, Wang B

OncoTargets and Therapy 2016, 9:5483-5488

Published Date: 6 September 2016

Association between insulin-like growth factor-binding protein-3 polymorphism -202 A/C and the risk of prostate cancer: a meta-analysis

Qin Z, Li X, Tang J, Jiang X, Yu Y, Wang C, Xu W, Hua Y, Yu B, Zhang W

OncoTargets and Therapy 2016, 9:5451-5459

Published Date: 6 September 2016

Identifying candidate agents for lung adenocarcinoma by walking the human interactome

Sun Y, Zhang R, Jiang Z, Xia R, Zhang J, Liu J, Chen F

OncoTargets and Therapy 2016, 9:5439-5450

Published Date: 1 September 2016

Clinical potential of necitumumab in non-small cell lung carcinoma

Genova C, Hirsch FR

OncoTargets and Therapy 2016, 9:5427-5437

Published Date: 31 August 2016

Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example

Gerratana L, De Maglio G, De Pellegrin A, Follador A, Rihawi K, Pizzolitto S, Puglisi F, Fasola G

OncoTargets and Therapy 2016, 9:5399-5404

Published Date: 30 August 2016

Long-term results of definitive concurrent chemoradiotherapy using S-1 in the treatment of geriatric patients with esophageal cancer

Lv S, Fang M, Yang J, Zhan W, Jia Y, Xu H, Song T

OncoTargets and Therapy 2016, 9:5389-5397

Published Date: 6 September 2016

Pitavastatin suppressed liver cancer cells in vitro and in vivo

You HY, Zhang WJ, Xie XM, Zheng ZH, Zhu HL, Jiang FZ

OncoTargets and Therapy 2016, 9:5383-5388

Published Date: 29 August 2016

Verteporfin, a suppressor of YAP–TEAD complex, presents promising antitumor properties on ovarian cancer

Feng J, Gou J, Jia J, Yi T, Cui T, Li Z

OncoTargets and Therapy 2016, 9:5371-5381

Published Date: 29 August 2016

Limb-salvage treatment of en-block resected distal femoral tumors with endoprosthesis of all-polyethylene tibial component: a 9-year follow-up study

Tang F, Zhou Y, Min L, Zhang WL, Shi R, Luo Y, Duan H, Tu CQ

OncoTargets and Therapy 2016, 9:5361-5369

Published Date: 13 September 2016

ALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway

Jiang J, Liu Y, Tang Y, Li L, Zeng R, Zeng S, Zhong M

OncoTargets and Therapy 2016, 9:5349-5360

Published Date: 29 August 2016

Knockdown of peroxisome proliferator-activated receptor gamma coactivator-1 alpha increased apoptosis of human endometrial cancer HEC-1A cells

Yang H, Yang R, Liu H, Ren Z, Wang C, Li D, Ma X

OncoTargets and Therapy 2016, 9:5329-5338

Published Date: 24 August 2016

Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma

Deng Y, Pang Q, Miao RC, Chen W, Zhou YY, Bi JB, Liu SS, Zhang JY, Qu K, Liu C

OncoTargets and Therapy 2016, 9:5317-5328

Published Date: 24 August 2016

Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma

Lin DZ, Qu N, Shi RL, Lu ZW, Ji QH, Wu WL

OncoTargets and Therapy 2016, 9:5307-5316

Published Date: 24 August 2016

Knockdown of Sall4 inhibits intrahepatic cholangiocarcinoma cell migration and invasion in ICC-9810 cells

Zhu L, Huang FZ, Deng G, Nie W, Huang W, Xu HB, Zheng SP, Yi ZJ, Wan T

OncoTargets and Therapy 2016, 9:5297-5305

Published Date: 24 August 2016

Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1

Nakahara Y, Takagi Y, Hosomi Y, Kagei A, Yamamoto T, Sawada T, Yomota M, Okuma Y, Mikura S, Okamura T

OncoTargets and Therapy 2016, 9:5287-5295

Published Date: 24 August 2016

Expression and prognostic significance of unique ULBPs in pancreatic cancer

Chen J, Zhu XX, Xu H, Fang HZ, Zhao JQ

OncoTargets and Therapy 2016, 9:5271-5279

Published Date: 25 August 2016

Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma

Guo HS, Xing YH, Mu AL, Li X, Li TS, Bian X, Yang CM, Zhang XL, Liu YF, Wang XG

OncoTargets and Therapy 2016, 9:5257-5270

Published Date: 25 August 2016

MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer

Liu D, Xia H, Wang F, Chen C, Long J

OncoTargets and Therapy 2016, 9:5245-5255

Published Date: 23 August 2016

Prognostic significance of TAZ expression in various cancers: a meta-analysis

Feng J, Ren P, Gou J, Li Z

OncoTargets and Therapy 2016, 9:5235-5244

Published Date: 23 August 2016

Association between BHMT gene rs3733890 polymorphism and cancer risk: evidence from a meta-analysis

Xu Y, Yan C, Hao Z, Zhou J, Fan S, Tai S, Yang C, Zhang L, Liang C

OncoTargets and Therapy 2016, 9:5225-5233

Published Date: 22 August 2016

Surgical procedures for papillary thyroid carcinoma located in the thyroid isthmus: an intention-to-treat analysis

Lei JY, Zhu JQ, Li ZH, Gong RX, Wei T

OncoTargets and Therapy 2016, 9:5209-5216

Published Date: 22 August 2016

Effect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKT

Zhang Y, Huang SN, Leng YH, Chen X, Liu TT, Wang HL, Wei FL, Luo DZ, Chen G, Wei ZX

OncoTargets and Therapy 2016, 9:5195-5202

Published Date: 29 August 2016

Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study

Huang WT, Wang HL, Yang H, Ren FH, Luo YH, Huang CQ, Liang YY, Liang HW, Chen G, Dang YW

OncoTargets and Therapy 2016, 9:5163-5180

Published Date: 22 August 2016

Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma

Qu Z, Yuan CH, Yin CQ, Guan Q, Chen H, Wang FB

OncoTargets and Therapy 2016, 9:5143-5152

Published Date: 18 August 2016

Co-expression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance

Jia W, Wang W, Ji CS, Niu JY, Lv YJ, Zhou HC, Hu B

OncoTargets and Therapy 2016, 9:5133-5142

Published Date: 18 August 2016

Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinoma

Lv X, Xia WX, Ke LR, Yang J, Qiu WZ, Yu YH, Liang H, Huang XJ, Liu GY, Zeng Q, Guo X, Xiang YQ

OncoTargets and Therapy 2016, 9:5123-5131

Published Date: 18 August 2016

Immune checkpoint inhibitors: the new frontier in non–small cell lung cancer treatment

El-Osta HE, Shahid K, Mills GM, Peddi P

OncoTargets and Therapy 2016, 9:5101-5116

Published Date: 16 August 2016

MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK

Cheng Y, Zhang X, Li P, Yang C, Tang J, Deng X, Yang X, Tao J, Lu Q, Li P

OncoTargets and Therapy 2016, 9:5091-5099

Published Date: 16 August 2016

Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel

Kus T, Aktas G, Kalender ME, Demiryurek AT, Ulasli M, Oztuzcu S, Sevinc A, Kul S, Camci C

OncoTargets and Therapy 2016, 9:5073-5080

Published Date: 12 August 2016

Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis

Huang WT, Chen ZX, He RQ, Wu YZ, Yin SY, Liang XN, Chen G, Yang H, Peng ZG, Yang LH

OncoTargets and Therapy 2016, 9:5061-5071

Published Date: 12 August 2016

Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells

Liu P, Zhang H, Wu X, Guo L, Wang F, Xia G, Chen B, Yin H, Wang Y, Li X

OncoTargets and Therapy 2016, 9:5049-5059

Published Date: 12 August 2016

New utility of an old marker: serum low-density lipoprotein predicts histopathological response of neoadjuvant chemotherapy in locally advanced gastric cancer

Zhou JC, Guo JF, Teng RY, Wang QC, Wang J, Wei Q, Li ZD, Shen JG, Wang LB

OncoTargets and Therapy 2016, 9:5041-5047

Published Date: 12 August 2016

PD-L1 expression in human cancers and its association with clinical outcomes

Wang X, Teng FF, Kong L, Yu JM

OncoTargets and Therapy 2016, 9:5023-5039

Published Date: 12 August 2016

Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk model

Shi RL, Qu N, Yang SW, Ma B, Lu ZW, Wen D, Sun GH, Wang Y, Ji QH

OncoTargets and Therapy 2016, 9:5015-5022

Published Date: 12 August 2016

Long noncoding RNA ZNFX1-AS1 suppresses growth of hepatocellular carcinoma cells by regulating the methylation of miR-9

Wang T, Ma SC, Qi X, Tang X, Cui D, Wang Z, Chi J, Li P, Zhai B

OncoTargets and Therapy 2016, 9:5005-5014

Published Date: 12 August 2016

Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer

Wang SW, Ren J, Yan YL, Xue CF, Tan L, Ma XW

OncoTargets and Therapy 2016, 9:4993-5003

Published Date: 16 August 2016

Successful treatment of angiosarcoma of the scalp with apatinib: a case report

Ji G, Hong L, Yang P

OncoTargets and Therapy 2016, 9:4989-4992

Published Date: 11 August 2016

Clinical implications of transforming growth factor-beta–induced gene-h3 protein expression in lung cancer

He CJ, Sun DW, Bai X, Li YB, Xu H, Xu SD

OncoTargets and Therapy 2016, 9:4983-4987

Published Date: 11 August 2016

ATG7 promotes the tumorigenesis of lung cancer but might be dispensable for prognosis predication: a clinicopathologic study

Sun SX, Wang ZH, Tang F, Hu PC, Yang ZT, Xue C, Gong J, Shi L, Xie CH

OncoTargets and Therapy 2016, 9:4975-4981

Published Date: 11 August 2016

Anorectal melanoma metastatic to the breast: a case report and review of the literature

Feng L, Qi DJ, Zhang QF

OncoTargets and Therapy 2016, 9:4969-4974

Published Date: 10 August 2016

Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases

Zhang Y, Luo J, He RQ, Huang WT, Li ZY, Li P, Dang YW, Chen G, Li SK

OncoTargets and Therapy 2016, 9:4959-4968

Published Date: 10 August 2016

Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned

Pinilla-Ibarz J, Sweet KL, Corrales-Yepez GM, Komrokji RS

OncoTargets and Therapy 2016, 9:4937-4957

Published Date: 10 August 2016

Antihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant setting

Seber S, Solmaz D, Yetisyigit T

OncoTargets and Therapy 2016, 9:4929-4935

Published Date: 9 August 2016

A rare case report of primary bone lymphoma and a brief review of the literature

Wang J, Fan S, Liu J, Song B,

OncoTargets and Therapy 2016, 9:4923-4928

Published Date: 9 August 2016

Incidental gallbladder cancer after cholecystectomy: 1990 to 2014

Dorobisz T, Dorobisz K, Chabowski M, Pawłowski W, Janczak D, Patrzałek D, Janczak D

OncoTargets and Therapy 2016, 9:4913-4916

Published Date: 8 August 2016

High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway

Yang XY, Zhang MY, Zhou Q, Wu SY, Zhao Y, Gu WY, Pan J, Cen JN, Chen ZX, Guo WG, Chen CS, Yan WH, Hu SY

OncoTargets and Therapy 2016, 9:4887-4899

Published Date: 8 August 2016

A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

Zhu L, Li X, Shen Y, Cao Y, Fang X, Chen J, Yuan Y

OncoTargets and Therapy 2016, 9:4879-4886

Published Date: 8 August 2016

Modulation of expression of the nuclear receptor NR0B2 (small heterodimer partner 1) and its impact on proliferation of renal carcinoma cells

Prestin K, Olbert M, Hussner J, Isenegger TL, Gliesche DG, Böttcher K, Zimmermann U, Meyer zu Schwabedissen HE

OncoTargets and Therapy 2016, 9:4867-4878

Published Date: 8 August 2016

Salvage therapies in relapsed and/or refractory myeloma: what is current and what is the future?

Thumallapally N, Yu H, Asti D, Vennepureddy A, Terjanian T

OncoTargets and Therapy 2016, 9:4843-4858

Published Date: 5 August 2016

PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis

Qian D, Cheng J, Ding X, Chen X, Chen X, Guan Y, Zhang B, Wang J, Er P, Qiu M, Zeng X, Guo Y, Wang H, Zhao L, Xie D, Yuan Z, Wang P, Pang Q

OncoTargets and Therapy 2016, 9:4821-4831

Published Date: 3 August 2016

A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer

Karakas Y, Esin E, Lacin S, Ceyhan K, Heper AO, Yalcin S

OncoTargets and Therapy 2016, 9:4815-4820

Published Date: 3 August 2016

Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients

Gu X, Gao XS, Xiong W, Guo W, Han L, Bai Y, Peng C, Cui M, Xie M

OncoTargets and Therapy 2016, 9:4805-4813

Published Date: 2 August 2016

Cutaneous basal cell carcinoma arising within a keloid scar: a case report

Goder M, Kornhaber R, Bordoni D, Winkler E, Haik J, Tessone A

OncoTargets and Therapy 2016, 9:4793-4796

Published Date: 2 August 2016

Comparison of planning target volumes based on three-dimensional and four-dimensional CT imaging of thoracic esophageal cancer

Wang W, Li JB, Zhang YJ, Shao Q, Xu M, Fan TY, Wang JZ

OncoTargets and Therapy 2016, 9:4785-4791

Published Date: 2 August 2016

Induction of apoptosis by Armillaria mellea constituent armillarikin in human hepatocellular carcinoma

Chen YJ, Chen CC, Huang HL

OncoTargets and Therapy 2016, 9:4773-4783

Published Date: 1 August 2016

Docetaxel-loaded lipid microbubbles combined with ultrasound-triggered microbubble destruction for targeted tumor therapy in MHCC-H cells

Zhang Y, Chang R, Li MQ, Zhao K, Zheng HZ, Zhou XD

OncoTargets and Therapy 2016, 9:4763-4771

Published Date: 1 August 2016

Risk factors and patterns of lymph node involvement in primary gastric large B-cell lymphoma: implications for target definition

Zhang X, Wang P, Zhao L, Yuan Z, Wang P

OncoTargets and Therapy 2016, 9:4757-4762

Published Date: 29 July 2016

Oncological outcome after lung metastasis in patients presenting with localized chondrosarcoma at extremities: Tokai Musculoskeletal Oncology Consortium study

Nakamura T, Matsumine A, Yamada S, Tsukushi S, Kawanami K, Ohno T, Katagiri H, Sugiura H, Yamada K, Yamada Y, Sudo A, Nishida Y

OncoTargets and Therapy 2016, 9:4747-4751

Published Date: 29 July 2016

RBBP6: a potential biomarker of apoptosis induction in human cervical cancer cell lines

Moela P, Motadi LR

OncoTargets and Therapy 2016, 9:4721-4735

Published Date: 29 July 2016

Primary yolk sac tumor of the gluteus: a case report and literature review

Li B, Jiang QQ, Zhang ST, Zhou Y, Zhang QF, OuYang L

OncoTargets and Therapy 2016, 9:4715-4719

Published Date: 2 August 2016

MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4

Yu M, Lin Y, Zhou Y, Jin H, Hou B, Wu Z, Li Z, Jian Z, Sun J

OncoTargets and Therapy 2016, 9:4705-4714

Published Date: 29 July 2016

Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy

Nemecek R, Berkovcova J, Radova L, Kazda T, Mlcochova J, Vychytilova-Faltejskova P, Slaby O, Svoboda M

OncoTargets and Therapy 2016, 9:4695-4703

Published Date: 28 July 2016

The impact of the extent of surgical resection on survival of gastric cancer patients

Angelov KG, Vasileva MB, Grozdev KS, Toshev SY, Sokolov MB, Todorov GT

OncoTargets and Therapy 2016, 9:4687-4694

Published Date: 28 July 2016

Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma

Azzariti A, Brunetti O, Porcelli L, Graziano G, Iacobazzi RM, Signorile M, Scarpa A, Lorusso V, Silvestris N

OncoTargets and Therapy 2016, 9:4681-4686

Published Date: 28 July 2016

Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer

Liu C, Huang Z, Wang QS, Sun B, Ding LJ, Meng XY, Wu SK

OncoTargets and Therapy 2016, 9:4653-4660

Published Date: 27 July 2016

Clinical implication of long noncoding RNA 91H expression profile in osteosarcoma patients

Xia WK, Lin QF, Shen D, Liu ZL, Su J, Mao WD

OncoTargets and Therapy 2016, 9:4645-4652

Published Date: 26 July 2016

MiR-203 is involved in the laryngeal carcinoma pathogenesis via targeting VEGFA and Cox-2

Xu L, Shen B, Chen TT, Dong P

OncoTargets and Therapy 2016, 9:4629-4637

Published Date: 26 July 2016

Identification of crucial microRNAs and genes in hypoxia-induced human lung adenocarcinoma cells

Geng Y, Deng L, Su D, Xiao J, Ge D, Bao Y, Jing H

OncoTargets and Therapy 2016, 9:4605-4616

Published Date: 25 July 2016

Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma

Sun Y, Hou L, Yang Y, Xie H, Yang Y, Li Z, Zhao H, Gao W, Su B

OncoTargets and Therapy 2016, 9:4583-4591

Published Date: 25 July 2016

Network analysis reveals potential markers for pediatric adrenocortical carcinoma

Kulshrestha A, Suman S, Ranjan R

OncoTargets and Therapy 2016, 9:4569-4581

Published Date: 26 July 2016

Green synthesis, characterization, and anticancer activity of hyaluronan/zinc oxide nanocomposites

Namvar F, Azizi S, Rahman HS, Mohamad R, Rasedee A, Soltani M, Rahim RA

OncoTargets and Therapy 2016, 9:4549-4559

Published Date: 26 July 2016

Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies

Ma JT, Sun X, Huang LT, Xiong ZC, Yuan M, Zhang SL, Han CB

OncoTargets and Therapy 2016, 9:4517-4526

Published Date: 22 July 2016

MicroRNA-490 inhibits tumorigenesis and progression in breast cancer

Zhao L, Zheng XY

OncoTargets and Therapy 2016, 9:4505-4516

Published Date: 22 July 2016

Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studies

Jiang X, Zhang M, Bai XY, Li S, Wu H

OncoTargets and Therapy 2016, 9:4491-4503

Published Date: 22 July 2016

Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis

Luo T, Chen J, Liu JJ, Li H, You XM, Wang HL, Zhu SL, Li LQ

OncoTargets and Therapy 2016, 9:4483-4489

Published Date: 21 July 2016

Clinical significance of TIPE expression in gastric carcinoma

Hu R, Qiu X, Hong S, Meng L, Hong X, Qiu J, Yang J, Zhuang G, Liu Z

OncoTargets and Therapy 2016, 9:4473-4481

Published Date: 25 July 2016

Mast cells positive to tryptase, endothelial cells positive to protease-activated receptor-2, and microvascular density correlate among themselves in hepatocellular carcinoma patients who have undergone surgery

Ammendola M, Sacco R, Sammarco G, Piardi T, Zuccalà V, Patruno R, Zullo A, Zizzo N, Nardo B, Marech I, Crovace A, Gadaleta CD, Pessaux P, Ranieri G

OncoTargets and Therapy 2016, 9:4465-4471

Published Date: 21 July 2016

Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia

Chen YJ, Fang LW, Su WC, Hsu WY, Yang KC, Huang HL

OncoTargets and Therapy 2016, 9:4453-4464

Published Date: 20 July 2016

Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results

Pham PV, Le HT, Vu BT, Pham VQ, Le PM, Phan NLC, Trinh NV, Nguyen HTL, Nguyen ST, Nguyen TL, Phan NK

OncoTargets and Therapy 2016, 9:4441-4451

Published Date: 21 July 2016

Congenital anomalies of the genitourinary system can help in diagnosis of the primary site of metastatic cancer: a case report and a review of the literature

Deptala A, Romanowicz A, Czerw A, Walecki J, Rogowski W, Nasierowska-Guttmejer A

OncoTargets and Therapy 2016, 9:4435-4440

Published Date: 20 July 2016

JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway

Liu Y, Wang YR, Ding GH, Yang TS, Yao L, Hua J, He ZG, Qian MP

OncoTargets and Therapy 2016, 9:4425-4433

Published Date: 20 July 2016

Functions and mechanisms of long noncoding RNAs in lung cancer

Peng ZZ, Zhang CF, Duan CJ

OncoTargets and Therapy 2016, 9:4411-4424

Published Date: 20 July 2016

FAT10 is associated with the malignancy and drug resistance of non-small cell lung cancer

Xue F, Zhu L, Meng QW, Wang L, Chen XS, Zhao YB, Xing Y, Wang XY, Cai L

OncoTargets and Therapy 2016, 9:4397-4409

Published Date: 19 July 2016

The expression status of TRX, AR, and cyclin D1 correlates with clinicopathological characteristics and ER status in breast cancer

Huang WS, Nie WW, Zhang WW, Wang YR, Zhu A, Guan XX

OncoTargets and Therapy 2016, 9:4377-4385

Published Date: 19 July 2016

Coffee consumption and risk of hepatocellular carcinoma: a meta-analysis of eleven epidemiological studies

Bai K, Cai Q, Jiang Y, Lv L

OncoTargets and Therapy 2016, 9:4369-4375

Published Date: 19 July 2016

Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer

Ricciardi GR, Franchina T, Russo A, Schifano S, Ferraro G, Adamo V

OncoTargets and Therapy 2016, 9:4351-4355

Published Date: 21 July 2016

Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction

Lu X, Duan L, Xie H, Lu X, Lu D, Lu D, Jiang N, Chen Y

OncoTargets and Therapy 2016, 9:4343-4349

Published Date: 18 July 2016

Association between CD14 SNP -159 C/T and gastric cancer: an independent case–control study and an updated meta-analysis

Gong AM, Li XY, Xie YQ, Jia ZD, Li YX, Zou YY, Xu CQ, Wang ZY

OncoTargets and Therapy 2016, 9:4337-4342

Published Date: 18 July 2016

Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance

Pyszniak M, Tabarkiewicz J, Łuszczki JJ

OncoTargets and Therapy 2016, 9:4323-4336

Published Date: 18 July 2016

Lung cancer with concurrent EGFR mutation and ROS1 rearrangement: a case report and review of the literature

Zhu YC, Xu CW, Ye XQ, Yin MX, Zhang JX, Du KQ, Zhang ZH, Hu J

OncoTargets and Therapy 2016, 9:4301-4305

Published Date: 15 July 2016

Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma

Tang WW, Liu ZH, Yang TX, Wang HJ, Cao XF

OncoTargets and Therapy 2016, 9:4289-4293

Published Date: 14 July 2016

Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies

Wu JY, Hu LR, Chen MY, Cao WJ, Chen HC, He TP

OncoTargets and Therapy 2016, 9:4277-4288

Published Date: 14 July 2016

Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma

Sun P, Chen C, Zhang F, Yang H, Bi XW, An X, Wang FH, Jiang WQ

OncoTargets and Therapy 2016, 9:4257-4264

Published Date: 13 July 2016

Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus

Zhang YF, Wei W, Wang JH, Xu L, Jian PE, Xiao CZ, Zhong XP, Shi M, Guo RP

OncoTargets and Therapy 2016, 9:4239-4246

Published Date: 12 July 2016

Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo

Zhang H, Chen R, Yang S, Liu W, Li K, Zhang H, Zhu X, Chen B

OncoTargets and Therapy 2016, 9:4215-4224

Published Date: 11 July 2016

Survival prognostic factors for patients with synchronous brain oligometastatic non-small-cell lung carcinoma receiving local therapy

Bai H, Xu J, Yang H, Jin B, Lou Y, Wu D, Han B

OncoTargets and Therapy 2016, 9:4207-4213

Published Date: 11 July 2016

Decreased expression of SLC39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer

Xu XM, Wang CG, Zhu YD, Chen WH, Shao SL, Jiang FN, Liao QD

OncoTargets and Therapy 2016, 9:4197-4205

Published Date: 11 July 2016

Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation

Zhu Y, Li M, Kong L, Yu J

OncoTargets and Therapy 2016, 9:4187-4196

Published Date: 11 July 2016

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial

von Au A, Milloth E, Diel I, Stefanovic S, Hennigs A, Wallwiener M, Heil J, Golatta M, Rom J, Sohn C, Schneeweiss A, Schuetz F, Domschke C

OncoTargets and Therapy 2016, 9:4173-4180

Published Date: 8 July 2016

Polymorphism in IGFBP3 gene is associated with prostate cancer risk: an updated meta-analysis

Qie YK, Nian XW, Liu XS, Hu HL, Zhang CW, Xie LG, Han RF, Wu CL, Xu Y

OncoTargets and Therapy 2016, 9:4163-4171

Published Date: 7 July 2016

Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer

Teng Y, Wang ZT, Ma L, Zhang L, Guo Y, Gu M, Wang ZY, Wang Y, Yue W

OncoTargets and Therapy 2016, 9:4151-4162

Published Date: 7 July 2016

Fundamental effects of PD-1 antibody on the body: a brief report

Wang W, Liu B, Liu G, Guo W

OncoTargets and Therapy 2016, 9:4137-4141

Published Date: 7 July 2016

Long-term survival and prognosis for primary clear cell carcinoma of the liver after hepatectomy

Chen ZS, Zhu SL, Qi LN, Li LQ

OncoTargets and Therapy 2016, 9:4129-4135

Published Date: 6 July 2016

Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer

Liu H, Huang C, Wu L, Wen B

OncoTargets and Therapy 2016, 9:4121-4127

Published Date: 6 July 2016

Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer

Kotaka M, Ikeda F, Tsujie M, Yoshioka S, Nakamoto Y, Ishii T, Kyogoku T, Kato T, Tsuji A, Kobayashi M

OncoTargets and Therapy 2016, 9:4113-4120

Published Date: 7 July 2016

Targeted therapy for localized non-small-cell lung cancer: a review

Paleiron N, Bylicki O, André M, Rivière E, Grassin F, Robinet G, Chouaïd C

OncoTargets and Therapy 2016, 9:4099-4104

Published Date: 5 July 2016

The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases

Pieper CC, Meyer C, Sprinkart AM, Block W, Ahmadzadehfar H, Schild HH, Mürtz P, Kukuk GM

OncoTargets and Therapy 2016, 9:4089-4098

Published Date: 5 July 2016

LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo

Chen L, Yang HX, Xiao YB, Tang XX, Li YQ, Han QQ, Fu JP, Yang YY, Zhu YC

OncoTargets and Therapy 2016, 9:4075-4087

Published Date: 4 July 2016

Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis

De Santis S, Borghesi C, Ricciardi S, Giovannoni D, Fulvi A, Migliorino MR, Marcassa C

OncoTargets and Therapy 2016, 9:4043-4052

Published Date: 4 July 2016

Icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study

He W, Zhang Y, Xiong Y, Dai FJ, Fan QX

OncoTargets and Therapy 2016, 9:4037-4041

Published Date: 1 July 2016

Chromatin assembly factor 1, subunit A (P150) facilitates cell proliferation in human hepatocellular carcinoma

Xu M, Jia Y, Liu Z, Ding L, Tian R, Gu H, Wang Y, Zhang H, Tu K, Liu Q

OncoTargets and Therapy 2016, 9:4023-4035

Published Date: 1 July 2016

Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis

Wei B, Yang S, Zhang B, Feng Y

OncoTargets and Therapy 2016, 9:4015-4022

Published Date: 1 July 2016

ALK-positive anaplastic large cell lymphoma with soft tissue involvement in a young woman

Gao KH, Li HT, Huang CH, Li HZ, Fang J, Tian C

OncoTargets and Therapy 2016, 9:3993-3996

Published Date: 1 July 2016

Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancreatic stump and other stump

Zeng XL, Wang HH, Meng MB, Wu ZQ, Song YC, Zhuang HQ, Qian D, Li FT, Zhao LJ, Yuan ZY, Wang P

OncoTargets and Therapy 2016, 9:3985-3992

Published Date: 30 June 2016

Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway

Yang H, Yang R, Liu H,α Ren Z, Kong F, Li D, Ma X

OncoTargets and Therapy 2016, 9:3963-3973

Published Date: 30 June 2016

Pri-let-7a-1 rs10739971 polymorphism is associated with gastric cancer prognosis and might affect mature let-7a expression

Li Y, Xu Q, Liu J, He C, Yuan Q, Xing C, Yuan Y

OncoTargets and Therapy 2016, 9:3951-3962

Published Date: 4 July 2016

The roles of serum CXCL16 in circulating Tregs and gastrointestinal stromal tumor cells

Xing YN, Zhang JY, Xu HM

OncoTargets and Therapy 2016, 9:3939-3949

Published Date: 29 June 2016

Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma

Yan Y, Xie M, Zhang L, Zhou X, Xie H, Zhou L, Zheng S, Wang W

OncoTargets and Therapy 2016, 9:3925-3937

Published Date: 30 June 2016

Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review

Xia QS, Xu J, Chen HY, Gao YZ, Gong FL, Hu LY, Yang L

OncoTargets and Therapy 2016, 9:3917-3923

Published Date: 29 June 2016

Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma

Zhang B, Li R, Chang CX, Han Y, Shi SB, Tian J

OncoTargets and Therapy 2016, 9:3901-3906

Published Date: 29 June 2016

Association between pesticide exposure and risk of kidney cancer: a meta-analysis

Xie B, Hu YF, Liang Z, Liu B, Zheng XY, Xie LP

OncoTargets and Therapy 2016, 9:3893-3900

Published Date: 28 June 2016

Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysis

Zhang CX, Wang SY, Chen SQ, Yang SL, Wan L, Xiong B

OncoTargets and Therapy 2016, 9:3883-3891

Published Date: 27 June 2016

Internal mammary sentinel lymph node biopsy: abandon or persist?

Qiu PF, Liu YB, Wang YS

OncoTargets and Therapy 2016, 9:3879-3882

Published Date: 27 June 2016

The clinical significance of γ-catenin in acute myeloid leukemia

Xu J, Wu W, Shen W, Liu P

OncoTargets and Therapy 2016, 9:3861-3871

Published Date: 27 June 2016

Downregulation of human Wnt3 in gastric cancer suppresses cell proliferation and induces apoptosis

Wang HS, Nie XB, Wu RB, Yuan HW, Ma YH, Liu XL, Zhang JY, Deng XL, Na Q, Jin HY, Bian YC, Gao YM, Wang YD, Chen WD

OncoTargets and Therapy 2016, 9:3849-3860

Published Date: 27 June 2016

LXY6090 – a novel manassantin A derivative – limits breast cancer growth through hypoxia-inducible factor-1 inhibition

Lai F, Liu Q, Liu X, Ji M, Xie P, Chen X

OncoTargets and Therapy 2016, 9:3829-3840

Published Date: 24 June 2016

Prognostic significance of metastatic lymph node ratio in squamous cell carcinoma of the cervix

Li C, Liu WH, Cheng YF

OncoTargets and Therapy 2016, 9:3791-3797

Published Date: 23 June 2016

Percutaneous microwave ablation combined with synchronous transcatheter arterial chemoembolization for the treatment of colorectal liver metastases: results from a follow-up cohort

Wu ZB, Si ZM, Qian S, Liu LX, Qu XD, Zhou B, Zhang W, Wang GZ, Liu R, Wang JH

OncoTargets and Therapy 2016, 9:3783-3789

Published Date: 23 June 2016

Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case–control studies

Zhang M, Fang T, Wang K, Mei H, Lv Z, Wang F, Cai Z, Liang C

OncoTargets and Therapy 2016, 9:3727-3737

Published Date: 22 June 2016

Correlation of primary middle and distal esophageal cancers motion with surrounding tissues using four-dimensional computed tomography

Wang W, Li J, Zhang Y, Shao Q, Xu M, Guo B, Shang D

OncoTargets and Therapy 2016, 9:3705-3710

Published Date: 22 June 2016

Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment

Bonanno L, Zago G, Marulli G, Del Bianco P, Schiavon M, Pasello G, Polo V, Canova F, Tonetto F, Loreggian L, Rea F, Conte PF, Favaretto A

OncoTargets and Therapy 2016, 9:3671-3681

Published Date: 21 June 2016

Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study

Ma X, Wang J, Xu Y, Zhang W, Liu J, Cao X, He A, Wang F, Gu L, Lei B, Wang J

OncoTargets and Therapy 2016, 9:3661-3669

Published Date: 20 June 2016

Potential role of S-adenosylmethionine in osteosarcoma development

Shi H, Mu WD, Zhang B, Meng T, Zhang ST, Zhou DS

OncoTargets and Therapy 2016, 9:3653-3659

Published Date: 20 June 2016

MicroRNA-190 regulates FOXP2 genes in human gastric cancer

Jia WZ, Yu T, An Q, Yang H, Zhang Z, Liu X, Xiao G

OncoTargets and Therapy 2016, 9:3643-3651

Published Date: 20 June 2016

The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma

Shen ED, Liu B, Yu XS, Xiang ZF, Huang HY

OncoTargets and Therapy 2016, 9:3633-3642

Published Date: 20 June 2016

A systematic review and meta-analysis of the risk of diarrhea associated with vandetanib treatment in carcinoma patients

Huo Z, Yu S, Hong S, Cao X, Xiu L, Liao Z, Li Y, Xiao H

OncoTargets and Therapy 2016, 9:3621-3631

Published Date: 20 June 2016

Roles of microRNA-99 family in human glioma

Zhang MY, Guo Y, Wu J, Chen FH, Dai ZJ, Fan SS, Li PC, Song T

OncoTargets and Therapy 2016, 9:3613-3619

Published Date: 20 June 2016

XuefuZhuyu Tang exerts antitumor effects by inhibiting glioma cell metastasis and invasion via regulating tumor microenvironment

Liu JM, Zhang J, Huang LW, Zhu XH, Chen W, Hu P

OncoTargets and Therapy 2016, 9:3603-3612

Published Date: 17 June 2016

High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis

Chen XY, Ru GQ, Ma YY, Xie J, Chen WY, Wang HJ, Wang SB, Li L, Jin KT, He XL, Mou XZ

OncoTargets and Therapy 2016, 9:3595-3602

Published Date: 16 June 2016

MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by targeting the PTEN/AKT pathway

Zhang H, Cao H, Xu D, Zhu K

OncoTargets and Therapy 2016, 9:3579-3588

Published Date: 16 June 2016

1p/19q codeletion and RET rearrangements in small-cell lung cancer

Lu H, Xu H, Xie F, Qin J, Han N, Fan Y, Mao W

OncoTargets and Therapy 2016, 9:3571-3577

Published Date: 16 June 2016

Association between GSTP1 Ile105Val polymorphism and urinary system cancer risk: evidence from 51 studies

Zhang Y, Yuan Y, Chen Y, Wang Z, Li F, Zhao Q

OncoTargets and Therapy 2016, 9:3565-3569

Published Date: 15 June 2016

miR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1

Zhang C, Chen X, Chen X, Wang X, Ji A, Jiang L, Sang F, Li F

OncoTargets and Therapy 2016, 9:3555-3563

Published Date: 15 June 2016

Intensity-modulated radiotherapy for gliomas: dosimetric effects of changes in gross tumor volume on organs at risk and healthy brain tissue

Yang Z, Zhang Z, Wang X, Hu Y, Lyu Z, Huo L, Wei R, Fu J, Hong J

OncoTargets and Therapy 2016, 9:3545-3554

Published Date: 15 June 2016

MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor

Xiao Y, Tian Q, He J, Huang M, Yang C, Gong L

OncoTargets and Therapy 2016, 9:3535-3544

Published Date: 15 June 2016

Cigarette smoking and risk of adult glioma: a meta-analysis of 24 observational studies involving more than 2.3 million individuals

Li HX, Peng XX, Zong Q, Zhang K, Wang MX, Liu YZ, Han GL

OncoTargets and Therapy 2016, 9:3511-3523

Published Date: 14 June 2016

Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy

Jiang P, Wang P, Sun X, Yuan Z, Zhan R, Ma X, Li W

OncoTargets and Therapy 2016, 9:3501-3509

Published Date: 13 June 2016

PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis

Han F, Hu R, Yang H, Liu J, Sui J, Xiang X, Wang F, Chu L, Song S

OncoTargets and Therapy 2016, 9:3485-3492

Published Date: 13 June 2016

Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells

Liu Y, Sun B, Liu T, Zhao X, Wang X, Li Y, Meng J, Gu Q, Liu F, Dong X, Liu P, Sun R, Zhao N

OncoTargets and Therapy 2016, 9:3473-3484

Published Date: 13 June 2016

Transcription factor activity of estrogen receptor α activation upon nonylphenol or bisphenol A treatment enhances the in vitro proliferation, invasion, and migration of neuroblastoma cells

Ma H, Yao Y, Wang C, Zhang L, Cheng L, Wang Y, Wang T, Liang E, Jia H, Ye Q, Hou M, Feng F

OncoTargets and Therapy 2016, 9:3451-3463

Published Date: 13 June 2016

Administration of polysaccharide from Panax notoginseng prolonged the survival of H22 tumor-bearing mice

Li HY, Gu LL, Zhong YY, Chen YJ, Zhang L, Zhang AR, Sobol RW, Chen T, Li J

OncoTargets and Therapy 2016, 9:3433-3441

Published Date: 8 June 2016

GPR30 decreases with vascular aging and promotes vascular smooth muscle cells maintaining differentiated phenotype and suppressing migration via activation of ERK1/2

Huang F, Yin J, Li K, Li Y, Qi H, Fang L, Yuan C, Liu W, Wang M, Li X

OncoTargets and Therapy 2016, 9:3415-3422

Published Date: 7 June 2016

The prognostic roles of ALDH1 isoenzymes in gastric cancer

Li K, Guo X, Wang Z, Li X, Bu Y, Bai X, Zheng L, Huang Y

OncoTargets and Therapy 2016, 9:3405-3414

Published Date: 7 June 2016

CEBPA mutations in patients with de novo acute myeloid leukemia: data analysis in a Chinese population

Su L, Gao SJ, Liu XL, Tan YH, Wang L, Li W

OncoTargets and Therapy 2016, 9:3399-3403

Published Date: 3 June 2016

A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors

Jiang Z, Zhang J, Li Z, Liu Y, Wang D, Han G

OncoTargets and Therapy 2016, 9:3387-3398

Published Date: 3 June 2016

Normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumors

Pop LA, Pileczki V, Cojocneanu-Petric RM, Petrut B, Braicu C, Jurj AM, Buiga R, Achimas-Cadariu P, Berindan-Neagoe I

OncoTargets and Therapy 2016, 9:3369-3380

Published Date: 2 June 2016

Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression

Zhang W, Zhou H, Yu Y, Li J, Li H, Jiang D, Chen Z, Yang D, Xu Z, Yu Z

OncoTargets and Therapy 2016, 9:3359-3368

Published Date: 2 June 2016

Significant association between long non-coding RNA HOTAIR polymorphisms and cancer susceptibility: a meta-analysis

Zhang J, Liu X, You LH, Zhou RZ

OncoTargets and Therapy 2016, 9:3335-3343

Published Date: 1 June 2016

Synthetic treatment of intracranial peripheral primitive neuroectodermal tumor with multiple metastasis: a case report

Zhang Y, Li HS, Li ZJ, Liu M, Yang L, Fan LY, Huang CS, Li BS

OncoTargets and Therapy 2016, 9:3327-3333

Published Date: 2 June 2016

The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer

Choi YJ, Chang WJ, Shin SW, Park KH, Kim ST, Kim YH

OncoTargets and Therapy 2016, 9:3307-3312

Published Date: 1 June 2016

Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer

Qiao XJ, Zhai XR, Wang JH, Zhao XT, Yang XJ, Lv JL, Ma L, Zhang LN, Wang Y, Zhang SC, Yue WT

OncoTargets and Therapy 2016, 9:3299-3305

Published Date: 1 June 2016

Clinical significance of B7-H6 protein expression in astrocytoma

Guo JG, Guo CC, He ZQ, Liu ZG, Wang Y, Mou YG

OncoTargets and Therapy 2016, 9:3291-3297

Published Date: 31 May 2016

MiR-502-3P suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SET

Jin H, Yu M, Lin Y, Hou B, Wu Z, Li Z, Sun J

OncoTargets and Therapy 2016, 9:3281-3289

Published Date: 31 May 2016

Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma

Nema R, Vishwakarma S, Agarwal R, Panday RK, Kumar A

OncoTargets and Therapy 2016, 9:3269-3280

Published Date: 31 May 2016

The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis

Chen ZL, Shen YW, Li ST, Li CL, Zhang LX, Yang J, Lv M, Lin YY, Wang X, Yang J

OncoTargets and Therapy 2016, 9:3233-3247

Published Date: 30 May 2016

The evaluative value of Sema3C and MFN2 co-expression detected by immunohistochemistry for prognosis in hepatocellular carcinoma patients after hepatectomy

Feng X, Zhu K, Liu J, Chen J, Tang J, Liang Y, Jin R, Liang X, Cai X

OncoTargets and Therapy 2016, 9:3213-3221

Published Date: 30 May 2016

Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis

Chen XW, Zhao JH, Li AL, Gao P, Sun JX, Song YX, Liu JJ, Chen P, Wang ZN

OncoTargets and Therapy 2016, 9:3205-3212

Published Date: 27 May 2016

Delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a review

Zhao F, Li MH, Kong L, Zhang GL, Yu JM

OncoTargets and Therapy 2016, 9:3197-3204

Published Date: 27 May 2016

Profile of nivolumab in the treatment of metastatic squamous non-small-cell lung cancer

Ang YLE, Lim JS, Soo RA

OncoTargets and Therapy 2016, 9:3187-3195

Published Date: 30 May 2016

Clinical features and treatment of squamous cell carcinoma of the breast

Zhang XM, Zhang BZ, Zang FL, Zhao LJ, Yuan ZY, Wang P

OncoTargets and Therapy 2016, 9:3181-3185

Published Date: 27 May 2016

Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy

Chen Z, Huang K, Lu Z, Deng S, Xiong J, Huang J, Li X, Tang F, Wang Z, Sun H, Wang L, Zhou S, Wang X, Jia Y, Hu T, Gui J, Wan D, Ma D, Li S, Wang S

OncoTargets and Therapy 2016, 9:3171-3179

Published Date: 27 May 2016

Do signal transduction cascades influence survival in triple-negative breast cancer? A preliminary study

Mumm JN, Kölbl AC, Jeschke U, Andergassen U

OncoTargets and Therapy 2016, 9:3163-3169

Published Date: 26 May 2016

Anti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiency

Bian X, Wu P, Sha H, Qian H, Wang Q, Cheng L, Yang Y, Yang M, Liu B

OncoTargets and Therapy 2016, 9:3153-3162

Published Date: 27 May 2016

Effect of YAP1 silencing on esophageal cancer

Zhao J, Li X, Yang Y, Zhu D, Zhang C, Liu D, Wu K, Zhao S

OncoTargets and Therapy 2016, 9:3137-3146

Published Date: 26 May 2016

Prognostic significance of neutrophil-to-lymphocyte ratio in rectal cancer: a meta-analysis

Dong YW, Shi YQ, He LW, Su PZ

OncoTargets and Therapy 2016, 9:3127-3134

Published Date: 25 May 2016

MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1

Li Y, Zeng C, Tu M, Jiang W, Dai Z, Hu Y, Deng Z, Xiao W

OncoTargets and Therapy 2016, 9:3101-3111

Published Date: 24 May 2016

Analysis of prostate bed motion using an endorectal balloon and cone beam computed tomography during postprostatectomy radiotherapy

Joo JH, Kim YJ, Kim YS, Cho YP, Lee HY, Jeong CY, Kwak J, Cho BC

OncoTargets and Therapy 2016, 9:3095-3100

Published Date: 24 May 2016

Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301

Han K, Meng W, Zhang JJ, Zhou Y, Wang YL, Su Y, Lin SC, Gan ZH, Sun YN, Min DL

OncoTargets and Therapy 2016, 9:3085-3094

Published Date: 26 May 2016

Long noncoding RNA ANRIL could be transactivated by c-Myc and promote tumor progression of non-small-cell lung cancer

Lu Y, Zhou XH, Xu L, Rong CH, Shen C, Bian W

OncoTargets and Therapy 2016, 9:3077-3084

Published Date: 24 May 2016

Restoration of miR-20a expression suppresses cell proliferation, migration, and invasion in HepG2 cells

Chen GS, Zhou N, Li JQ, Li T, Zhang ZQ, Si ZZ

OncoTargets and Therapy 2016, 9:3067-3076

Published Date: 27 May 2016

URG4 expression is a novel prognostic factor for the progression of nasopharyngeal carcinoma and overall survival of patient

Yu G, Meng QX, Zhang T, Zeng C, He BF, Zhang SS

OncoTargets and Therapy 2016, 9:3059-3065

Published Date: 23 May 2016

Prognostic role of miR-9 expression in various human malignant neoplasms: a meta-analysis

Liu XD, Luo ZY, Peng HX, Jiang H, Xu L

OncoTargets and Therapy 2016, 9:3039-3047

Published Date: 23 May 2016

Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports

Sun HL, Pan YQ, He BS, Nie ZL, Lin K, Peng HX, Cho WC, Wang SK

OncoTargets and Therapy 2016, 9:3017-3023

Published Date: 20 May 2016

Targeting gastrointestinal stromal tumors: the role of regorafenib

Schroeder B, Li Z, Cranmer LD, Jones RL, Pollack SM

OncoTargets and Therapy 2016, 9:3009-3016

Published Date: 20 May 2016

Onivyde for the therapy of multiple solid tumors

Zhang H

OncoTargets and Therapy 2016, 9:3001-3007

Published Date: 20 May 2016

Association between cooking oil fume exposure and lung cancer among Chinese nonsmoking women: a meta-analysis

Xue Y, Jiang Y, Jin S, Li Y

OncoTargets and Therapy 2016, 9:2987-2992

Published Date: 19 May 2016

Integrated miRNA-risk gene-pathway pair network analysis provides prognostic biomarkers for gastric cancer

Cai H, Xu J, Han Y, Lu Z, Han T, Ding Y, Ma L

OncoTargets and Therapy 2016, 9:2975-2986

Published Date: 19 May 2016

Non-small-cell lung cancer cells combat epidermal growth factor receptor tyrosine kinase inhibition through immediate adhesion-related responses

Wang HY, Hsu MK, Wang KH, Tseng CP, Chen FC, Hsu JTA

OncoTargets and Therapy 2016, 9:2961-2973

Published Date: 19 May 2016

Low-grade nasopharyngeal papillary adenocarcinoma: a case report and review of the literature

Wang XL, Yan HJ, Luo YJ, Fan TY

OncoTargets and Therapy 2016, 9:2955-2959

Published Date: 18 May 2016

Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors

Wu X, Zhang H, Salmani JMM, Fu R, Chen B

OncoTargets and Therapy 2016, 9:2935-2943

Published Date: 17 May 2016

Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma

Xu J, Liu X, Yang S, Zhang X, Shi Y

OncoTargets and Therapy 2016, 9:2911-2917

Published Date: 17 May 2016

Antitumor effect of manumycin on colorectal cancer cells by increasing the reactive oxygen species production and blocking PI3K-AKT pathway

Zhang JY, Jiang H, Xie L, Hu J, Li L, Yang M, Cheng L, Liu BR, Qian XP

OncoTargets and Therapy 2016, 9:2885-2895

Published Date: 24 May 2016

Recent advancements in erythrocytes, platelets, and albumin as delivery systems

Xu PP, Wang RJ, Wang XH, Ouyang J

OncoTargets and Therapy 2016, 9:2873-2884

Published Date: 17 May 2016

miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma

Liu C, Li M, Hu Y, Shi N, Yu H, Liu H, Lian H

OncoTargets and Therapy 2016, 9:2865-2871

Published Date: 19 May 2016

Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway

Sun Y, Tao C, Huang X, He H, Shi H, Zhang Q, Wu H

OncoTargets and Therapy 2016, 9:2845-2853

Published Date: 12 May 2016

Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?

Shakespeare TP, Wilcox SW, Aherne NJ

OncoTargets and Therapy 2016, 9:2819-2824

Published Date: 11 May 2016

Sophoridinol derivative 05D induces tumor cells apoptosis by topoisomerase1-mediated DNA breakage

Zhao W, Zhang C, Bi C, Ye C, Song D, Liu X, Shao R

OncoTargets and Therapy 2016, 9:2805-2817

Published Date: 11 May 2016

Silencing of carboxypeptidase E inhibits cell proliferation, tumorigenicity, and metastasis of osteosarcoma cells

Fan SL, Li X, Li LM, Wang LG, Du ZZ, Yang Y, Zhao JS, Li Y

OncoTargets and Therapy 2016, 9:2795-2803

Published Date: 10 May 2016

Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors

Barth RF, Wu G, Meisen WH, Nakkula RJ, Yang W, Huo T, Kellough DA, Kaumaya P, Turro C, Agius LM, Kaur B

OncoTargets and Therapy 2016, 9:2769-2781

Published Date: 10 May 2016

Orbital metastasis as the initial presentation of lung adenocarcinoma: a case report

Sun LC, Qi YL, Sun XD, Yu JM, Meng X

OncoTargets and Therapy 2016, 9:2743-2748

Published Date: 9 May 2016

miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer

Molinari C, Salvi S, Foca F, Teodorani N, Saragoni L, Puccetti M, Passardi A, Tamberi S, Avanzolini A, Lucci E, Calistri D

OncoTargets and Therapy 2016, 9:2735-2742

Published Date: 6 May 2016

Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma

Banzi M, De Blasio S, Lallas A, Longo C, Moscarella E, Alfano R, Argenziano G

OncoTargets and Therapy 2016, 9:2725-2733

Published Date: 6 May 2016

Ruguo key genes and tumor driving factors identification of bladder cancer based on the RNA-seq profile

Zhang M, Li H, Zou D, Gao J

OncoTargets and Therapy 2016, 9:2717-2723

Published Date: 5 May 2016

A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy

Wang J, Tian Y, Tang Y, Wang X, Li N, Ren H, Fang H, Feng Y, Wang S, Song Y, Liu Y, Wang W, Li Y, Jin J

OncoTargets and Therapy 2016, 9:2701-2707

Published Date: 5 May 2016

HOXB7 as a promising molecular marker for metastasis in cancers: a meta-analysis

Liu FT, Ou YX, Zhang GP, Qiu C, Luo HL, Zhu PQ

OncoTargets and Therapy 2016, 9:2693-2699

Published Date: 6 May 2016

Shorter telomere length of T-cells in peripheral blood of patients with lung cancer

Qian Y, Ding T, Wei L, Cao S, Yang L

OncoTargets and Therapy 2016, 9:2675-2682

Published Date: 4 May 2016

Emerging treatment options for myelofibrosis: focus on pacritinib

Chow V, Weissman A, O’Connell CL, Mehrvar A, Akhtari M

OncoTargets and Therapy 2016, 9:2655-2665

Published Date: 4 May 2016

Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis

Liu YX, Wang XS, Wang YF, Hu XC, Yan JQ, Zhang YL, Wang W, Yang RJ, Feng YY, Gao SG, Feng XS

OncoTargets and Therapy 2016, 9:2649-2654

Published Date: 4 May 2016

miR-125b inhibited epithelialal–mesenchymal transition of triple-negative breast cancer by targeting MAP2K7

Hong LQ, Pan F, Jiang HF, Zhang LH, Liu YH, Cai CS, Hua CZ, Luo X, Sun JH, Chen ZJ

OncoTargets and Therapy 2016, 9:2639-2648

Published Date: 4 May 2016

Tissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer – a meta-analysis

Chen Z, Liu H, Jin W, Ding Z, Zheng S, Yu Y

OncoTargets and Therapy 2016, 9:2615-2624

Published Date: 4 May 2016

Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study

Lin KY, Cheng SM, Tsai SL, Tsai JY, Lin CH, Cheung CHA

OncoTargets and Therapy 2016, 9:2601-2613

Published Date: 3 May 2016

Correlation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcinoma patients

Tang Q, Hu QY, Piao YF, Hua YH

OncoTargets and Therapy 2016, 9:2585-2591

Published Date: 2 May 2016

Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches

Pathan AAK, Panthi B, Khan Z, Koppula PR, Alanazi MS, Sachchidanand, Parine NR, Chourasia M

OncoTargets and Therapy 2016, 9:2575-2584

Published Date: 2 May 2016

Stathmin1 increases radioresistance by enhancing autophagy in non-small-cell lung cancer cells

Zhang X, Ji JF, Yang Y, Zhang J, Shen LF

OncoTargets and Therapy 2016, 9:2565-2574

Published Date: 29 April 2016

Haploidentical hematopoietic stem cell transplantation without total body irradiation for pediatric acute leukemia: a single-center experience

Mu YS, Qin MQ, Wang B, Li SD, Zhu GH, Zhou X, Yang J, Wang K, Lin W, Zheng HY

OncoTargets and Therapy 2016, 9:2557-2563

Published Date: 2 May 2016

Prognostic significance of miR-126 in various cancers: a meta-analysis

Dong Y, Fu C, Guan H, Zhang Z, Zhou T, Li BS

OncoTargets and Therapy 2016, 9:2547-2555

Published Date: 28 April 2016

Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen

Salacz ME, Kast RE, Saki N, Brüning A, Karpel-Massler G, Halatsch ME

OncoTargets and Therapy 2016, 9:2535-2545

Published Date: 27 April 2016

Midazolam regulated caspase pathway, endoplasmic reticulum stress, autophagy, and cell cycle to induce apoptosis in MA-10 mouse Leydig tumor cells

So EC, Chen YC, Wang SC, Wu CC, Huang MC, Lai MS, Pan BS, Kang FC, Huang BM

OncoTargets and Therapy 2016, 9:2519-2533

Published Date: 27 April 2016

Paeoniflorin prevents hypoxia-induced epithelial–mesenchymal transition in human breast cancer cells

Zhou Z, Wang S, Song C, Hu Z

OncoTargets and Therapy 2016, 9:2511-2518

Published Date: 27 April 2016

Diagnostic value of BRAFV600E-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis

Su X, Jiang X, Xu X, Wang W, Teng X, Shao A, Teng L

OncoTargets and Therapy 2016, 9:2495-2509

Published Date: 27 April 2016

Tandem mass spectrometry-based newborn screening strategy could be used to facilitate rapid and sensitive lung cancer diagnosis

Huang T, Cao YF, Zeng J, Dong J, Sun XY, Chen JX, Gao P

OncoTargets and Therapy 2016, 9:2479-2487

Published Date: 26 April 2016

Serum biomarker panels for diagnosis of gastric cancer

Tong WH, Ye F, He L, Cui LF, Cui M, Hu Y, Li W, Jiang J, Zhang DY, Suo J

OncoTargets and Therapy 2016, 9:2455-2463

Published Date: 26 April 2016

Irreversible electroporation: state of the art

Wagstaff PGK, Buijs M, van den Bos W, de Bruin DM, Zondervan PJ, de la Rosette JJMCH, Laguna Pes MP

OncoTargets and Therapy 2016, 9:2437-2446

Published Date: 22 April 2016

Metadherin regulates epithelial–mesenchymal transition in carcinoma

Wang Z, Tang ZY, Yin Z, Wei YB, Liu LF, Yan B, Zhou KQ, Nian YQ, Gao YL, Yang JR

OncoTargets and Therapy 2016, 9:2429-2436

Published Date: 21 April 2016

Complete transthoracic resection of giant posterior mediastinal goiter: case report and review of surgical strategies

Zhao H, Ren D, Liu Y, Li X, Wu Y, Chen G, Chen J

OncoTargets and Therapy 2016, 9:2415-2419

Published Date: 22 April 2016

Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases

He YY, Sun WW, Wang Y, Ren SX, Li XF, Li JY, Rivard CJ, Zhou CC, Hirsch FR

OncoTargets and Therapy 2016, 9:2409-2414

Published Date: 21 April 2016

AEG-1 as a predictor of sensitivity to neoadjuvant chemotherapy in advanced epithelial ovarian cancer

Wang Y, Jin X, Song H, Meng F

OncoTargets and Therapy 2016, 9:2385-2392

Published Date: 20 April 2016

ROI for outlining an entire tumor is a reliable approach for quantification of lung cancer tumor vascular parameters using CT perfusion

Ma E, Ren A, Gao B, Yang M, Zhao Q, Wang W, Li K

OncoTargets and Therapy 2016, 9:2377-2384

Published Date: 27 April 2016

Vitamin D postpones the progression of epithelial ovarian cancer induced by 7, 12-dimethylbenz [a] anthracene both in vitro and in vivo

Liu LZ, Hu ZY, Zhang HM, Hou YF, Zhang ZL, Zhou GM, Li BY

OncoTargets and Therapy 2016, 9:2365-2375

Published Date: 19 April 2016

Oral vinorelbine: a feasible and safe partner for radiotherapy in the treatment of locally advanced non-small cell lung cancer

Perri F, Lazzari G, Della Vittoria Scarpati G, Silvano G

OncoTargets and Therapy 2016, 9:2359-2364

Published Date: 19 April 2016

Massive chest wall resection and reconstruction for malignant disease

Foroulis CN, Kleontas AD, Tagarakis G, Nana C, Alexiou I, Grosomanidis V, Tossios P, Papadaki E, Kioumis I, Baka S, Zarogoulidis P, Anastasiadis K

OncoTargets and Therapy 2016, 9:2349-2358

Published Date: 19 April 2016

The predictive and prognostic values of factors associated with visceral pleural involvement in resected lung adenocarcinomas

Zhang HB, Lu C, Lu YJ, Yu B, Lv FZ, Zhu ZH

OncoTargets and Therapy 2016, 9:2337-2348

Published Date: 20 April 2016

Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer

He Q, Xu Q, Wu W, Chen L, Sun W, Ying JE

OncoTargets and Therapy 2016, 9:2329-2335

Published Date: 20 April 2016

Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancer

Zheng WQ, Jiang CH, Li RF

OncoTargets and Therapy 2016, 9:2317-2327

Published Date: 18 April 2016

MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial–mesenchymal transition

Jiang SB, He XJ, Xia YJ, Hu WJ, Luo JG, Zhang J, Tao HQ

OncoTargets and Therapy 2016, 9:2305-2315

Published Date: 18 April 2016

Carvacrol suppresses proliferation and invasion in human oral squamous cell carcinoma

Dai W, Sun C, Huang S, Zhou Q

OncoTargets and Therapy 2016, 9:2297-2304

Published Date: 18 April 2016

Clinicopathological characteristics of patients with HER2-positive breast cancer and the efficacy of trastuzumab in the People’s Republic of China

Zhou P, Jiang YZ, Hu X, Sun W, Liu YR, Liu F, Luo RC, Shao ZM

OncoTargets and Therapy 2016, 9:2287-2295

Published Date: 18 April 2016

Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes

Sochacki AL, Fischer MA, Savona MR

OncoTargets and Therapy 2016, 9:2273-2286

Published Date: 15 April 2016

Smad3 and phospho-Smad3 are potential markers of invasive nonfunctioning pituitary adenomas

Liu C, Li Z, Wu D, Li C, Zhang Y

OncoTargets and Therapy 2016, 9:2265-2271

Published Date: 15 April 2016

DUSP4/MKP2 overexpression is associated with BRAFV600E mutation and aggressive behavior of papillary thyroid cancer

Ma B, Shi RL, Yang SW, Zhou L, Qu N, Liao T, Wang Y, Wang YL, Ji QH

OncoTargets and Therapy 2016, 9:2255-2263

Published Date: 15 April 2016

Esophageal cancer stem cells and implications for future therapeutics

Qian X, Tan C, Wang F, Yang B, Ge Y, Guan Z, Cai J

OncoTargets and Therapy 2016, 9:2247-2254

Published Date: 19 April 2016

Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma

Wu H, Shi XL, Zhang HJ, Song QJ, Yang XB, Hu WD, Mei GL, Chen X, Mao QS, Chen Z

OncoTargets and Therapy 2016, 9:2227-2236

Published Date: 18 April 2016

BC200 LncRNA a potential predictive marker of poor prognosis in esophageal squamous cell carcinoma patients

Zhao RH, Zhu CH, Li XK, Cao W, Zong H, Cao XG, Hu HY

OncoTargets and Therapy 2016, 9:2221-2226

Published Date: 15 April 2016

Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer

Fu X, Chen G, Cai ZD, Wang C, Liu ZZ, Lin ZY, Wu YD, Liang YX, Han ZD, Liu JC, Zhong WD

OncoTargets and Therapy 2016, 9:2211-2220

Published Date: 15 April 2016

Short- and long-term outcomes of laparoscopic surgery vs open surgery for transverse colon cancer: a retrospective multicenter study

Kim JW, Kim JY, Kang BM, Lee BH, Kim BC, Park JH

OncoTargets and Therapy 2016, 9:2203-2209

Published Date: 15 April 2016

Ectopic adrenocorticotropic hormone syndrome caused by neuroendocrine tumors of the thymus: 30-year experience with 16 patients at a single institute in the People’s Republic of China

Chen YY, Li SQ, Liu HS, Qin YZ, Li L, Huang C, Bi YL, Meng YX, He J, Zhou XY, Ma DJ

OncoTargets and Therapy 2016, 9:2193-2201

Published Date: 26 April 2016

Association between two interleukin-2 gene polymorphisms and cancer susceptibility: a meta-analysis

Zhang M, Tan X, Huang J, Xie L, Wang H, Shi J, Lu W, Lv Z, Mei H, Liang C

OncoTargets and Therapy 2016, 9:2181-2192

Published Date: 19 April 2016

Identification of HSPA8 as a candidate biomarker for endometrial carcinoma by using iTRAQ-based proteomic analysis

Shan N, Zhou W, Zhang S, Zhang Y

OncoTargets and Therapy 2016, 9:2169-2179

Published Date: 13 April 2016

Effects of exercise intervention in breast cancer survivors: a meta-analysis of 33 randomized controlled trails

Zhu G, Zhang X, Wang Y, Xiong H, Zhao Y, Sun F

OncoTargets and Therapy 2016, 9:2153-2168

Published Date: 13 April 2016

Metastasis-associated lung adenocarcinoma transcript 1 promotes the proliferation of chondro­sarcoma cell via activating Notch-1 signaling pathway

Xu FQ, Zhang ZQ, Fang YC, Li XL, Sun Y, Xiong CZ, Yan LQ, Wang Q

OncoTargets and Therapy 2016, 9:2143-2151

Published Date: 13 April 2016

Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinoma

Zeng FC, Zeng MQ, Huang L, Li YL, Gao BM, Chen JJ, Xue RZ, Tang ZY

OncoTargets and Therapy 2016, 9:2131-2141

Published Date: 12 April 2016

ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen

Sensorn I, Sukasem C, Sirachainan E, Chamnanphon M, Pasomsub E, Trachu N, Supavilai P, Pinthong D, Wongwaisayawan S

OncoTargets and Therapy 2016, 9:2121-2129

Published Date: 12 April 2016

Simple models based on gamma-glutamyl transpeptidase and platelets for predicting survival in hepatitis B-associated hepatocellular carcinoma

Pang Q, Bi JB, Wang ZX, Xu XS, Qu K, Miao RC, Chen W, Zhou YY, Liu C

OncoTargets and Therapy 2016, 9:2099-2109

Published Date: 12 April 2016

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes

Sun Y, Joks M, Xu LM, Chen XL, Qian D, You JQ, Yuan ZY

OncoTargets and Therapy 2016, 9:2069-2080

Published Date: 6 April 2016

Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects

Yu XJ, Li YL, Yu YD, Lei JH, Wan GX, Cao FJ

OncoTargets and Therapy 2016, 9:2049-2056

Published Date: 6 April 2016

Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma

Chen R, Allibone S, Bartlett NL, Brice P, Chen A, Pose K, Rich L, Bonthapally V, Garfin PM, Fanale M

OncoTargets and Therapy 2016, 9:2027-2034

Published Date: 6 April 2016

Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients

Wang Y, Cheng Y, Yu G, Jia B, Hu Z, Zhang L

OncoTargets and Therapy 2016, 9:1997-2005

Published Date: 5 April 2016

Detection of EML4-ALK fusion gene and features associated with EGFR mutations in Chinese patients with non-small-cell lung cancer

Wen MM, Wang XJ, Sun Y, Xia JH, Fan LB, Xing H, Zhang ZP, Li XF

OncoTargets and Therapy 2016, 9:1989-1995

Published Date: 5 April 2016

Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer

Ma YM, Zhao S

OncoTargets and Therapy 2016, 9:1981-1988

Published Date: 4 April 2016

Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis

Zhao XT, Liu FZ, Zhang Y, Li PH

OncoTargets and Therapy 2016, 9:1961-1968

Published Date: 4 April 2016

Profile of ramucirumab in the treatment of metastatic non-small-cell lung cancer

Cooper MR, Binkowski C, Hartung J, Towle J

OncoTargets and Therapy 2016, 9:1953-1960

Published Date: 4 April 2016

A genetic variant in large tumor suppressor kinase 2 of Hippo signaling pathway contributes to prognosis of hepatocellular carcinoma

Shen LL, Wen J, Zhao TT, Hu ZB, Song C, Gu DY, He ML, Lee NP, Xu Z, Chen JF

OncoTargets and Therapy 2016, 9:1945-1951

Published Date: 4 April 2016

Advances in targeted and immunobased therapies for colorectal cancer in the genomic era

Seow HF, Yip WK, Fifis T

OncoTargets and Therapy 2016, 9:1899-1920

Published Date: 31 March 2016

Prognostic significance of circulating tumor cells in esophageal carcinoma: a meta-analysis

Qiao GL, Qi WX, Jiang WH, Chen Y, Ma LJ

OncoTargets and Therapy 2016, 9:1889-1897

Published Date: 31 March 2016

Concurrent cisplatin-based chemoradiotherapy versus exclusive radiotherapy in high-risk cervical cancer: a meta-analysis

Meng XY, Liao Y, Liu XP, Li S, Shi MJ, Zeng XT

OncoTargets and Therapy 2016, 9:1875-1888

Published Date: 31 March 2016

Pragmatic medicine in solid cancer: a translational alternative to precision medicine

Brábek J, Rosel D, Fernandes M

OncoTargets and Therapy 2016, 9:1839-1855

Published Date: 5 April 2016

Influence of negative lymph node in No 7 on survival of patients with middle thoracic esophageal squamous cell carcinoma

Zhang JL, Heng XY, Luo Y, Fu QX, Li ZR, Che FY, Li BS

OncoTargets and Therapy 2016, 9:1831-1837

Published Date: 30 March 2016

Tumoral angiogenesis in both adrenal adenomas and nonadenomas: a promising computed tomography biomarker for diagnosis

Wang X, Li K, Sun H, Zhao J, Zhang Z, Zheng L, Li W, Bai R, Zhang G

OncoTargets and Therapy 2016, 9:1823-1830

Published Date: 30 March 2016

Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2

Liu J, Wang H, Wang Y, Li Z, Pan Y, Liu Q, Yang M, Wang J

OncoTargets and Therapy 2016, 9:1813-1822

Published Date: 29 March 2016

Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway

Zhang HJ, Tao J, Sheng L, Hu X, Rong RM, Xu M, Zhu TY

OncoTargets and Therapy 2016, 9:1801-1812

Published Date: 29 March 2016

Comorbidity as an independent prognostic factor in elderly patients with peripheral T-cell lymphoma

Zhao H, Wang T, Wang Y, Yu Y, Wang X, Zhao Z, Yang H, Yan B, Wu X, Da W, Zhang Y

OncoTargets and Therapy 2016, 9:1795-1799

Published Date: 24 March 2016

miR-98 functions as a tumor suppressor in salivary adenoid cystic carcinomas

Liu XN, Zhang WC, Guo H, Yue JL, Zhuo SS

OncoTargets and Therapy 2016, 9:1777-1786

Published Date: 23 March 2016

Tremelimumab: research and clinical development

Comin-Anduix B, Escuin-Ordinas H, Ibarrondo FJ

OncoTargets and Therapy 2016, 9:1767-1776

Published Date: 23 March 2016

A meta-analysis of clinical trials assessing the effect of radiofrequency ablation for breast cancer

Chen J, Zhang C, Li F, Xu L, Zhu H, Wang S, Liu X, Zha X, Ding Q, Ling L, Zhou W, Sun X

OncoTargets and Therapy 2016, 9:1759-1766

Published Date: 23 March 2016

Efficacy of multimodal treatment for leptomeningeal metastases in a lung cancer harboring an EGFR mutation

Morichika D, Kubo T, Gotoda H, Tamura T, Ohashi K, Hotta K, Tabata M, Kurozumi K, Tanimoto M, Kiura K

OncoTargets and Therapy 2016, 9:1753-1758

Published Date: 22 March 2016

Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes

Wang T, Liu Y, Zhou B, Wang Z, Liang NC, Zhang YD, Dong ZH, Li J

OncoTargets and Therapy 2016, 9:1735-1741

Published Date: 22 March 2016

Clinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosis

Li JJ, Liang L, Liu YR, Luo YH, Liang XN, Luo DZ, Feng ZB, Dang YW, Yang LH, Chen G

OncoTargets and Therapy 2016, 9:1721-1734

Published Date: 21 March 2016

The interleukin-18 gene promoter -607 A/C polymorphism contributes to non-small-cell lung cancer risk in a Chinese population

Jia YC, Zang AM, Jiao SC, Chen SM, Yan F

OncoTargets and Therapy 2016, 9:1715-1719

Published Date: 21 March 2016

Up-regulated expression of phospholipase C, β1 is associated with tumor cell proliferation and poor prognosis in hepatocellular carcinoma

Li J, Zhao X, Wang D, He W, Zhang S, Cao W, Huang Y, Wang L, Zhou S, Luo K

OncoTargets and Therapy 2016, 9:1697-1706

Published Date: 21 March 2016

Statin use and mortality of patients with prostate cancer: a meta-analysis

Meng Y, Liao YB, Xu P, Wei WR, Wang J

OncoTargets and Therapy 2016, 9:1689-1696

Published Date: 21 March 2016

Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis

Shen H, Zhan M, Wang W, Yang D, Wang J

OncoTargets and Therapy 2016, 9:1679-1688

Published Date: 22 March 2016

High expression of Sox10 correlates with tumor aggressiveness and poor prognosis in human nasopharyngeal carcinoma

Zhao Y, Liu ZG, Tang J, Zou RF, Chen XY, Jiang GM, Qiu YF, Wang H

OncoTargets and Therapy 2016, 9:1671-1677

Published Date: 21 March 2016

Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study

Gao S, Zhu G, Lin Y, Fan X, Qian P, Zhu J, Yu Y

OncoTargets and Therapy 2016, 9:1657-1670

Published Date: 21 March 2016

Upregulation of metastasis-associated gene 2 promotes cell proliferation and invasion in nasopharyngeal carcinoma

Wu MH, Ye XX, Deng XB, Wu YX, Li XF, Zhang L

OncoTargets and Therapy 2016, 9:1647-1656

Published Date: 18 March 2016

Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review

Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito KI, Tateishi A, Yoshizawa A, Takayama F

OncoTargets and Therapy 2016, 9:1641-1646

Published Date: 18 March 2016

miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1

Huang YW, Liu JT, Fan LL, Wang F, Yu HQ, Wei W, Sun GP

OncoTargets and Therapy 2016, 9:1623-1633

Published Date: 17 March 2016

The CT and US features of Ewing’s sarcoma/primary neuroectodermal tumor of the kidney: two case reports and review of literature

Zhang DF, Li ZH, Gao DP, Yang GJ, Ding YY, Wang GS, Dong XX

OncoTargets and Therapy 2016, 9:1599-1603

Published Date: 17 March 2016

Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma

Zhao J, Chen F, Zhou Q, Pan W, Wang X, Xu J, Ni L, Yang H

OncoTargets and Therapy 2016, 9:1589-1597

Published Date: 17 March 2016

The efficacy and safety of nivolumab in the treatment of advanced melanoma: a meta-analysis of clinical trials

Jin CH, Zhang XL, Zhao KL, Xu J, Zhao M, Xu XH

OncoTargets and Therapy 2016, 9:1571-1578

Published Date: 16 March 2016

Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data

Chen C, Zhang LG, Liu J, Han H, Chen N, Yao AL, Kang SS, Gao WX, Shen H, Zhang LJ, Li YP, Cao FH, Li ZG

OncoTargets and Therapy 2016, 9:1545-1557

Published Date: 16 March 2016

Comparison of single agent versus combined chemotherapy in previously treated patients with advanced urothelial carcinoma: a meta-analysis

Wu XJ, Zhi Y, He P, Zhou XZ, Zheng J, Chen ZW, Zhou ZS

OncoTargets and Therapy 2016, 9:1535-1543

Published Date: 15 March 2016

miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22

Xiao J, Li Y, Zhang W, Jiang Y, Du B, Tan Y

OncoTargets and Therapy 2016, 9:1525-1534

Published Date: 16 March 2016

Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma

Fu H, Ma C, Guan W, Cheng W, Feng F, Wang H

OncoTargets and Therapy 2016, 9:1519-1523

Published Date: 15 March 2016

Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor

Yang CJ, Tsai MJ, Hung JY, Tsai YM, Lee JY, Chou SH, Liu TC, Shen MC, Huang MS, Chong IW

OncoTargets and Therapy 2016, 9:1511-1518

Published Date: 15 March 2016

Association between APE1 Asp148Glu polymorphism and the risk of urinary cancers: a meta-analysis of 18 case–control studies

Zhong JH, Zhao Z, Liu J, Yu HL, Zhou JY, Shi R

OncoTargets and Therapy 2016, 9:1499-1510

Published Date: 15 March 2016

Prognostic role of hypoxia-inducible factor-1 alpha expression in osteosarcoma: a meta-analysis

Ren HY, Zhang YH, Li HY, Xie T, Sun LL, Zhu T, Wang SD, Ye ZM

OncoTargets and Therapy 2016, 9:1477-1487

Published Date: 14 March 2016

Effects of CYP3A5 genetic polymorphism and smoking on the prognosis of non-small-cell lung cancer

Jiang LP, Zhu ZT, He CY

OncoTargets and Therapy 2016, 9:1461-1469

Published Date: 14 March 2016

Antitumor activity of pluripotent cell-engineered vaccines and their potential to treat lung cancer in relation to different levels of irradiation

Zhang Y, Duan X, Zhang W, Wu A, Yang H, Wu D, Wei Y, Chen X

OncoTargets and Therapy 2016, 9:1425-1436

Published Date: 11 March 2016

The effect of antagonizing RGD-binding integrin activity in papillary thyroid cancer cell lines

Cheng W, Feng F, Ma C, Wang H

OncoTargets and Therapy 2016, 9:1415-1423

Published Date: 11 March 2016

Ovarian small-cell carcinoma hypercalcemic type successfully treated: a case report and literature review

Wang JJ, Liu Q, Wu N, Zhou XD, Wang H, Wang X, Tu P, Zhou XJ, Shi QL

OncoTargets and Therapy 2016, 9:1409-1414

Published Date: 11 March 2016

A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detection

Wang Q, Sun T, Cao Y, Gao P, Dong J, Fang Y, Fang Z, Sun X, Zhu Z

OncoTargets and Therapy 2016, 9:1389-1398

Published Date: 11 March 2016

Quantitative assessment of caveolin-1 G14713A polymorphism and cancer susceptibility in the Asian population

Tang JJ, Wang G, Li Q, Song RF

OncoTargets and Therapy 2016, 9:1381-1387

Published Date: 10 March 2016

Prognostic role of microRNA-150 in various carcinomas: a meta-analysis

Wang W, Wang X, Zhang Y, Wang D, Gao H, Wang L, Gao S

OncoTargets and Therapy 2016, 9:1371-1379

Published Date: 11 March 2016

Impact of the care provided by gynecologic oncologists on outcomes of cervical cancer patients treated with radical hysterectomy

Wu MF, Li J, Lu HW, Wang LJ, Zhang BZ, Lin ZQ

OncoTargets and Therapy 2016, 9:1361-1370

Published Date: 10 March 2016

Association of thymidylate synthase expression and clinical outcomes of gastric cancer patients treated with fluoropyrimidine-based chemotherapy: a meta-analysis

Gao YH, Cui JX, Xi HQ, Cai AZ, Shen WS, Li JY, Zhang KC, Wei B, Chen L

OncoTargets and Therapy 2016, 9:1339-1350

Published Date: 9 March 2016

Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma

Lu Z, Yao Y, Song Q, Yang J, Zhao X, Yang P, Kang J

OncoTargets and Therapy 2016, 9:1327-1337

Published Date: 9 March 2016

Diagnostic value of two-dimensional shear wave elastography in papillary thyroid microcarcinoma

Duan SB, Yu J, Li X, Han ZY, Zhai HY, Liang P

OncoTargets and Therapy 2016, 9:1311-1317

Published Date: 9 March 2016

Zinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer

Zhang Y, Liu G, Wu S, Jiang F, Xie J, Wang Y

OncoTargets and Therapy 2016, 9:1303-1310

Published Date: 29 March 2016

Role of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patients

Li MJ, He Q, Li M, Luo F, Guan YS

OncoTargets and Therapy 2016, 9:1291-1302

Published Date: 9 March 2016

Decreased apolipoprotein A-I level indicates poor prognosis in extranodal natural killer/T-cell lymphoma, nasal type

Quan Q, Chen Q, Chen P, Jiang L, Li T, Qiu H, Zhang B

OncoTargets and Therapy 2016, 9:1281-1290

Published Date: 14 March 2016

Association of OPN rs11730582 polymorphism with cancer risk: a meta-analysis

He LL, Wang Y

OncoTargets and Therapy 2016, 9:1275-1280

Published Date: 7 March 2016

The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis

Liu YL, Zhang HM, Pan HM, Bao YH, Xue J, Wang TC, Dong XC, Li XL, Bao HG

OncoTargets and Therapy 2016, 9:1241-1249

Published Date: 7 March 2016

MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1

He X, Wei Y, Wang Y, Liu L, Wang W, Li N

OncoTargets and Therapy 2016, 9:1231-1239

Published Date: 7 March 2016

Integrating subpathway analysis to identify candidate agents for hepatocellular carcinoma

Wang J, Li M, Wang Y, Liu X

OncoTargets and Therapy 2016, 9:1221-1230

Published Date: 7 March 2016

Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma

Shankar A, Borin TF, Iskander A, Varma NR, Achyut BR, Jain M, Mikkelsen T, Guo AM, Chwang WB, Ewing JR, Bagher-Ebadian H, Arbab AS

OncoTargets and Therapy 2016, 9:1205-1219

Published Date: 9 March 2016

The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer

Ding X, Qiu L, Zhang L, Xi J, Li D, Huang X, Zhao Y, Wang X, Sun Q

OncoTargets and Therapy 2016, 9:1189-1204

Published Date: 8 March 2016

Profile of farletuzumab and its potential in the treatment of solid tumors

Sato S, Itamochi H

OncoTargets and Therapy 2016, 9:1181-1188

Published Date: 7 March 2016

The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population

Sha N, Xu H, Chen T, Tian DW, Xie WQ, Xie LG, Zhang Y, Xing C, Liu XT, Shen ZH, Wu ZL, Hu HL, Wu CL

OncoTargets and Therapy 2016, 9:1175-1179

Published Date: 7 March 2016

Screening miRNAs for early diagnosis of colorectal cancer by small RNA deep sequencing and evaluation in a Chinese patient population

Wang X, Chen L, Jin H, Wang S, Zhang Y, Tang X, Tang G

OncoTargets and Therapy 2016, 9:1159-1166

Published Date: 7 March 2016

Association between L55M polymorphism in Paraoxonase 1 and cancer risk: a meta-analysis based on 21 studies

Chen L, Lu W, Fang L, Xiong H, Wu X, Zhang M, Wu S, Yu D

OncoTargets and Therapy 2016, 9:1151-1158

Published Date: 4 March 2016

Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization

Hu Y, Chen W, Chen S, Huang Z

OncoTargets and Therapy 2016, 9:1145-1149

Published Date: 3 March 2016

miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells

Zhang M, Dong BB, Lu M, Zheng MJ, Chen H, Ding JZ, Xu AM, Xu YH

OncoTargets and Therapy 2016, 9:1123-1133

Published Date: 3 March 2016

Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiforme

Kusumawidjaja G, Gan PZ, Ong WS, Teyateeti A, Dankulchai P, Tan DYH, Chua ET, Chua KL, Tham CK, Wong FY, Chua ML

OncoTargets and Therapy 2016, 9:1115-1122

Published Date: 2 March 2016

YAP induces cisplatin resistance through activation of autophagy in human ovarian carcinoma cells

Xiao L, Shi XY, Zhang Y, Zhu Y, Zhu L, Tian W, Zhu BK, Wei ZL

OncoTargets and Therapy 2016, 9:1105-1114

Published Date: 16 March 2016

Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase

Qin T, Zhou NN, Zeng YD, Dinglin XX, Zhao YY, Liu H, Chen LK

OncoTargets and Therapy 2016, 9:1095-1103

Published Date: 1 March 2016

Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma

Li GJ, Xu HW, Ji JJ, Yang F, Gao BQ

OncoTargets and Therapy 2016, 9:1085-1093

Published Date: 1 March 2016

SPAG9 is involved in hepatocarcinoma cell migration and invasion via modulation of ELK1 expression

Yan QY, Lou GH, Qian Y, Qin B, Xu XP, Wang YN, Liu YN, Dong XJ

OncoTargets and Therapy 2016, 9:1067-1075

Published Date: 1 March 2016

Feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a Phase II trial

Martínez E, Martínez M, Rico M, Hernández B, Casas F, Viñolas N, Pérez-Casas A, Dómine M, Mínguez J

OncoTargets and Therapy 2016, 9:1057-1066

Published Date: 1 March 2016

Polymorphisms of vitamin D receptor gene TaqI susceptibility of prostate cancer: a meta-analysis

Fei XW, Liu NN, Li HF, Shen YT, Guo JM, Wu ZQ

OncoTargets and Therapy 2016, 9:1033-1045

Published Date: 1 March 2016

Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment

Kashima J, Horio H, Okuma Y, Hosomi Y, Hishima T

OncoTargets and Therapy 2016, 9:1029-1032

Published Date: 29 February 2016

Quality of life of patients with lung cancer

Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A

OncoTargets and Therapy 2016, 9:1023-1028

Published Date: 29 February 2016

Overexpression of Livin promotes migration and invasion of colorectal cancer cells by induction of epithelial–mesenchymal transition via NF-κB activation

Ge Y, Cao XK, Wang DL, Sun W, Sun HL, Han B, Cui JP, Liu BL

OncoTargets and Therapy 2016, 9:1011-1021

Published Date: 29 February 2016

Orchestrating epigenetic roles targeting ocular tumors

Wen X, Lu L, Zhang H, Fan X

OncoTargets and Therapy 2016, 9:1001-1009

Published Date: 29 February 2016

The pro-apoptotic effects of TIPE2 on AA rat fibroblast-like synoviocytes via regulation of the DR5–caspase–NF-κB pathway in vitro

Shi C, Zhang S, Hong S, Pang J, Yesibulati Y, Yin P, Zhuang G

OncoTargets and Therapy 2016, 9:993-1000

Published Date: 29 February 2016

A comparative study of idarubicin 12 mg/m2 and 8 mg/m2 combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients

Zhou L, Liu X, Liu H, Zhu W, Cai X, Song K, Zheng C, Tang B, Sun Z

OncoTargets and Therapy 2016, 9:985-991

Published Date: 29 February 2016

Analyses of prognostic factors in cases of non-small cell lung cancer with multiple brain metastases

Gong X, Zhou D, Liang S, Zhou C

OncoTargets and Therapy 2016, 9:977-983

Published Date: 1 March 2016

Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer

Ma B, Ma Q, Wang H, Zhang G, Zhang H, Wang X

OncoTargets and Therapy 2016, 9:959-976

Published Date: 29 February 2016

Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer

Liu X, Xu P, Qiu H, Liu J, Chen S, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z, Sun X

OncoTargets and Therapy 2016, 9:949-958

Published Date: 26 February 2016

Recurrent squamous cell carcinoma of the skin treated successfully with single agent cetuximab therapy

Seber S, Gonultas A, Ozturk O, Yetisyigit T

OncoTargets and Therapy 2016, 9:945-948

Published Date: 25 February 2016

Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases

Wada Y, Takami Y, Tateishi M, Ryu T, Mikagi K, Saitsu H

OncoTargets and Therapy 2016, 9:937-943

Published Date: 25 February 2016

Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer

Shen YW, Zhang XM, Li ST, Lv M, Yang J, Wang F, Chen ZL, Wang BY, Li P, Chen L, Yang J

OncoTargets and Therapy 2016, 9:929-935

Published Date: 24 February 2016

Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer

Ławicki S, Zajkowska M, Głażewska EK, Będkowska GE, Szmitkowski M

OncoTargets and Therapy 2016, 9:911-919

Published Date: 24 February 2016

Association between three exonuclease 1 polymorphisms and cancer risks: a meta-analysis

Chen ZY, Zheng SR, Zhong JH, Zhuang XD, Zhou JY

OncoTargets and Therapy 2016, 9:899-910

Published Date: 23 February 2016

Arsenic trioxide inhibits viability and induces apoptosis through reactivating the Wnt inhibitor secreted frizzled related protein-1 in prostate cancer cells

Zheng L, Jiang H, Zhang ZW, Wang KN, Wang QF, Li QL, Jiang T

OncoTargets and Therapy 2016, 9:885-894

Published Date: 23 February 2016

Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients

Jiang C, Hu WM, Liao FX, Yang Q, Chen P, Rong YM, Guo GF, Yin CX, Zhang B, He WZ, Xia LP

OncoTargets and Therapy 2016, 9:877-883

Published Date: 23 February 2016

Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis

Qiang G, Liang C, Xiao F, Yu Q, Wen H, Song Z, Tian Y, Shi B, Guo Y, Liu D

OncoTargets and Therapy 2016, 9:869-876

Published Date: 22 February 2016

Type I enteropathy-associated T-cell lymphoma in the colon of a 29-year-old patient and a brief literature review

Zhang JC, Wang Y, Wang XF, Zhang FX

OncoTargets and Therapy 2016, 9:863-868

Published Date: 22 February 2016

Potential impact of 18FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus

Liu S, Zhu H, Li W, Zhang B, Ma L, Guo Z, Huang Y, Song P, Yu J, Guo H

OncoTargets and Therapy 2016, 9:855-862

Published Date: 22 February 2016

The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations

Zheng DF, Wang R, Zhang Y, Pan YJ, Cheng XH, Cheng C, Zheng SB, Li H, Gong RX, Li Y, Shen XX, Sun YH, Chen HQ

OncoTargets and Therapy 2016, 9:833-843

Published Date: 22 February 2016

Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasis

Xu T, Zong YY, Peng LP, Kong S, Zhou ML, Zou JQ, Liu JL, Miao RZ, Sun XC, Li LP

OncoTargets and Therapy 2016, 9:815-822

Published Date: 19 February 2016

Association of polymorphisms in WWOX gene with risk and outcome of osteosarcoma in a sample of the young Chinese population

Zhang N, Jiang Z, Ren W, Yuan L, Zhu Y

OncoTargets and Therapy 2016, 9:807-813

Published Date: 19 February 2016

Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia

Wu YJ, Wang H, Liang JH, Miao Y, Liu L, Qiu HR, Qiao C, Wang R, Li JY

OncoTargets and Therapy 2016, 9:797-805

Published Date: 18 February 2016

PBOV1 promotes prostate cancer proliferation by promoting G1/S transition

Pan TJ, Wu RP, Liu B, Wen HD, Tu Z, Guo J, Yang JR, Shen GQ

OncoTargets and Therapy 2016, 9:787-795

Published Date: 16 February 2016

Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma

Kaseb AO, Morris JS, Iwasaki M, Al-Shamsi HO, Raghav KP, Girard L, Cheung S, Nguyen V, Elsayes KM, Xiao L, Abdel-Wahab R, Shalaby AS, Hassan M, Hassabo HM, Wolff RA, Yao JC

OncoTargets and Therapy 2016, 9:773-780

Published Date: 15 February 2016

Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics

Yang F, Lyu SX, Dong SY, Liu YH, Zhang XH, Wang OC

OncoTargets and Therapy 2016, 9:761-772

Published Date: 12 February 2016

Association of polymorphisms hOGG1 rs1052133 and hMUTYH rs3219472 with risk of nasopharyngeal carcinoma in a Chinese population

Xie Y, Wu Y, Zhou X, Yao M, Ning S, Wei Z

OncoTargets and Therapy 2016, 9:755-760

Published Date: 12 February 2016

Effects of electromagnetic radiation exposure on bone mineral density, thyroid, and oxidative stress index in electrical workers

Kunt H, Şentürk İ, Gönül Y, Korkmaz M, Ahsen A, Hazman Ö, Bal A, Genç A, Songur A

OncoTargets and Therapy 2016, 9:745-754

Published Date: 12 February 2016

Primary renal carcinoid tumor: case report and review of the literature

Li B, Cui TY, Ban ZQ, Luo L, Sun LJ

OncoTargets and Therapy 2016, 9:741-743

Published Date: 23 February 2016

Monitoring cancer stem cells: insights into clinical oncology

Lin SC, Xu YC, Gan ZH, Han K, Hu HY, Yao Y, Huang MZ, Min DL

OncoTargets and Therapy 2016, 9:731-740

Published Date: 11 February 2016

Values of 99mTc-methoxyisobutylisonitrile imaging after first-time large-dose 131I therapy in treating differentiated thyroid cancer

Pan X, Duan D, Zhu Y, Pang H, Guan L, Lv Z

OncoTargets and Therapy 2016, 9:723-730

Published Date: 10 February 2016

Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight

Peddi P, Paryani B, Takalkar A, Bundrick P, Ponugupati J, Nair B, El-Osta H

OncoTargets and Therapy 2016, 9:705-709

Published Date: 9 February 2016

Long noncoding RNAs in gastric cancer: functions and clinical applications

Wang J, Sun J, Wang J, Song Y, Gao P, Shi J, Chen P, Wang Z

OncoTargets and Therapy 2016, 9:681-697

Published Date: 10 February 2016

Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation

Liu J, Xing L, Meng X, Yue J, Meng X, Xie P, Li X, Kong L, Yu J

OncoTargets and Therapy 2016, 9:671-679

Published Date: 5 February 2016

Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE review

Jeong S, Kim JH, Kim MG, Han N, Kim IW, Kim T, Oh JM

OncoTargets and Therapy 2016, 9:655-669

Published Date: 9 February 2016

Radix Tetrastigma hemsleyani flavone inhibits proliferation, migration, and invasion of human lung carcinoma A549 cells

Zhong LR, Zheng JX, Sun QQ, Wei KM, Hu YJ

OncoTargets and Therapy 2016, 9:635-641

Published Date: 4 February 2016

Potassium-3-beta-hydroxy-20-oxopregn-5-en-17-alpha-yl sulfate: a novel inhibitor of 78 kDa glucose-regulated protein

Mhaidat NM, Al-Balas QA, Alzoubi KH, AlEjielat RF

OncoTargets and Therapy 2016, 9:627-634

Published Date: 3 February 2016

Intracellular calcium is a target of modulation of apoptosis in MCF-7 cells in the presence of IgA adsorbed to polyethylene glycol

Honorio-França AC, Nunes GT, Fagundes DLG, Marchi PGF, Fernandes RTS, França JL, França-Botelho AC, Moraes LCA, Varotti FP, França EL

OncoTargets and Therapy 2016, 9:617-626

Published Date: 3 February 2016

Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study

Zhang Y, Xie LG, Chen T, Xie WQ, Wu ZL, Xu H, Xing C, Sha N, Shen ZH, Qie YK, Liu XT, Hu HL, Wu CL

OncoTargets and Therapy 2016, 9:605-611

Published Date: 28 January 2016

Advances in dosimetry and biological predictors of radiation-induced esophagitis

Yu Y, Guan H, Dong Y, Xing L, Li X

OncoTargets and Therapy 2016, 9:597-603

Published Date: 28 January 2016

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients

Wang H, Wang L, Lu Y, Chen XQ, Geng QR, Wang WD, Xia ZJ

OncoTargets and Therapy 2016, 9:587-595

Published Date: 28 January 2016

Correlation between XRCC1 Arg399Gln genetic polymorphisms and susceptibility to bladder cancer: a meta-analysis

Liu N, Fei X, Shen Y, Shi W, Ma J

OncoTargets and Therapy 2016, 9:579-586

Published Date: 28 January 2016

Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis

Zhang K, Zhang L, Zhou J, Hao Z, Fan S, Yang C, Liang C

OncoTargets and Therapy 2016, 9:567-577

Published Date: 27 January 2016

Biomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRAS

Liu J, Hu J, Cheng L, Ren W, Yang M, Liu B, Xie L, Qian X

OncoTargets and Therapy 2016, 9:557-565

Published Date: 27 January 2016

Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma

Lei ZG, Ren XH, Wang SS, Liang XH, Tang YL

OncoTargets and Therapy 2016, 9:545-555

Published Date: 27 January 2016

Conservative treatment of coexisting microinvasive squamous and adenocarcinoma of the cervix: report of two cases and literature review

Sopracordevole F, Di Giuseppe J, Cervo S, Buttignol M, Giorda G, Ciavattini A, Canzonieri V

OncoTargets and Therapy 2016, 9:539-544

Published Date: 27 January 2016

Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine

Wittke S, Baxmann S, Fahlenkamp D, Kiessig ST

OncoTargets and Therapy 2016, 9:523-537

Published Date: 27 January 2016

Oct-4 is associated with gastric cancer progression and prognosis

Jiang WL, Zhang PF, Li GF, Dong JH, Wang XS, Wang YY

OncoTargets and Therapy 2016, 9:517-522

Published Date: 27 January 2016

Long-term gene therapy with Del1 fragment using nonviral vectors in mice with explanted tumors

Kitano H, Mamiya A, Ishikawa T, Egoshi K, Kokubun S, Hidai C

OncoTargets and Therapy 2016, 9:503-516

Published Date: 25 January 2016

PD-1/PD-L1 blockades in non-small-cell lung cancer therapy

Jing W, Li MM, Zhang Y, Teng FF, Han AQ, Kong L, Zhu H

OncoTargets and Therapy 2016, 9:489-502

Published Date: 25 January 2016

Abnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer

Shao W, Wang Q, Wang F, Jiang Y, Xu M, Xu J

OncoTargets and Therapy 2016, 9:477-487

Published Date: 25 January 2016

Utility of blood procalcitonin concentration in the management of cancer patients with infections

Durnaś B, Wątek M, Wollny T, Niemirowicz K, Marzec M, Bucki R, Góźdź S

OncoTargets and Therapy 2016, 9:469-475

Published Date: 22 January 2016

Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis

Tang WW, Huang CW, Tang CY, Xu J, Wang HJ

OncoTargets and Therapy 2016, 9:455-460

Published Date: 22 January 2016

Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer

Ma B, Wang J, Song Y, Gao P, Sun J, Chen X, Yang Y, Wang Z

OncoTargets and Therapy 2016, 9:445-453

Published Date: 21 January 2016

Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis

Xu HX, Tian YJ, Yuan X, Liu Y, Wu H, Liu Q, Wu GS, Wu KM

OncoTargets and Therapy 2016, 9:431-444

Published Date: 21 January 2016

New developments in the management of chronic lymphocytic leukemia: role of ofatumumab

Laurenti L, Innocenti I, Autore F, Sica S, Efremov DG

OncoTargets and Therapy 2016, 9:421-429

Published Date: 20 January 2016

TDRG1 functions in testicular seminoma are dependent on the PI3K/Akt/mTOR signaling pathway

Wang Y, Gan Y, Tan Z, Zhou J, Kitazawa R, Jiang X, Tang Y, Yang J

OncoTargets and Therapy 2016, 9:409-420

Published Date: 20 January 2016

Polymorphisms in pre-miRNA genes and cooking oil fume exposure as well as their interaction on the risk of lung cancer in a Chinese nonsmoking female population

Yin Z, Li H, Cui Z, Ren Y, Li X, Wu W, Guan P, Qian B, Rothman N, Lan Q, Zhou B

OncoTargets and Therapy 2016, 9:395-401

Published Date: 19 January 2016

Expression and prognostic significance of contactin 1 in human hepatocellular carcinoma

Li GY, Huang M, Pan TT, Jia WD

OncoTargets and Therapy 2016, 9:387-394

Published Date: 19 January 2016

Cost-effectiveness of radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer

Chai YL, Wang J, Wang T, Shi F, Wang JQ, Su J, Yang YY, Zhou X, Ma HL, He B, Liu Z

OncoTargets and Therapy 2016, 9:349-354

Published Date: 19 January 2016

Knockdown of TMEM16A suppressed MAPK and inhibited cell proliferation and migration in hepatocellular carcinoma

Deng L, Yang J, Chen H, Ma B, Pan K, Su C, Xu F, Zhang J

OncoTargets and Therapy 2016, 9:325-333

Published Date: 14 January 2016

Single sternal metastasis due to malignant melanoma with unexpected long-term survival: a case report

Gogakos AS, Paliouras D, Asteriou C, Rallis T, Lazopoulos A, Chatzinikolaou F, Zissimopoulos A, Tsavlis D, Tsirgogianni K, Zarogoulidis K, Porpodis K, Tsakiridis K, Pitsiou G, Kioumis I, Karapantzos I, Karapantzou C, Sachpekidis N, Zarogoulidis P, Barbetakis N

OncoTargets and Therapy 2016, 9:321-323

Published Date: 18 January 2016

Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme

Hou AW, Zhao LZ, Zhao FZ, Wang WL, Niu JY, Li BX, Zhou ZJ, Zhu DY

OncoTargets and Therapy 2016, 9:315-320

Published Date: 13 January 2016

MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells

Ruan WD, Wang P, Feng S, Xue Y, Zhang B

OncoTargets and Therapy 2016, 9:303-313

Published Date: 18 January 2016

The amplification of 1q21 is an adverse prognostic factor in patients with multiple myeloma in a Chinese population

Yu W, Guo R, Qu X, Qiu H, Li J, Zhang R, Chen L

OncoTargets and Therapy 2016, 9:295-302

Published Date: 12 January 2016

WISP3 is highly expressed in a subset of colorectal carcinomas with a better prognosis

Lu Y, Wang X, Sun X, Feng W, Guo H, Tang C, Deng A, Bao Y

OncoTargets and Therapy 2016, 9:287-293

Published Date: 12 January 2016

Telomerase reverse transcriptase methylation predicts lymph node metastasis and prognosis in patients with gastric cancer

Wu Y, Li G, He D, Yang F, He G, He L, Zhang H, Deng Y, Fan M, Shen L, Zhou D, Zhang Z

OncoTargets and Therapy 2016, 9:279-286

Published Date: 11 January 2016

Polymorphisms in RAD51 and their relation with breast cancer in Saudi females

Tulbah S, Alabdulkarim H, Alanazi M, Parine NR, Shaik J, Pathan AA, Al-Amri A, Khan W, Warsy A

OncoTargets and Therapy 2016, 9:269-277

Published Date: 11 January 2016

ALK-positive anaplastic large cell lymphoma with prominent bone involvement in a 13-year-old boy

Tian C, Yu Y, Yang HL, Zhu L, Wang YF, Zhang YZ

OncoTargets and Therapy 2016, 9:265-268

Published Date: 11 January 2016

The synergistic anticancer effect of cisplatin combined with Oldenlandia diffusa in osteosarcoma MG-63 cell line in vitro

Pu F, Chen F, Lin S, Chen S, Zhang Z, Wang B, Shao Z

OncoTargets and Therapy 2016, 9:255-263

Published Date: 11 January 2016

Silencing of Foxp3 delays the growth of murine melanomas and modifies the tumor immunosuppressive environment

Franco-Molina MA, Miranda-Hernández DF, Mendoza-Gamboa E, Zapata-Benavides P, Coronado-Cerda EE, Sierra-Rivera CA, Saavedra-Alonso S, Taméz-Guerra RS, Rodríguez-Padilla C

OncoTargets and Therapy 2016, 9:243-253

Published Date: 12 January 2016

Overexpression of p53 activated by small activating RNA suppresses the growth of human prostate cancer cells

Ge Q, Wang C, Ruan Y, Chen Z, Liu J, Ye Z

OncoTargets and Therapy 2016, 9:231-241

Published Date: 8 January 2016

Association between polymorphisms in selected inflammatory response genes and the risk of prostate cancer

Chen J, Ying XM, Huang XM, Huang P, Yan SC

OncoTargets and Therapy 2016, 9:223-229

Published Date: 11 January 2016

Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients

Iliev R, Stanik M, Fedorko M, Poprach A, Vychytilova-Faltejskova P, Slaba K, Svoboda M, Fabian P, Pacik D, Dolezel J, Slaby O

OncoTargets and Therapy 2016, 9:217-222

Published Date: 8 January 2016

PI3K inhibitors as new cancer therapeutics: implications for clinical trial design

Massacesi C, Di Tomaso E, Urban P, Germa C, Quadt C, Trandafir L, Aimone P, Fretault N, Dharan B, Tavorath R, Hirawat S

OncoTargets and Therapy 2016, 9:203-210

Published Date: 7 January 2016

Bioinformatics analysis of hepatitis C virus genotype 2a-induced human hepatocellular carcinoma in Huh7 cells

Xu P, Wu M, Chen H, Xu J, Wu M, Li M, Qian F, Xu J

OncoTargets and Therapy 2016, 9:191-202

Published Date: 8 January 2016

Expression and clinical significance of Nectin-4 in hepatocellular carcinoma

Ma J, Sheng ZY, Lv Y, Liu WB, Yao QY, Pan TT, Xu ZJ, Zhang CH, Xu GL

OncoTargets and Therapy 2016, 9:183-190

Published Date: 6 January 2016

The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis

Xie FJ, Lu HY, Zheng QQ, Qin J, Gao Y, Zhang YP, Hu X, Mao WM

OncoTargets and Therapy 2016, 9:171-181

Published Date: 6 January 2016

Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review

Cao Y, Zhu LZ, Jiang MJ, Yuan Y

OncoTargets and Therapy 2016, 9:149-158

Published Date: 31 December 2015

Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients

Li Z, Ma YY, Wang J, Zeng XF, Li R, Kang W, Hao XK

OncoTargets and Therapy 2016, 9:139-148

Published Date: 31 December 2015

Detection of lung adenocarcinoma with ROS1 rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic features

Cao B, Wei P, Liu Z, Bi R, Lu Y, Zhang L, Zhang J, Yang Y, Shen C, Du X, Zhou X

OncoTargets and Therapy 2016, 9:131-138

Published Date: 31 December 2015

High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy

Wang CY, Fu XL, Cai XW, Wu XH, Hu XC, Fan M, Xiang JQ, Zhang YW, Chen HQ, Jiang GL, Zhao KL

OncoTargets and Therapy 2016, 9:117-122

Published Date: 30 December 2015

Dairy consumption and lung cancer risk: a meta-analysis of prospective cohort studies

Yu Y, Li H, Xu K, Li X, Hu C, Wei H, Zeng X, Jing X

OncoTargets and Therapy 2016, 9:111-116

Published Date: 30 December 2015

MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1

Lu Y, Hu JJ, Sun W, Li S, Deng S, Li M

OncoTargets and Therapy 2016, 9:99-109

Published Date: 30 December 2015

Association between promoter polymorphisms of OPN gene and cancer risk: a meta-analysis

Liu JW, He CY, Yuan Q, Wang ZN, Xing CZ, Yuan Y

OncoTargets and Therapy 2016, 9:87-97

Published Date: 30 December 2015

Prognostic value of lymph node ratio in patients with small-cell carcinoma of the cervix based on data from a large national registry

Zhou J, Sun JY, Chen SY, Li FY, Lin HX, Wu SG, He ZY

OncoTargets and Therapy 2016, 9:67-73

Published Date: 23 December 2015

Genetic variants in insulin-like growth factor binding protein-3 are associated with prostate cancer susceptibility in Eastern Chinese Han men

Zhang G, Zhu Y, Liu F, Gu CY, Chen H, Xu JF, Ye DW

OncoTargets and Therapy 2016, 9:61-66

Published Date: 22 December 2015

Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis

Teng JJ, Zhang J, Zhang TY, Zhang S, Li BS

OncoTargets and Therapy 2016, 9:37-47

Published Date: 21 December 2015

Expression of interleukin 1β in gastric cancer tissue and its effects on gastric cancer

Yin S, Lan C, Pei H, Zhu Z

OncoTargets and Therapy 2016, 9:31-35

Published Date: 21 December 2015

Dendrobium candidum inhibits MCF-7 cells proliferation by inducing cell cycle arrest at G2/M phase and regulating key biomarkers

Sun J, Guo Y, Fu XQ, Wang YS, Liu Y, Huo B, Sheng J, Hu X

OncoTargets and Therapy 2016, 9:21-30

Published Date: 21 December 2015

Clinical efficacy of computed tomography-guided iodine-125 seed implantation therapy in patients with advanced spinal metastatic tumors

Zhang LY, Lu J, Wang ZM, Cheng YS, Teng GJ, Chen KM

OncoTargets and Therapy 2016, 9:7-12

Published Date: 18 December 2015

Correlation of 18F-fluoroethyl tyrosine positron-emission tomography uptake values and histomorphological findings by stereotactic serial biopsy in newly diagnosed brain tumors using a refined software tool

Lopez WO, Cordeiro JG, Albicker U, Doostkam S, Nikkhah G, Kirch RD, Trippel M, Reithmeier T

OncoTargets and Therapy 2015, 8:3803-3815

Published Date: 17 December 2015

Prognostic and clinicopathological significance of serum interleukin-6 expression in colorectal cancer: a systematic review and meta-analysis

Wang Z, Wu P, Wu D, Zhang ZG, Hu GM, Zhao S, Lai YC, Huang J

OncoTargets and Therapy 2015, 8:3793-3801

Published Date: 16 December 2015

The role of CD44 in epithelial–mesenchymal transition and cancer development

Xu HX, Tian YJ, Yuan X, Wu H, Liu Q, Pestell RG, Wu KM

OncoTargets and Therapy 2015, 8:3783-3792

Published Date: 16 December 2015

Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience

Wang P, Wang C, Li H, Shi B, Wang J, Zhong L

OncoTargets and Therapy 2015, 8:3775-3781

Published Date: 16 December 2015

Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker

Serban F, Artene SA, Georgescu AM, Purcaru SO, Tache DE, Alexandru O, Dricu A

OncoTargets and Therapy 2015, 8:3767-3774

Published Date: 16 December 2015

Role of NSC319726 in ovarian cancer based on the bioinformatics analyses

Xue J, Yang G, Ding H, Wang P, Wang CH

OncoTargets and Therapy 2015, 8:3757-3765

Published Date: 15 December 2015

Prognostic impact of initial maximum standardized uptake value of 18F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib

Kus T, Aktas G, Sevinc A, Kalender ME, Yilmaz M, Kul S, Oztuzcu S, Oktay C, Camci C

OncoTargets and Therapy 2015, 8:3749-3756

Published Date: 15 December 2015

GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma

Chen J, Yang P, Yang J, Wen Z, Zhang B, Zheng X

OncoTargets and Therapy 2015, 8:3731-3742

Published Date: 15 December 2015

Risks on N-acetyltransferase 2 and bladder cancer: a meta-analysis

Zhu Z, Zhang J, Jiang W, Zhang X, Li Y, Xu X

OncoTargets and Therapy 2015, 8:3715-3720

Published Date: 11 December 2015

Non-leukemic myeloid sarcoma involving the vulva, vagina, and cervix: a case report and literature review

Yu Y, Qin X, Yan S, Wang W, Sun Y, Zhang M

OncoTargets and Therapy 2015, 8:3707-3713

Published Date: 10 December 2015

Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer

Yan XB, Peng TC, Huang D

OncoTargets and Therapy 2015, 8:3703-3706

Published Date: 8 December 2015

Profile of nintedanib in the treatment of solid tumors: the evidence to date

Awasthi N, Schwarz RE

OncoTargets and Therapy 2015, 8:3691-3701

Published Date: 8 December 2015

Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis

Xie LG, Sun Y, Chen T, Tian DW, Li YJ, Zhang Y, Ding N, Shen ZH, Xu H, Nian XW, Sha N, Han RF, Hu HL, Wu CL

OncoTargets and Therapy 2015, 8:3679-3690

Published Date: 7 December 2015

Crosstalk with cancer-associated fibroblasts induces resistance of non-small cell lung cancer cells to epidermal growth factor receptor tyrosine kinase inhibition

Choe C, Shin YS, Kim C, Choi SJ, Lee J, Kim SY, Cho YB, Kim J

OncoTargets and Therapy 2015, 8:3665-3678

Published Date: 7 December 2015

Echinacoside induces apoptotic cancer cell death by inhibiting the nucleotide pool sanitizing enzyme MTH1

Dong L, Wang H, Niu J, Zou M, Wu N, Yu D, Wang Y, Zou Z

OncoTargets and Therapy 2015, 8:3649-3664

Published Date: 8 December 2015

Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer

Qin J, Ke J, Xu JF, Wang FR, Zhou YL, Jiang YS, Wang ZW

OncoTargets and Therapy 2015, 8:3639-3648

Published Date: 7 December 2015

First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma

Bongiovanni A, Riva N, Ricci M, Liverani C, La Manna F, De Vita A, Foca F, Mercatali L, Severi S, Amadori D, Ibrahim T

OncoTargets and Therapy 2015, 8:3613-3619

Published Date: 3 December 2015

Inhibitive effects of 15-deoxy-Δ12,14-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis

Chen K, Dai W, Wang F, Xia Y, Li J, Li S, Liu T, Zhang R, Wang J, Lu W, Zhou Y, Yin Q, Zheng Y, Abudumijiti H, Chen R, Lu J, Zhou Y, Guo C

OncoTargets and Therapy 2015, 8:3585-3593

Published Date: 1 December 2015

The relationship between UGT1A1 gene polymorphism and irinotecan effect on extensive-stage small-cell lung cancer

Xiao XG, Xia S, Zou M, Mei Q, Zhou L, Wang SJ, Chen Y

OncoTargets and Therapy 2015, 8:3575-3583

Published Date: 3 December 2015

A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy

Williams CB, McMahon C, Ali SM, Abramovitz M, Williams KA, Klein J, McKean H, Yelensky R, George Jr TJ, Elvin JA, Soman S, Lipson D, Chmielecki J, Morosini D, Miller VA, Stephens PJ, Ross JS, Leyland-Jones B

OncoTargets and Therapy 2015, 8:3561-3564

Published Date: 1 December 2015

Inhibition of TGF-β signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer

Lin RL, Yi S, Gong LL, Liu WS, Wang P, Liu NB, Zhao LJ, Wang P

OncoTargets and Therapy 2015, 8:3549-3559

Published Date: 2 December 2015

Ultrasound-guided RNA interference targeting HIF-1 alpha improves the effects of transarterial chemoembolization in rat liver tumors

Chen CS, Zhao Q, Qian S, Li HL, Guo CY, Zhang W, Yan ZP, Liu R, Wang JH

OncoTargets and Therapy 2015, 8:3539-3548

Published Date: 27 November 2015

The XRCC1 Arg194Trp polymorphism is significantly associated with lung adenocarcinoma: a case-control study in an Eastern European Caucasian group

Cătană A, Pop M, Hincu BD, Pop IV, Petrişor FM, Porojan MD, Popp RA

OncoTargets and Therapy 2015, 8:3533-3538

Published Date: 27 November 2015

Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis

Wang HP, Li ZJ, Sun YL, Xu ZF, Han JJ, Song B, Song WT, Qin C, Yin L

OncoTargets and Therapy 2015, 8:3523-3531

Published Date: 27 November 2015

The association between osteopontin and survival in non-small-cell lung cancer patients: a meta-analysis of 13 cohorts

Wang Y, Yang J, Liu H, Bi JR, Liu Y, Chen YY, Cao JY, Lu YJ

OncoTargets and Therapy 2015, 8:3513-3521

Published Date: 26 November 2015

Ability of PITX2 methylation to predict survival in patients with prostate cancer

Li JZ, Zhang Y, Wen B, Li M, Wang YJ

OncoTargets and Therapy 2015, 8:3507-3512

Published Date: 24 November 2015

Expression of CPEB4 in invasive ductal breast carcinoma and its prognostic significance

Sun HT, Wen X, Han T, Liu ZH, Li SB, Wang JG, Liu XP

OncoTargets and Therapy 2015, 8:3499-3506

Published Date: 26 November 2015

Effect of gyromagnetic fields on human prostatic adenocarcinoma cells

Lei H, Xu Y, Guan R, Li M, Hui Y, Gao Z, Yang B, Xin Z

OncoTargets and Therapy 2015, 8:3489-3497

Published Date: 24 November 2015

Polo-like kinase 2 acting as a promoter in human tumor cells with an abundance of TAp73

Hu ZB, Xu ZY, Liao XH, Yang X, Dong C, Luk K, Jin AM, Lu H

OncoTargets and Therapy 2015, 8:3475-3488

Published Date: 20 November 2015

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma

Lee VHF, Leung DKC, Luk MY, Tong CC, Law MWM, Ng SCY, Wong KK, Poon RTP, Kwong DLW, Leung TW

OncoTargets and Therapy 2015, 8:3457-3464

Published Date: 20 November 2015

High DEPTOR expression correlates with poor prognosis in patients with esophageal squamous cell carcinoma

Liu NB, Zhang JH, Liu YF, Li J, Zhang ZZ, Li JW, Liu WY, Huang C, Shen T, Gu CW, Gao DY, Wu X, Wu X

OncoTargets and Therapy 2015, 8:3449-3455

Published Date: 19 November 2015

Diagnostic value of SHOX2 DNA methylation in lung cancer: a meta-analysis

Zhao QT, Guo T, Wang HE, Zhang XP, Zhang H, Wang ZK, Yuan Z, Duan GC

OncoTargets and Therapy 2015, 8:3433-3439

Published Date: 19 November 2015

Profile of bevacizumab and its potential in the treatment of cervical cancer

Fisher CM, Schefter TE

OncoTargets and Therapy 2015, 8:3425-3431

Published Date: 19 November 2015

Baseline blood immunological profiling differentiates between Her2– breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response

Tudoran O, Virtic O, Balacescu L, Lisencu C, Fetica B, Gherman C, Balacescu O, Berindan-Neagoe I

OncoTargets and Therapy 2015, 8:3415-3423

Published Date: 18 November 2015

Novel prognostic genes of diffuse large B-cell lymphoma revealed by survival analysis of gene expression data

Li CL, Zhu B, Chen J, Huang XB

OncoTargets and Therapy 2015, 8:3407-3413

Published Date: 18 November 2015

Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection

Sha N, Xie L, Chen T, Xing C, Liu X, Zhang Y, Shen Z, Xu H, Wu Z, Hu H, Wu C

OncoTargets and Therapy 2015, 8:3401-3406

Published Date: 18 November 2015

Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3

Luan YX, Zhang SY, Zuo L, Zhou LX

OncoTargets and Therapy 2015, 8:3391-3400

Published Date: 17 November 2015

Experience with combination of nimotuzumab and intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma

Zhai RP, Ying HM, Kong FF, Du CR, Huang S, Zhou JJ, Hu CS

OncoTargets and Therapy 2015, 8:3383-3390

Published Date: 18 November 2015

Dynamin-related protein 1 is involved in micheliolide-induced breast cancer cell death

Jia Y, Zhou L, Tian C, Shi Y, Wang C, Tong Z

OncoTargets and Therapy 2015, 8:3371-3381

Published Date: 16 November 2015

Prognostic value of Bcl-2 expression in patients with non-small-cell lung cancer: a meta-analysis and systemic review

Zhang J, Wang SF, Wang L, Wang R, Chen SF, Pan B, Sun YH, Chen HQ

OncoTargets and Therapy 2015, 8:3361-3369

Published Date: 18 November 2015

Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients

Sato Y, Matsusaka S, Suenaga M, Shinozaki E, Mizunuma N

OncoTargets and Therapy 2015, 8:3329-3336

Published Date: 11 November 2015

Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients

Niu J, Andres G, Kramer K, Kundranda MN, Alvarez RH, Klimant E, Parikh AR, Tan B, Staren ED, Markman M

OncoTargets and Therapy 2015, 8:3323-3328

Published Date: 11 November 2015

O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway

Zhang P, Wang CL, Ma T, You SY

OncoTargets and Therapy 2015, 8:3305-3313

Published Date: 9 November 2015

Detection of epidermal growth factor receptor mutation in plasma as a biomarker in Chinese patients with early-stage non-small cell lung cancer

Guo K, Zhang ZP, Han L, Han J, Wang J, Zhou YA, Liu HG, Tong LP, Li XF, Yan XL

OncoTargets and Therapy 2015, 8:3289-3296

Published Date: 6 November 2015

The association between XRCC1 Arg399Gln polymorphism and risk of leukemia in different populations: a meta-analysis of case-control studies

Wang F, Zhao Q, He HR, Zhai YJ, Lu J, Hu HB, Zhou JS, Yang YH, Li YJ

OncoTargets and Therapy 2015, 8:3277-3287

Published Date: 6 November 2015

Use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in Chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis

Tian R, Ye HX, Zhang BG, Gu DY, Zhang BW, Teng ZP, Jin MY, Chen JF, Qi JW

OncoTargets and Therapy 2015, 8:3255-3263

Published Date: 5 November 2015

miR-21 inhibits the effects of cyclooxygenase-2 inhibitor NS398 on apoptosis and invasion in gastric cancer cells

Li HQ, Cheng J, Mao YQ, Jiang M, Fan XM

OncoTargets and Therapy 2015, 8:3245-3253

Published Date: 4 November 2015

Management experiences of primary angiosarcoma of breast: a retrospective study from single institute in the People’s Republic of China

Hu QC, Mei X, Feng Y, Ma JL, Yang ZZ, Shao ZM, Yu XL, Guo XM

OncoTargets and Therapy 2015, 8:3237-3243

Published Date: 4 November 2015

Implication of lncRNAs in pathogenesis of esophageal cancer

Tang WW, Wu QQ, Li SQ, Tong YS, Liu ZH, Yang TX, Xu Y, Cao XF

OncoTargets and Therapy 2015, 8:3219-3226

Published Date: 3 November 2015

miR-132 can inhibit glioma cells invasion and migration by target MMP16 in vitro

Wang HZ, Li XT, Wu C, Wu ZW, Li YY, Yang TQ, Chen GL, Xie XS, Huang YL, Du ZW, Zhou YX

OncoTargets and Therapy 2015, 8:3211-3218

Published Date: 3 November 2015

Correlation of C-X-C chemokine receptor 2 upregulation with poor prognosis and recurrence in human glioma

Yang L, Liu Z, Wu R, Yao Q, Gu Z, Liu M

OncoTargets and Therapy 2015, 8:3203-3209

Published Date: 2 November 2015

Combination of cetuximab and PP242 synergistically suppress the progression of wild-type KRAS colorectal carcinoma

Cheng L, Xia Z, Bian X, Li G, Hu J, Cao Y, Wang Q, Qian X

OncoTargets and Therapy 2015, 8:3185-3192

Published Date: 2 November 2015

miR-122 inhibits metastasis and epithelial–mesenchymal transition of non-small-cell lung cancer cells

Qin HF, Sha JP, Jiang CX, Gao XM, Qu LL, Yan HY, Xu TJ, Jiang QY, Gao HJ

OncoTargets and Therapy 2015, 8:3175-3184

Published Date: 29 October 2015

Treating patients with advanced rectal cancer and lateral pelvic lymph nodes with preoperative chemoradiotherapy based on pretreatment imaging

Otowa Y, Yamashita K, Kanemitsu K, Sumi Y, Yamamoto M, Kanaji S, Imanishi T, Nakamura T, Suzuki S, Tanaka K, Kakeji Y

OncoTargets and Therapy 2015, 8:3169-3173

Published Date: 29 October 2015

MicroRNA-328 enhances cellular motility through posttranscriptional regulation of PTPRJ in human hepatocellular carcinoma

Luo X, Yang S, Zhou C, Pan F, Li Q, Ma S

OncoTargets and Therapy 2015, 8:3159-3167

Published Date: 28 October 2015

A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C

Liao F, He W, Jiang C, Yin C, Guo G, Chen X, Qiu H, Rong Y, Zhang B, Xu D, Xia L

OncoTargets and Therapy 2015, 8:3135-3142

Published Date: 27 October 2015

SKF95365 induces apoptosis and cell-cycle arrest by disturbing oncogenic Ca2+ signaling in nasopharyngeal carcinoma cells

Zhang J, Wei J, He Q, Lin Y, Liang R, Ye J, Zhang Z, Li Y

OncoTargets and Therapy 2015, 8:3123-3133

Published Date: 27 October 2015

Serum dickkopf-1 as a biomarker in screening gastrointestinal cancers: a systematic review and meta-analysis

Liang B, Zhong L, He Q, Wang S, Pan Z, Wang T, Zhao Y

OncoTargets and Therapy 2015, 8:3115-3122

Published Date: 22 October 2015

Prognostic value of Notch-1 expression in hepatocellular carcinoma: a meta-analysis

Wu T, Jiao M, Jing L, Wang MC, Sun HF, Li Q, Bai YY, Wei YC, Nan KJ, Guo H

OncoTargets and Therapy 2015, 8:3105-3114

Published Date: 22 October 2015

Potential therapeutic strategy for gastric cancer peritoneal metastasis by NKG2D ligands-specific T cells

Liu XQ, Sun ML, Yu S, Liu K, Li XR, Shi H

OncoTargets and Therapy 2015, 8:3095-3104

Published Date: 22 October 2015

Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumor

Zhong G, Qi J, Huo S, Xue H, Xu Z, Li J, Zhou Y, Wu M, Li L

OncoTargets and Therapy 2015, 8:3079-3086

Published Date: 22 October 2015

A DNA vaccine encoding mutated HPV58 mE6E7-Fc-GPI fusion antigen and GM-CSF and B7.1

Wang H, Yu J, Li L

OncoTargets and Therapy 2015, 8:3067-3077

Published Date: 23 October 2015

Combined olaparib and oxaliplatin inhibits tumor proliferation and induces G2/M arrest and γ-H2AX foci formation in colorectal cancer

Xu K, Chen Z, Cui Y, Qin C, He Y, Song X

OncoTargets and Therapy 2015, 8:3047-3054

Published Date: 20 October 2015

Forkhead box protein A1 is a prognostic predictor and promotes tumor growth of gastric cancer

Ren H, Zhang P, Tang Y, Wu M, Zhang W

OncoTargets and Therapy 2015, 8:3029-3039

Published Date: 20 October 2015

miR-195 is a key regulator of Raf1 in thyroid cancer

Wang F, Jiang C, Sun Q, Yan F, Wang L, Fu Z, Liu T, Hu F

OncoTargets and Therapy 2015, 8:3021-3028

Published Date: 20 October 2015

EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinoma

Ren YY, Yao YB, Ma Q, Zhong DS

OncoTargets and Therapy 2015, 8:3017-3020

Published Date: 20 October 2015

SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas

Zheng S, Pan Y, Wang R, Li Y, Cheng C, Shen X, Li B, Zheng D, Sun Y, Chen H

OncoTargets and Therapy 2015, 8:3009-3016

Published Date: 19 October 2015

MicroRNA-766 targeting regulation of SOX6 expression promoted cell proliferation of human colorectal cancer

Li YC, Li CF, Chen LB, Li DD, Yang L, Jin JP, Zhang B

OncoTargets and Therapy 2015, 8:2981-2988

Published Date: 20 October 2015

Links between cancer stem cells and epithelial– mesenchymal transition

Wang SS, Jiang J, Liang XH, Tang YL

OncoTargets and Therapy 2015, 8:2973-2980

Published Date: 16 October 2015

Mutation analysis underlying the downregulation of the thyroid hormone receptor β1 gene in the Chinese breast cancer population

Ling YQ, Ling XL, Fan L, Wang Y, Li Q

OncoTargets and Therapy 2015, 8:2967-2972

Published Date: 16 October 2015

Differential regulation of human Eag1 channel expression by serum and epidermal growth factor in lung and breast cancer cells

Acuña-Macías I, Vera E, Vázquez-Sánchez AY, Mendoza-Garrido ME, Camacho J

OncoTargets and Therapy 2015, 8:2959-2965

Published Date: 16 October 2015

Molecular profiling in the treatment of colorectal cancer: focus on regorafenib

Yan Y, Grothey A

OncoTargets and Therapy 2015, 8:2949-2957

Published Date: 15 October 2015

A human leucyl-tRNA synthetase as an anticancer target

Gao G, Yao Y, Li K, Mashausi DS, Li D, Negi H, Kamle S, Chen H, Wu Z, Zhou H, Li D

OncoTargets and Therapy 2015, 8:2933-2942

Published Date: 15 October 2015

Deregulation of secreted frizzled-related proteins is associated with aberrant β-catenin activation in the carcinogenesis of oral submucous fibrosis

Zhou S, Chen L, Mashrah M, Zhu Y, Liu J, Yang X, He Z, Wang L, Xiang T, Yao Z, Guo F, Yang W, Zhang C

OncoTargets and Therapy 2015, 8:2923-2931

Published Date: 14 October 2015

EGFR-TKIs in adjuvant treatment of lung cancer: to give or not to give?

Milovancev A, Stojsic V, Zaric B, Kovacevic T, Sarcev T, Perin B, Zarogoulidis K, Tsirgogianni K, Freitag L, Darwiche K, Tsavlis D, Zissimopoulos A, Stratakos G, Zarogoulidis P

OncoTargets and Therapy 2015, 8:2915-2921

Published Date: 13 October 2015

Genetic polymorphisms of CYP1A1 and risk of leukemia: a meta-analysis

Lu J, Zhao Q, Zhai YJ, He HR, Yang LH, Gao F, Zhou RS, Zheng J, Ma XC

OncoTargets and Therapy 2015, 8:2883-2902

Published Date: 12 October 2015

Study of internal mammary sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy

Cao XS, Cong BB, Sun X, Qiu PF, Wang YS

OncoTargets and Therapy 2015, 8:2873-2874

Published Date: 9 October 2015

Changing attitudes toward needle biopsies of breast cancer in Shanghai: experience and current status over the past 8 years

Hao S, Liu ZB, Ling H, Chen JJ, Shen JP, Yang WT, Shao ZM

OncoTargets and Therapy 2015, 8:2865-2871

Published Date: 9 October 2015

Role of estrogen in lung cancer based on the estrogen receptor-epithelial mesenchymal transduction signaling pathways

Zhao XZ, Liu Y, Zhou LJ, Wang ZQ, Wu ZH, Yang XY

OncoTargets and Therapy 2015, 8:2849-2863

Published Date: 9 October 2015

Postoperative intensity-modulated radiation therapy provides favorable local control and low toxicities in patients with soft tissue sarcomas in the extremities and trunk wall

Wang JY, Wang SL, Song YW, Liu XF, Jin J, Wang WH, Yu ZH, Liu YP, Li YX

OncoTargets and Therapy 2015, 8:2843-2847

Published Date: 9 October 2015

CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma

Chen RW, Xu YF, Du XJ, Liu N, Li YQ, He QM, Tang LL, Mao YP, Sun Y, Chen L, Ma J

OncoTargets and Therapy 2015, 8:2835-2842

Published Date: 8 October 2015

Does night-shift work increase the risk of prostate cancer? a systematic review and meta-analysis

Rao D, Yu H, Bai Y, Zheng X, Xie L

OncoTargets and Therapy 2015, 8:2817-2826

Published Date: 5 October 2015

Molecular diagnostics of a single drug-resistant multiple myeloma case using targeted next-generation sequencing

Ikeda H, Ishiguro K, Igarashi T, Aoki Y, Hayashi T, Ishida T, Sasaki Y, Tokino T, Shinomura Y

OncoTargets and Therapy 2015, 8:2805-2815

Published Date: 5 October 2015

Association between the COMT Val158Met polymorphism and risk of cancer: evidence from 99 case–control studies

Zhou Q, Wang Y, Chen AH, Tao YL, Song HM, Li W, Tao J, Zuo MZ

OncoTargets and Therapy 2015, 8:2791-2803

Published Date: 5 October 2015

Spotlight on decitabine for myelodysplastic syndromes in Chinese patients

Jing Y, Shen X, Mei Q, Han W

OncoTargets and Therapy 2015, 8:2783-2790

Published Date: 3 October 2015

Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials

Zhao LD, Li W, Zhang HY, Hou N, Guo LW, Gao QL

OncoTargets and Therapy 2015, 8:2775-2781

Published Date: 3 October 2015

ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases

Ungur R, Tempescul A, Berthou C, Bagacean C, Radeanu D, Muresan A, Zdrenghea M

OncoTargets and Therapy 2015, 8:2771-2773

Published Date: 1 October 2015

Increased risk of developing lung cancer in Asian patients carrying the TERT rs2736098 G>A polymorphism: evidence from 3,354 cases and 3,518 controls

Yang ZH, Zhang XL, Fang SR, Tan Y, Yan HJ, Gu W, Wang JH

OncoTargets and Therapy 2015, 8:2757-2765

Published Date: 30 September 2015

Anti-DR5 mAb inhibits proliferation of human fibroblast-like synovial cells and reduces their cytokine secretion in vitro

Zhang M, Shi C, Xia C, Yang J, Niu X, Zhuang G, Yin P

OncoTargets and Therapy 2015, 8:2745-2755

Published Date: 29 September 2015

Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients

Zhao QT, Yang Y, Xu S, Zhang XP, Wang HE, Zhang H, Wang ZK, Yuan Z, Duan GC

OncoTargets and Therapy 2015, 8:2731-2738

Published Date: 29 September 2015

Comparative study on individual aromatase inhibitors on cardiovascular safety profile: a network meta-analysis

Zhao XH, Liu L, Li K, Li WS, Zhao L, Zou HW

OncoTargets and Therapy 2015, 8:2721-2730

Published Date: 29 September 2015

The predictive effect of overexpressed miR-34a on good survival of cancer patients: a systematic review and meta-analysis

Wang J, Dan GR, Zhao JQ, Ding Y, Ye F, Sun HQ, Jiang F, Cheng J, Yuan FH, Zou ZM

OncoTargets and Therapy 2015, 8:2709-2719

Published Date: 25 September 2015

Validation study of the modified injection technique for internal mammary sentinel lymph node biopsy in breast cancer

Cong BB, Cao XS, Qiu PF, Liu YB, Zhao T, Chen P, Wang CJ, Zhang ZP, Sun X, Wang YS

OncoTargets and Therapy 2015, 8:2705-2708

Published Date: 24 September 2015

A study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer

Jia W, Fei GH, Hu JG, Hu XW

OncoTargets and Therapy 2015, 8:2699-2704

Published Date: 23 September 2015

miR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of non-small-cell lung cancer

Ni R, Huang Y, Wang J

OncoTargets and Therapy 2015, 8:2689-2697

Published Date: 22 September 2015

Associations of polymorphisms in NAT2 gene with risk and metastasis of osteosarcoma in young Chinese population

Huang Z, Yuan L, Jiang Z, Wang D

OncoTargets and Therapy 2015, 8:2675-2680

Published Date: 22 September 2015

Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway

Cai Y, He J, Zhang D

OncoTargets and Therapy 2015, 8:2657-2664

Published Date: 21 September 2015

Diarrhea as initial manifestation of pulmonary artery intimal sarcoma: a case report and literature review

Xu X, Zhang R, Hu H, Ye W, Wang J, Chen L, Qiu L, Ying K

OncoTargets and Therapy 2015, 8:2651-2656

Published Date: 18 September 2015

Combination of Bcl-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphoma

Wang J, Zhou M, Xu JY, Chen B, Ouyang J

OncoTargets and Therapy 2015, 8:2645-2650

Published Date: 18 September 2015

miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma MG-63 cells by targeting VEGFA

Wang L, Shan M, Yang F, Liu Y, Qi H, Zhou L, Qiu L, Li Y

OncoTargets and Therapy 2015, 8:2635-2642

Published Date: 16 September 2015

Role of DFNA5 in hearing loss and cancer – a comment on Rakusic et al

Croes L, Op de Beeck K, Van Camp G

OncoTargets and Therapy 2015, 8:2613-2615

Published Date: 15 September 2015

Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors

Dai F, Zhang XM, Shen WR, Chen J, Liu LC, Gao GJ

OncoTargets and Therapy 2015, 8:2601-2611

Published Date: 15 September 2015

Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy

Wang H, Wang L, Wuxiao ZJ, Huang HQ, Jiang WQ, Li ZM, Lu Y, Xia ZJ

OncoTargets and Therapy 2015, 8:2589-2599

Published Date: 14 September 2015

Protein tyrosine phosphatase SHP-1 sensitizes EGFR/HER-2 positive breast cancer cells to trastuzumab through modulating phosphorylation of EGFR and HER-2

Wu YF, Li R, Zhang JY, Wang G, Liu B, Huang XF, Zhang T, Luo RC

OncoTargets and Therapy 2015, 8:2577-2587

Published Date: 14 September 2015

Prognostic role of LSD1 in various cancers: evidence from a meta-analysis

Wu J, Hu LX, Du YY, Kong FL, Pan YY

OncoTargets and Therapy 2015, 8:2565-2570

Published Date: 15 September 2015

The engineered Salmonella typhimurium inhibits tumorigenesis in advanced glioma

Chen JQ, Zhan YF, Wang W, Jiang SN, Li XY

OncoTargets and Therapy 2015, 8:2555-2563

Published Date: 15 September 2015

New developments in the management of advanced melanoma – role of pembrolizumab

Improta G, Leone I, Donia M, Gieri S, Pelosi G, Fraggetta F

OncoTargets and Therapy 2015, 8:2535-2543

Published Date: 14 September 2015

The clinical analysis of acute pancreatitis in colorectal cancer patients undergoing chemotherapy after operation

Ji YL, Han Z, Shao LM, Li YL, Zhao L, Zhao YH

OncoTargets and Therapy 2015, 8:2527-2533

Published Date: 11 September 2015

The expression and clinical significance of HDGF in osteosarcoma

Chen Z, Qiu S, Lu X

OncoTargets and Therapy 2015, 8:2509-2517

Published Date: 9 September 2015

Treatment and survival analyses of completely resected thymic carcinoma patients

Mao Y, Wu S

OncoTargets and Therapy 2015, 8:2503-2507

Published Date: 9 September 2015

Association between the polymorphisms of urokinase plasminogen activation system and cancer risk: a meta-analysis

Xu Z, Meng LL, Lin JZ, Ling Y, Chen SX, Lin N

OncoTargets and Therapy 2015, 8:2493-2502

Published Date: 9 September 2015

Thyroid transcription factor-1 expression is significantly associated with mutations in exon 21 of the epidermal growth factor receptor gene in Chinese patients with lung adenocarcinoma

Zhao QC, Xu S, Liu JH, Li Y, Fan YG, Shi T, Wei S, Tang SC, Liu HY, Chen J

OncoTargets and Therapy 2015, 8:2469-2478

Published Date: 7 September 2015

No associations between aromatase gene polymorphisms and breast cancer risk in Saudi patients

Alanazi M, Alabdulkarim HA, Shaik JP, Al Naeem A, Elrobh M, Al Amri A, al-Mukaynizi FB, Semlali A, Warsy A, Parine NR

OncoTargets and Therapy 2015, 8:2453-2459

Published Date: 3 September 2015

A common genetic variation in CEBPE and acute lymphoblastic leukemia: a meta-analysis of the available evidence

Zhang XX, Du YF, Zhai YJ, Gao F, Yang YJ, Ma XC, Lu J, Zheng J

OncoTargets and Therapy 2015, 8:2443-2451

Published Date: 7 September 2015

Treatment compliance and severe adverse events limit the use of tyrosine kinase inhibitors in refractory thyroid cancer

Chrisoulidou A, Mandanas S, Margaritidou E, Mathiopoulou L, Boudina M, Georgopoulos K, Pazaitou-Panayiotou K

OncoTargets and Therapy 2015, 8:2435-2442

Published Date: 3 September 2015

The expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosis

Ying J, Xu Q, Liu B, Zhang G, Chen L, Pan H

OncoTargets and Therapy 2015, 8:2427-2433

Published Date: 1 September 2015

Dietary fiber, whole grains, carbohydrate, glycemic index, and glycemic load in relation to risk of prostate cancer

Wang RJ, Tang JE, Chen Y, Gao JG

OncoTargets and Therapy 2015, 8:2415-2426

Published Date: 2 September 2015

Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer

Yang Q, Yin CX, Liao FX, Huang YY, He WZ, Jiang C, Guo GF, Zhang B, Xia LP

OncoTargets and Therapy 2015, 8:2407-2413

Published Date: 1 September 2015

The distinctive nature of adenocarcinoma of the lung

Roviello G

OncoTargets and Therapy 2015, 8:2399-2406

Published Date: 2 September 2015

Chronic neutrophilic leukemia: a clinical perspective

Menezes J, Cigudosa JC

OncoTargets and Therapy 2015, 8:2383-2390

Published Date: 1 September 2015

The impact of histological types on the efficacy of angiogenesis inhibitors in the treatment of advanced NSCLC: a meta-analysis of randomized controlled trials

Zhang J, Liu J, Chen HG, Wu WB, Li XJ, Wu YH, Zhang K, Gu LJ

OncoTargets and Therapy 2015, 8:2375-2382

Published Date: 31 August 2015

Apoptotic effect of cordycepin combined with cisplatin and/or paclitaxel on MA-10 mouse Leydig tumor cells

Kang FC, Chen PJ, Pan BS, Lai MS, Chen YC, Huang BM

OncoTargets and Therapy 2015, 8:2345-2360

Published Date: 1 September 2015

The prognosis factor of adjuvant radiation therapy after surgery in uterine sarcomas

Hou HL, Meng MB, Chen XL, Zhao LJ, Zhu L, Zhang BL, Wang P

OncoTargets and Therapy 2015, 8:2339-2344

Published Date: 28 August 2015

Clinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancer

Sokolov M, Angelov K, Vasileva M, Atanasova MP, Vlahova A, Todorov G

OncoTargets and Therapy 2015, 8:2329-2337

Published Date: 1 September 2015

Micheliolide overcomes KLF4-mediated cisplatin resistance in breast cancer cells by downregulating glutathione

Jia Y, Zhang C, Zhou L, Xu H, Shi Y, Tong Z

OncoTargets and Therapy 2015, 8:2319-2327

Published Date: 28 August 2015

Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy

Zhang H, Wang M, Shi T, Shen L, Zhu J, Sun M, Deng Y, Liang L, Li G, Wu Y, Fan M, Wei Q, Zhang Z

OncoTargets and Therapy 2015, 8:2291-2301

Published Date: 27 August 2015

Effects of magnetic nanoparticles of Fe3O4 combinated with gambogic acid on apoptosis of SMMC-7721 cells

Tian L, Chen BA, Cheng J, Guo QL

OncoTargets and Therapy 2015, 8:2285-2290

Published Date: 26 August 2015

Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas

Dequanter D, Shahla M, Aubert C, Deniz Y, Lothaire P

OncoTargets and Therapy 2015, 8:2279-2283

Published Date: 26 August 2015

Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas

Cong D, He MZ, Chen SL, Liu XL, Liu XD, Sun H

OncoTargets and Therapy 2015, 8:2271-2277

Published Date: 26 August 2015

Cemented allograft-prosthesis composite reconstruction for the proximal femur tumor

Min L, Tang F, Duan H, Zhou Y, Zhang WL, Shi R, Tu CQ

OncoTargets and Therapy 2015, 8:2261-2269

Published Date: 25 August 2015

Trametinib: a MEK inhibitor for management of metastatic melanoma

Lugowska I, Koseła-Paterczyk H, Kozak K, Rutkowski P

OncoTargets and Therapy 2015, 8:2251-2259

Published Date: 25 August 2015

Expressions and clinical significance of autophagy-related markers Beclin1, LC3, and EGFR in human cervical squamous cell carcinoma

Hu YF, Lei X, Zhang HY, Ma JW, Yang WW, Chen ML, Cui J, Zhao H

OncoTargets and Therapy 2015, 8:2243-2249

Published Date: 24 August 2015

Comparing two assays for clinical genomic profiling: the devil is in the data

Squillace RM, Frampton GM, Stephens PJ, Ross JS, Miller VA

OncoTargets and Therapy 2015, 8:2237-2242

Published Date: 24 August 2015

MicroRNA-212 inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting FOXA1

Tu H, Wei G, Cai Q, Chen X, Sun Z, Cheng C, Zhang L, Feng Y, Zhou H, Zhou B, Zeng T

OncoTargets and Therapy 2015, 8:2227-2235

Published Date: 24 August 2015

Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer

Xiao XG, Wang SJ, Xia S, Zou M, Li Y, Wei Y, Mei Q, Chen Y

OncoTargets and Therapy 2015, 8:2209-2214

Published Date: 21 August 2015

Disruption of NF-κB signaling by fluoxetine attenuates MGMT expression in glioma cells

Song T, Li H, Tian Z, Xu C, Liu J, Guo Y

OncoTargets and Therapy 2015, 8:2199-2208

Published Date: 20 August 2015

Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review

Zagouri F, Sergentanis TN, Chrysikos D, Dimopoulos MA, Bamias A

OncoTargets and Therapy 2015, 8:2187-2198

Published Date: 20 August 2015

The association between miR-499 polymorphism and cancer susceptibility: a meta-analysis

Xu Z, Zhang E, Duan W, Sun C, Bai S, Tan X

OncoTargets and Therapy 2015, 8:2179-2186

Published Date: 20 August 2015

Morphologic patterns and imaging features of intracranial hemangiopericytomas: a retrospective analysis

Pang HP, Yao ZW, Ren Y, Liu GB, Zhang JW, Feng XY

OncoTargets and Therapy 2015, 8:2169-2178

Published Date: 20 August 2015

Current and emerging treatment options for hairy cell leukemia

López-Rubio M, Garcia-Marco JA

OncoTargets and Therapy 2015, 8:2147-2156

Published Date: 19 August 2015

Clinical efficacy of percutaneous vertebroplasty combined with intensity-modulated radiotherapy for spinal metastases in patients with NSCLC

Li Y, Qing Y, Zhang ZM, Li MX, Xie JY, Wang G, Wang D

OncoTargets and Therapy 2015, 8:2139-2145

Published Date: 19 August 2015

Alteration of ASIC1 expression in clear cell renal cell carcinoma

Li Y, Xu G, Huang K, Wang J, Zhang J, Liu J, Wang Z, Chen G

OncoTargets and Therapy 2015, 8:2121-2127

Published Date: 14 August 2015

CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies

Mao Q, Qiu M, Dong G, Xia W, Zhang S, Xu Y, Wang J, Rong Y, Xu L, Jiang F

OncoTargets and Therapy 2015, 8:2111-2120

Published Date: 13 August 2015

Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer

Liu XJ, Liu WL, Yang FM, Yang XQ, Lu XF

OncoTargets and Therapy 2015, 8:2101-2109

Published Date: 13 August 2015

Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis

Cheng Y, Deng X, Yang X, Li P, Zhang X, Li P, Tao J, Lu Q, Wang Z

OncoTargets and Therapy 2015, 8:2089-2096

Published Date: 11 August 2015

Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib

Zheng WX, Yan F, Xue Q, Wu GJ, Qin WJ, Wang FL, Qin J, Tian CJ, Yuan JL

OncoTargets and Therapy 2015, 8:2081-2088

Published Date: 10 August 2015

PP4R1 accelerates cell growth and proliferation in HepG2 hepatocellular carcinoma

Wu G, Ma ZY, Qian JM, Liu B

OncoTargets and Therapy 2015, 8:2067-2074

Published Date: 7 August 2015

Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers

Cojocneanu Petric R, Braicu C, Raduly L, Zanoaga O, Dragos N, Monroig P, Dumitrascu D, Berindan-Neagoe I

OncoTargets and Therapy 2015, 8:2053-2066

Published Date: 6 August 2015

Nivolumab in the treatment of malignant melanoma: review of the literature

Mashima E, Inoue A, Sakuragi Y, Yamaguchi T, Sasaki N, Hara Y, Omoto D, Ohmori S, Haruyama S, Sawada Y, Yoshioka M, Nishio D, Nakamura M

OncoTargets and Therapy 2015, 8:2045-2051

Published Date: 6 August 2015

Meta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancer

Chen YY, Wang LW, Wang SY, Wu BB, Wang ZM, Chen FF, Xiong B

OncoTargets and Therapy 2015, 8:2033-2043

Published Date: 4 August 2015

Computer-aided classification of lung nodules on computed tomography images via deep learning technique

Hua KL, Hsu CH, Hidayati SC, Cheng WH, Chen YJ

OncoTargets and Therapy 2015, 8:2015-2022

Published Date: 4 August 2015

Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)

Spitaleri G, Biffi R, Barberis M, Fumagalli C, Toffalorio F, Catania C, Noberasco C, Lazzari C, de Marinis F, De Pas T

OncoTargets and Therapy 2015, 8:1997-2003

Published Date: 18 August 2015

The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b

Ma Q, Chen Z, Jia G, Lu X, Xie X, Jin W

OncoTargets and Therapy 2015, 8:1979-1988

Published Date: 10 August 2015

Low claudin-6 expression correlates with poor prognosis in patients with non-small cell lung cancer

Wang Q, Zhang Y, Zhang T, Han ZG, Shan L

OncoTargets and Therapy 2015, 8:1971-1977

Published Date: 31 July 2015

The role of 18F-FDG PET/CT imaging in patient with malignant PEComa treated with mTOR inhibitor

Sun L, Sun XR, Li YH, Xing LG

OncoTargets and Therapy 2015, 8:1967-1970

Published Date: 30 July 2015

−148 C/T polymorphism of Axin2 contributes to a decreased risk of cancer: evidence from a meta-analysis

Zhong AY, Pan X, Shi MH, Xu HJ

OncoTargets and Therapy 2015, 8:1957-1966

Published Date: 29 July 2015

Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis

Liang JB, Li BH, Yuan L, Ye ZM

OncoTargets and Therapy 2015, 8:1949-1955

Published Date: 29 July 2015

Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer

Lv Y, Zhao S, Han J, Zheng L, Yang Z, Zhao L

OncoTargets and Therapy 2015, 8:1941-1948

Published Date: 29 July 2015

Determination and validation of mTOR kinase-domain 3D structure by homology modeling

Lakhlili W, Chevé G, Yasri A, Ibrahimi A

OncoTargets and Therapy 2015, 8:1923-1930

Published Date: 30 July 2015

Whole blood defensin mRNA expression is a predictive biomarker of docetaxel response in castration-resistant prostate cancer

Kohli M, Young CYF, Tindall DJ, Nandy D, McKenzie KM, Bevan GH, Donkena KV

OncoTargets and Therapy 2015, 8:1915-1922

Published Date: 30 July 2015

Malignant glomus tumor of the lung with multiorgan metastases: case report and literature review

Dong LL, Chen EG, Sheikh IS, Jiang ZN, Huang AH, Ying KJ

OncoTargets and Therapy 2015, 8:1909-1914

Published Date: 28 July 2015

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma

Cheng CT, Chu YY, Yeh CN, Huang SC, Chen MH, Wang SY, Tsai CY, Chiang KC, Chen YY, Ma MC, Liu CT, Chen TW, Yeh TS

OncoTargets and Therapy 2015, 8:1899-1907

Published Date: 28 July 2015

The expression and significance of Gal-3 and MUC1 in colorectal cancer and colon cancer

Wang H, Wang L

OncoTargets and Therapy 2015, 8:1893-1898

Published Date: 27 July 2015

Is there any association between hormonal contraceptives and cervical neoplasia in a poor Nigerian setting?

Ajah LO, Chigbu CO, Ozumba BC, Oguanuo TC, Ezeonu PO

OncoTargets and Therapy 2015, 8:1887-1892

Published Date: 27 July 2015

Investigation of brain tumors using 18F-fluorobutyl ethacrynic amide and its metabolite with positron emission tomography

Huang YC, Huang HL, Yeh CN, Lin KJ, Yu CS

OncoTargets and Therapy 2015, 8:1877-1885

Published Date: 24 July 2015

miR-20b overexpression is predictive of poor prognosis in gastric cancer

Xue TM, Tao LD, Zhang M, Xu GC, Zhang J, Zhang PJ

OncoTargets and Therapy 2015, 8:1871-1876

Published Date: 24 July 2015

p27Kip1 and Ser10-phosphorylated p27Kip1 in breast cancer: clinical significance and expression

Song W, Xie RL, Zhu AY, Xu YM, Shi YQ, Shen Y, Zhang WW, Yang F, Guan XX

OncoTargets and Therapy 2015, 8:1863-1869

Published Date: 24 July 2015

Ganetespib: research and clinical development

Jhaveri K, Modi S

OncoTargets and Therapy 2015, 8:1849-1858

Published Date: 24 July 2015

Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?

Giannos A, Filipits M, Zagouri F, Brandstetter A, Tsigginou A, Sotiropoulou M, Papaspyrou I, Sergentanis TN, Psaltopoulou T, Rodolakis A, Antsaklis A, Dimopoulos MA, Dimitrakakis C

OncoTargets and Therapy 2015, 8:1843-1847

Published Date: 23 July 2015

Association between GSTP1 polymorphisms and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis

Pu FF, Chen FX, Chen SF, Wang BC, Liu JX, Shao ZW

OncoTargets and Therapy 2015, 8:1835-1842

Published Date: 23 July 2015

Follicular dendritic cell sarcoma: two rare cases and a brief review of the literature

Ma Y, Sun JJ, Yang CC, Yuan DD, Liu J

OncoTargets and Therapy 2015, 8:1823-1830

Published Date: 24 July 2015

Diffuse anterior retinoblastoma: current concepts

Yang J, Dang Y, Zhu Y, Zhang C

OncoTargets and Therapy 2015, 8:1815-1821

Published Date: 22 July 2015

Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy

Wei B, Huang Q, Zhong X

OncoTargets and Therapy 2015, 8:1805-1814

Published Date: 21 July 2015

MTA1 promotes proliferation and invasion in human gastric cancer cells

Yao Y, Feng S, Xiao M, Li Y, Yang L, Gong J

OncoTargets and Therapy 2015, 8:1785-1794

Published Date: 20 July 2015

miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer

Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, Yu L

OncoTargets and Therapy 2015, 8:1773-1783

Published Date: 20 July 2015

Volasertib for AML: clinical use and patient consideration

Hao Z, Kota V

OncoTargets and Therapy 2015, 8:1761-1771

Published Date: 17 July 2015

IL-2 -330T/G polymorphism and cancer risk: a meta-analysis

Zhao HY, Wang R

OncoTargets and Therapy 2015, 8:1753-1760

Published Date: 17 July 2015

Single nucleotide polymorphisms of microRNA processing genes and outcome of non-Hodgkin’s lymphoma

Gao Y, Diao L, Li H, Guo Z

OncoTargets and Therapy 2015, 8:1735-1741

Published Date: 15 July 2015

B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells

Zhang W, Wang J, Wang Y, Dong F, Zhu M, Wan W, Li H, Wu F, Yan X, Ke X

OncoTargets and Therapy 2015, 8:1721-1733

Published Date: 14 July 2015

A tale of the two PEGylated liposomal doxorubicins

Chou HH, Lin H, Liu JM

OncoTargets and Therapy 2015, 8:1719-1720

Published Date: 13 July 2015

The prognostic significance of protein tyrosine phosphatase 4A2 in breast cancer

Zhao D, Guo L, Neves H, Yuen HF, Zhang SD, McCrudden CM, Wen Q, Zhang J, Zeng Q, Kwok HF, Lin Y

OncoTargets and Therapy 2015, 8:1707-1717

Published Date: 13 July 2015

Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury

Mizuno T, Sato W, Ishikawa K, Terao Y, Takahashi K, Noda Y, Yuzawa Y, Nagamatsu T

OncoTargets and Therapy 2015, 8:1701-1706

Published Date: 10 July 2015

Screening of potential diagnostic markers and therapeutic targets against colorectal cancer

Tian XQ, Sun DF, Zhao SL, Xiong H, Fang JY

OncoTargets and Therapy 2015, 8:1691-1699

Published Date: 8 July 2015

AKT2-knockdown suppressed viability with enhanced apoptosis, and attenuated chemoresistance to temozolomide of human glioblastoma cells in vitro and in vivo

Cui Y, Lin J, Zuo JL, Zhang L, Dong Y, Hu GH, Luo C, Chen JX, Lu YC

OncoTargets and Therapy 2015, 8:1681-1690

Published Date: 8 July 2015

Association between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjects

Ao X, Liu Y, Bai XY, Qu X, Xu Z, Hu G, Chen M, Wu H

OncoTargets and Therapy 2015, 8:1671-1680

Published Date: 7 July 2015

FH535 inhibited metastasis and growth of pancreatic cancer cells

Wu MY, Liang RR, Chen K, Shen M, Tian YL, Li DM, Duan WM, Gui Q, Gong FR, Lian L, Li W, Tao M

OncoTargets and Therapy 2015, 8:1651-1670

Published Date: 6 July 2015

High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer

Han T, Liu Z, Li H, Xie W, Zhang R, Zhu L, Guo F, Han Y, Sheng Y, Xie X

OncoTargets and Therapy 2015, 8:1643-1649

Published Date: 6 July 2015

Mixed acinar-endocrine carcinoma of pancreas: a case report and brief review of the literature

Liu Z, Dong C, Wang C, Liu Q, Sun D, Wang L

OncoTargets and Therapy 2015, 8:1633-1642

Published Date: 3 July 2015

Microwave ablation: state-of-the-art review

Hernández JI, Cepeda MFJ, Valdés F, Guerrero GD

OncoTargets and Therapy 2015, 8:1627-1632

Published Date: 6 July 2015

Expression of MMP-1/PAR-1 and patterns of invasion in oral squamous cell carcinoma as potential prognostic markers

Fan HX, Chen Y, Ni BX, Wang S, Sun M, Chen D, Zheng JH

OncoTargets and Therapy 2015, 8:1619-1626

Published Date: 3 July 2015

Rapidly progressive stage IVB mycosis fungoides treated with low-dose total skin electron beam therapy

Chowdhary M, Kabbani AA, Rimtepathip P, Cole Jr DA, Cohen DJ

OncoTargets and Therapy 2015, 8:1597-1601

Published Date: 1 July 2015

Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer

Ling XL, Zhang T, Hou XM, Zhao D

OncoTargets and Therapy 2015, 8:1589-1595

Published Date: 30 June 2015

Prognostic analysis of Chinese patients with metastasis renal cell cancer receiving sorafenib: results from a multicenter long-term follow-up retrospective study

Guo F, Han T, Liu Z, Song X, Zhang Q, Kong X, Li C, Li Z, Li C, Qu S, Zheng Z, Piao Y, Han Y, Xie X

OncoTargets and Therapy 2015, 8:1581-1588

Published Date: 26 June 2015

Profile of blinatumomab and its potential in the treatment of relapsed/refractory acute lymphoblastic leukemia

Ribera JM, Ferrer A, Ribera J, Genescà E

OncoTargets and Therapy 2015, 8:1567-1574

Published Date: 24 June 2015

Role of integrin-linked kinase in drug resistance of lung cancer

Jia Z

OncoTargets and Therapy 2015, 8:1561-1565

Published Date: 23 June 2015

Enhanced NK cell adoptive antitumor effects against breast cancer in vitro via blockade of the transforming growth factor-β signaling pathway

Zhao Y, Hu JY, Li RG, Song J, Kang YJ, Liu S, Zhang DW

OncoTargets and Therapy 2015, 8:1553-1559

Published Date: 22 June 2015

Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis

Lu M, Li J, Luo Z, Zhang S, Xue S, Wang K, Shi Y, Zhang C, Chen H, Li Z

OncoTargets and Therapy 2015, 8:1543-1552

Published Date: 22 June 2015

Detection of epidermal growth factor receptor mutation in lung cancer by droplet digital polymerase chain reaction

Xu Q, Zhu Y, Bai Y, Wei X, Zheng X, Mao M, Zheng G

OncoTargets and Therapy 2015, 8:1533-1541

Published Date: 22 June 2015

Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients

Obacz J, Brychtova V, Podhorec J, Fabian P, Dobes P, Vojtesek B, Hrstka R

OncoTargets and Therapy 2015, 8:1523-1532

Published Date: 24 June 2015

Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer

Zhao Y, Dong XQ, Li RG, Ma X, Song J, Li YJ, Zhang DW

OncoTargets and Therapy 2015, 8:1511-1521

Published Date: 19 June 2015

Axillary and internal mammary sentinel lymph node biopsy in male breast cancer patients: case series and review

Cao X, Wang C, Liu Y, Qiu P, Cong B, Wang Y

OncoTargets and Therapy 2015, 8:1499-1502

Published Date: 17 June 2015

IL-27 rs153109 polymorphism increases the risk of colorectal cancer in Chinese Han population

Lyu SX, Ye LC, Wang OC, Huang GL, Yang F, Liu YH, Dong SY

OncoTargets and Therapy 2015, 8:1493-1497

Published Date: 16 June 2015

Exploration of peptide T7 and its derivative as integrin αvβ3-targeted imaging agents

He X, Hao Y, Long W, Song N, Fan S, Meng A

OncoTargets and Therapy 2015, 8:1483-1491

Published Date: 15 June 2015

Prognostic role of HOTAIR in four estrogen-dependent malignant tumors: a meta-analysis

Li J, Wen W, Zhao S, Wang JX, Chen JY, Wang YR, Zhang QY

OncoTargets and Therapy 2015, 8:1471-1482

Published Date: 15 June 2015

CpG oligodeoxyribonucleotide 7909 enhances radiosensitivity via downregulating Oct-4 expression in radioresistant lung cancer cells

Xing N, Qiao T, Zhuang X, Yuan S, Zhang Q, Xu G

OncoTargets and Therapy 2015, 8:1443-1449

Published Date: 12 June 2015

Analysis of clinical efficacy of CyberKnife® treatment for locally advanced pancreatic cancer

Song YC, Yuan ZY, Li FT, Dong Y, Zhuang HQ, Wang JS, Chen HM, Wang P

OncoTargets and Therapy 2015, 8:1427-1431

Published Date: 12 June 2015

Extracellular matrix as target for antitumor therapy

Harisi R, Jeney A

OncoTargets and Therapy 2015, 8:1387-1398

Published Date: 9 June 2015

A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer

Pan QX, Su ZJ, Zhang JH, Wang CR, Ke SY

OncoTargets and Therapy 2015, 8:1375-1385

Published Date: 16 June 2015

Axitinib versus sorafenib as a second-line therapy in Asian patients with metastatic renal cell carcinoma: results from a randomized registrational study

Qin S, Bi F, Jin J, Cheng Y, Guo J, Ren X, Huang Y, Tarazi J, Tang J, Chen C, Kim S, Ye D

OncoTargets and Therapy 2015, 8:1363-1373

Published Date: 8 June 2015

An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib

Zhang Y, Tang HP, Li J, Li M

OncoTargets and Therapy 2015, 8:1351-1354

Published Date: 8 June 2015

Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen

Perri F, Pisconti S, Conson M, Pacelli R, Della Vittoria Scarpati G, Gnoni A, D’Aniello C, Cavaliere C, Licchetta A, Cella L, Giuliano M, Schiavone C, Falivene S, Di Lorenzo G, Buonerba C, Ravo V, Muto P

OncoTargets and Therapy 2015, 8:1345-1349

Published Date: 8 June 2015

Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?

Kus T, Aktas G, Sevinc A, Kalender ME, Camci C

OncoTargets and Therapy 2015, 8:1341-1343

Published Date: 5 June 2015

The role of Nanog expression in tamoxifen-resistant breast cancer cells

Arif K, Hussain I, Rea C, El-Sheemy M

OncoTargets and Therapy 2015, 8:1327-1334

Published Date: 3 June 2015

Alectinib for choroidal metastasis in a patient with crizotinib-resistant ALK rearranged positive non-small cell lung cancer

Okuma Y, Tanaka Y, Kamei T, Hosomi Y, Okamura T

OncoTargets and Therapy 2015, 8:1321-1325

Published Date: 3 June 2015

Bevacizumab plus cisplatin and helical tomotherapy in treatment of locally advanced nasopharyngeal carcinoma

Li JX, Zhao ZF, Wu X, Yao J, Ma L, Ye R, Niu BL, Liang LQ, Zhao X, Wang QQ

OncoTargets and Therapy 2015, 8:1315-1319

Published Date: 2 June 2015

Sudden bilateral hearing loss in gastric cancer as the only symptom of disease

Rakusic Z, Misir Krpan A, Stupin Polancec D, Jakovcevic A, Bisof V

OncoTargets and Therapy 2015, 8:1285-1289

Published Date: 2 June 2015

Hyperthermia combined with 5-fluorouracil promoted apoptosis and enhanced thermotolerance in human gastric cancer cell line SGC-7901

Liu T, Ye YW, Zhu AL, Yang Z, Fu Y, Wei CQ, Liu Q, Zhao CL, Wang GJ, Zhang XF

OncoTargets and Therapy 2015, 8:1265-1270

Published Date: 27 May 2015

The clinical significances of the abnormal expressions of Piwil1 and Piwil2 in colonic adenoma and adenocarcinoma

Wang HL, Chen BB, Cao XG, Wang J, Hu, XF, Mu XQ, Chen XB

OncoTargets and Therapy 2015, 8:1259-1264

Published Date: 27 May 2015

Clinical and pathological analysis of 116 cases of adult adrenal cortical adenoma and literature review

Jia AH, Du HQ, Fan MH, Li YH, Xu JL, Niu GF, Bai J, Zhang GZ, Ren YB

OncoTargets and Therapy 2015, 8:1251-1257

Published Date: 28 May 2015

Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for the treatment of advanced intrahepatic cholangiocarcinoma

Yang GW, Zhao Q, Qian S, Zhu L, Qu XD, Zhang W, Yan ZP, Cheng JM, Liu QX, Liu R, Wang JH

OncoTargets and Therapy 2015, 8:1245-1250

Published Date: 26 May 2015

Positive feedback between oncogenic KRAS and HIF-1α confers drug resistance in colorectal cancer

Wang Y, Lei F, Rong W, Zeng Q, Sun W

OncoTargets and Therapy 2015, 8:1229-1237

Published Date: 26 May 2015

Clinical analysis of 50 Eastern Asian patients with primary pulmonary large-cell neuroendocrine carcinoma

Zhang XK, Qin T, Zeng YD, Zhao YY, Hou X, Fang WF, Hong SD, Zhou T, Hu ZH, Yang YP, Ma YX, Xue C, Huang Y, Zhao HY, Zhang L

OncoTargets and Therapy 2015, 8:1219-1227

Published Date: 26 May 2015

Antiproliferative effects and molecular mechanisms of troglitazone in human cervical cancer in vitro

Ye J, Yin L, Xie P, Wu J, Huang J, Zhou G, Xu H, Lu E, He X

OncoTargets and Therapy 2015, 8:1211-1218

Published Date: 26 May 2015

Oral treatment with the herbal formula B307 alleviates cardiac toxicity in doxorubicin-treated mice via suppressing oxidative stress, inflammation, and apoptosis

Lien CY, Chuang TY, Hsu CH, Lin CL, Wang SE, Sheu SJ, Chien CT, Wu CH

OncoTargets and Therapy 2015, 8:1193-1210

Published Date: 26 May 2015

HGF and NRG1 protein expression are not poor prognostic markers in surgically resected lung adenocarcinoma

Pan B, Wang R, Huang YL, Garfield D, Zhang J, Chen HQ

OncoTargets and Therapy 2015, 8:1185-1191

Published Date: 25 May 2015

DDMC-p53 gene therapy with or without cisplatin and microwave ablation

Hohenforst-Schmidt W, Zarogoulidis P, Stopek J, Vogl T, Hübner F, Turner JF, Browning R, Zarogoulidis K, Drevelegas A, Drevelegas K, Darwiche K, Freitag L, Rittger H

OncoTargets and Therapy 2015, 8:1165-1173

Published Date: 20 May 2015

The prognostic significance of fibroblast growth factor receptor 4 in non-small-cell lung cancer

Huang H, Feng H, Qiao H, Ren Z, Zhu G

OncoTargets and Therapy 2015, 8:1157-1164

Published Date: 22 May 2015

Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology

Aprile G, Leone F, Giampieri R, Casagrande M, Marino D, Faloppi L, Cascinu S, Fasola G, Scartozzi M

OncoTargets and Therapy 2015, 8:1149-1156

Published Date: 22 May 2015

Anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma with involvement of the urinary bladder: a case report and review of literature

Liang X, Wang Y, Zhang J, Cheng H, Wang J, Dang Y, Li H, Zhou R, Zhang J, Qiao Q

OncoTargets and Therapy 2015, 8:1143-1147

Published Date: 19 May 2015

Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01)

Suenaga M, Fujimoto Y, Matsusaka S, Shinozaki E, Akiyoshi T, Nagayama S, Fukunaga Y, Oya M, Ueno M, Mizunuma N, Yamaguchi T

OncoTargets and Therapy 2015, 8:1111-1118

Published Date: 18 May 2015

Radium-223 for the treatment of castration-resistant prostate cancer

El-Amm J, Aragon-Ching JB

OncoTargets and Therapy 2015, 8:1103-1109

Published Date: 18 May 2015

Comparison of tumor markers using different detection devices

Tao R, Tu SH, Liu C, Yang Q, Zhu M, Shen JF

OncoTargets and Therapy 2015, 8:1083-1090

Published Date: 19 May 2015

Circulating VEGF as a biomarker for diagnosis of ovarian cancer: a systematic review and a meta-analysis

Liang B, He Q, Zhong L, Wang S, Pan Z, Wang T, Zhao Y

OncoTargets and Therapy 2015, 8:1075-1082

Published Date: 15 May 2015

Primary paraesophageal Ewing’s sarcoma: an uncommon case report and literature review

Tarazona N, Navarro L, Cejalvo JM, Gambardella V, Pérez-Fidalgo JA, Sempere A, Navarro S, Cervantes A

OncoTargets and Therapy 2015, 8:1053-1059

Published Date: 14 May 2015

Lung cancer drug therapy in Hungary – 3-year experience

Moldvay J, Rokszin G, Abonyi-Tóth Z, Katona L, Fábián K, Kovács G

OncoTargets and Therapy 2015, 8:1031-1038

Published Date: 11 May 2015

Evaluation of clinical breast examination and breast ultrasonography among pregnant women in Abakaliki, Nigeria

Ezeonu PO, Ajah LO, Onoh RC, Lawani LO, Enemuo VC, Agwu UM

OncoTargets and Therapy 2015, 8:1025-1029

Published Date: 13 May 2015

ABCB1 C3435T polymorphism is associated with leukemia susceptibility: evidence from a meta-analysis

Ma L, Ruan L, Liu H, Yang H, Feng Y

OncoTargets and Therapy 2015, 8:1009-1015

Published Date: 5 May 2015

Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients

Lu H, Liu XJ, Guo FF, Tan SF, Wang GJ, Liu HJ, Wang JM, He XF, Mo YS, Shi BK

OncoTargets and Therapy 2015, 8:985-990

Published Date: 30 April 2015

SIRT1 expression is associated with poor prognosis of lung adenocarcinoma

Li C, Wang L, Zheng L, Zhan X, Xu B, Jiang J, Wu C

OncoTargets and Therapy 2015, 8:977-984

Published Date: 30 April 2015

GSTM1 null genotype and gastric cancer risk in the Chinese population: an updated meta-analysis and review

Zhang XL, Cui YH

OncoTargets and Therapy 2015, 8:969-975

Published Date: 28 April 2015

Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making

Weiss GJ, Hoff BR, Whitehead RP, Sangal A, Gingrich SA, Penny RJ, Mallery DW, Morris SM, Thompson EJ, Loesch DM, Khemka V

OncoTargets and Therapy 2015, 8:959-967

Published Date: 24 April 2015

Effect of blood type on survival of Chinese patients with esophageal squamous cell carcinoma

Qin J, Wu SG, Sun JY, Lin HX, He ZY, Li Q

OncoTargets and Therapy 2015, 8:947-953

Published Date: 23 April 2015

Randomized Phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer

Fushida S, Kaji M, Oyama K, Hirono Y, Nezuka H, Takeda T, Tsukada T, Fujimoto D, Ohyama S, Fujimura T, Ohta T

OncoTargets and Therapy 2015, 8:939-941

Published Date: 23 April 2015

Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis

Tedeschi AL, Eslami Z, Garoufalis E, Saleh RR, Omeroglu A, Altinel G, Ait-Tihyaty M, Jean-Claude B, Mihalcioiu C

OncoTargets and Therapy 2015, 8:911-919

Published Date: 21 April 2015

Comparison of uncommon EGFR exon 21 L858R compound mutations with single mutation

Peng L, Song ZG, Jiao SC

OncoTargets and Therapy 2015, 8:905-910

Published Date: 21 April 2015

HES1 is an independent prognostic factor for acute myeloid leukemia

Tian C, Tang Y, Wang T, Yu Y, Wang X, Wang Y, Zhang Y

OncoTargets and Therapy 2015, 8:899-904

Published Date: 22 April 2015

Comparison of single-agent chemotherapy and targeted therapy to first-line treatment in patients aged 80 years and older with advanced non-small-cell lung cancer

Zhang QQ, Wang ZH, Guo J, Liu LY, Han X, Li MM, Fang S, Bi X, Tang N, Liu Y

OncoTargets and Therapy 2015, 8:893-898

Published Date: 20 April 2015

Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond

Kanaan Z, Kloecker GH, Paintal A, Perez CA

OncoTargets and Therapy 2015, 8:885-892

Published Date: 20 April 2015

Synergistic inhibition of colon carcinoma cell growth by Hedgehog-Gli1 inhibitor arsenic trioxide and phosphoinositide 3-kinase inhibitor LY294002

Cai X, Yu K, Zhang L, Li Y, Li Q, Yang Z, Shen T, Duan L, Xiong W, Wang W

OncoTargets and Therapy 2015, 8:877-883

Published Date: 17 April 2015

Enzalutamide for patients with metastatic castration-resistant prostate cancer

Ramadan WH, Kabbara WK, Al Basiouni Al Masri HS

OncoTargets and Therapy 2015, 8:871-876

Published Date: 17 April 2015

Outcome of surgical resection for brain metastases and radical treatment of the primary tumor in Chinese non–small-cell lung cancer patients

Li Z, Zhang X, Jiang X, Guo C, Sai K, Yang Q, He Z, Wang Y, Chen Z, Li W, Mou Y

OncoTargets and Therapy 2015, 8:855-860

Published Date: 16 April 2015

Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2

Zhang P, Luo HS, Li M, Tan SY

OncoTargets and Therapy 2015, 8:845-854

Published Date: 16 April 2015

The significance of combining VEGFA, FLT1, and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab

Zhang SD, McCrudden CM, Meng C, Lin Y, Kwok HF

OncoTargets and Therapy 2015, 8:835-843

Published Date: 15 April 2015

DNA ploidy of cervical epithelial cells should be a cure criterion of high-risk HPV infection in Xinjiang Uygur women

Feng YC, Yang J, Liu CM, Cheng ZZ, Huang YC

OncoTargets and Therapy 2015, 8:827-833

Published Date: 13 April 2015

Profile of nimotuzumab in the treatment of high-grade glioma

Yang Q, Guo C, Chen Z

OncoTargets and Therapy 2015, 8:819-825

Published Date: 13 April 2015

Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal cancer: a meta-analysis

Yang X, Huang Y, Feng JF, Liu JS

OncoTargets and Therapy 2015, 8:789-794

Published Date: 10 April 2015

The effects of PGC-1α on the proliferation and energy metabolism of malignant endometrial cancer cells

Ren Z, Yang H, Wang C, Ma X

OncoTargets and Therapy 2015, 8:769-774

Published Date: 9 April 2015

GSK1838705A, an insulin-like growth factor-1 receptor/insulin receptor inhibitor, induces apoptosis and reduces viability of docetaxel-resistant prostate cancer cells both in vitro and in vivo

Zhou F, Chen X, Fan S, Tai S, Jiang C, Zhang Y, Hao Z, Zhou J, Shi H, Zhang L, Liang C

OncoTargets and Therapy 2015, 8:753-760

Published Date: 10 April 2015

Gene expression profile analysis of colorectal cancer to investigate potential mechanisms using bioinformatics

Kou YB, Zhang SY, Chen XP, Hu SY

OncoTargets and Therapy 2015, 8:745-752

Published Date: 8 April 2015

Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals

Sun B, Li J, Shao D, Pan Y, Chen Y, Li S, Yao X, Li H, Liu W, Zhang M, Zhang X, Chen L

OncoTargets and Therapy 2015, 8:735-744

Published Date: 7 April 2015

A chromosomal passenger complex protein signature model predicts poor prognosis for non-small-cell lung cancer

Xia R, Chen S, Chen Y, Zhang W, Zhu R, Deng A

OncoTargets and Therapy 2015, 8:721-726

Published Date: 7 April 2015

Development of a preliminary nomogram to predict progression of bone scan for castration-resistant prostate cancer

Lin GW, Ye DW, Jia HX, Dai B, Zhang HL, Zhu Y, Shi GH, Ma CG

OncoTargets and Therapy 2015, 8:713-719

Published Date: 7 April 2015

Treatment and prognosis of Masaoka stage 3 thymic carcinoma: a retrospective study of 32 cases

Sun Y, Liu J, Yu X

OncoTargets and Therapy 2015, 8:699-702

Published Date: 6 April 2015

A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report

De Divitiis C, von Arx C, Carbone R, Tatangelo F, Di Girolamo E, Romano GM, Ottaiano A, de Lutio di Castelguidone E, Iaffaioli RV, Tafuto S

OncoTargets and Therapy 2015, 8:669-675

Published Date: 31 March 2015

Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment

Gui T, Yuan GW, Shen K, Cao DY, Yang JX, Wu M, Lang JH

OncoTargets and Therapy 2015, 8:661-667

Published Date: 23 March 2015

Clinical significance of ALDH2 rs671 polymorphism in esophageal cancer: evidence from 31 case-control studies

Zhao TT, Wang C, Shen LL, Gu DY, Xu Z, Zhang XL, Xu Y, Chen JF

OncoTargets and Therapy 2015, 8:649-659

Published Date: 23 March 2015

Elevated expression of NEDD9 is associated with metastatic activity in gastric cancer

Zhang SS, Wu LH, Liu Q, Chen KS, Zhang XF

OncoTargets and Therapy 2015, 8:633-640

Published Date: 10 March 2015

Early enteral and parenteral nutritional support after hepatectomy in patients with hepatic carcinoma: a systematic review and meta-analysis

Gao LB, Tian H, Wang XG, Yu XF, Guan Y, Chen ML, Zhang J

OncoTargets and Therapy 2015, 8:623-631

Published Date: 10 March 2015

Expression and clinical significance of fibroblast growth factor 1 in gastric adenocarcinoma

Liu NQ, Zhang JG, Sun SX, Yang LG, Zhou ZJ, Sun QL, Niu J

OncoTargets and Therapy 2015, 8:615-621

Published Date: 9 March 2015

The association between the migration inhibitory factor -173G/C polymorphism and cancer risk: a meta-analysis

Zhang X, Weng WH, Xu W, Wang YL, Yu WJ, Tang X, Ma LF, Pan QH, Wang JY, Sun FY

OncoTargets and Therapy 2015, 8:601-613

Published Date: 10 March 2015

Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer

Zhao Q, Qian S, Zhu L, Qu XD, Zhang W, Yan ZP, Cheng JM, Liu QX, Liu R, Wang JH

OncoTargets and Therapy 2015, 8:595-600

Published Date: 9 March 2015

Epoetin beta for the treatment of chemotherapy-induced anemia: an update

Galli L, Ricci C, Egan CG

OncoTargets and Therapy 2015, 8:583-591

Published Date: 5 March 2015

Human papillomavirus 16 infection predicts poor outcome in patients with esophageal squamous cell carcinoma

Xi R, Zhang X, Chen X, Pan S, Hui B, Zhang L, Fu S, Li X, Zhang X, Gong T, Guo J, Che S

OncoTargets and Therapy 2015, 8:573-581

Published Date: 5 March 2015

Accumulation of p53 is prognostic for aromatase inhibitor resistance in early-stage postmenopausal patients with ER-positive breast cancer

Jia XQ, Hong Q, Cheng JY, Li JW, Wang YJ, Mo M, Shao ZM, Shen ZZ, Liu GY

OncoTargets and Therapy 2015, 8:549-555

Published Date: 3 March 2015

The role of miR-29b in cancer: regulation, function, and signaling

Yan B, Guo Q, Fu FJ, Wang Z, Yin Z, Wei YB, Yang JR

OncoTargets and Therapy 2015, 8:539-548

Published Date: 3 March 2015

Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer

Ohhara Y, Suenaga M, Matsusaka S, Shinozaki E, Mizunuma N, Yamaguchi T

OncoTargets and Therapy 2015, 8:529-537

Published Date: 3 March 2015

An update on PARP inhibitors for the treatment of cancer

Benafif S, Hall M

OncoTargets and Therapy 2015, 8:519-528

Published Date: 26 February 2015

Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair

Liu H, Yang W, Gao H, Jiang T, Gu B, Dong Q, Xu W, Wu S, Sun X

OncoTargets and Therapy 2015, 8:509-518

Published Date: 25 February 2015

Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthase

Asuncion Valenzuela MM, Castro I, Gonda A, Diaz Osterman CJ, Jutzy JM, Aspe JR, Khan S, Neidigh JW, Wall NR

OncoTargets and Therapy 2015, 8:495-507

Published Date: 26 February 2015

Validation of the Memorial Sloan Kettering Cancer Center nomogram for predicting non-sentinel lymph node metastasis in sentinel lymph node-positive breast-cancer patients

Bi X, Wang Y, Li M, Chen P, Zhou Z, Liu Y, Zhao T, Zhang Z, Wang C, Sun X, Qiu P

OncoTargets and Therapy 2015, 8:487-493

Published Date: 23 February 2015

Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions

Chudecka-Głaz AM, Cymbaluk-Płoska AA, Menkiszak JL, Pius-Sadowska E, Machaliński BB, Sompolska-Rzechuła A, Rzepka-Górska IA

OncoTargets and Therapy 2015, 8:471-485

Published Date: 23 February 2015

Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells

Irimie AI, Braicu C, Zanoaga O, Pileczki V, Gherman C, Berindan-Neagoe I, Campian RS

OncoTargets and Therapy 2015, 8:461-470

Published Date: 20 February 2015

Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?

Mellai M, Piazzi A, Casalone C, Grifoni S, Melcarne A, Annovazzi L, Cassoni P, Denysenko T, Valentini MC, Cistaro A, Schiffer D

OncoTargets and Therapy 2015, 8:451-460

Published Date: 19 February 2015

The imaging features of metanephric adenoma: a case report and review of literature

Hu YC, Wu L, Yan LF, Zhang W, Cui GB

OncoTargets and Therapy 2015, 8:445-449

Published Date: 13 February 2015

Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma

Wang HH, Zaorsky NG, Meng MB, Wu ZQ, Zeng XL, Jiang B, Jiang C, Zhao LJ, Yuan ZY, Wang P

OncoTargets and Therapy 2015, 8:437-444

Published Date: 13 February 2015

Single-nucleotide polymorphisms of microRNA processing machinery genes and risk of colorectal cancer

Zhao Y, Du Y, Zhao S, Guo Z

OncoTargets and Therapy 2015, 8:421-425

Published Date: 12 February 2015

High mobility group box-1 and its clinical value in breast cancer

Sun S, Zhang W, Cui Z, Chen Q, Xie P, Zhou C, Liu B, Peng X, Zhang Y

OncoTargets and Therapy 2015, 8:413-419

Published Date: 12 February 2015

Use of allogeneic platelet gel in the management of chemotherapy extravasation injuries: a case report

Di Costanzo G, Loquercio G, Marcacci G, Iervolino V, Mori S, Petruzziello A, Barra P, Cacciapuoti C

OncoTargets and Therapy 2015, 8:401-404

Published Date: 9 February 2015

The clue of a possible etiology about spontaneous regression of hepatocellular carcinoma: a perspective on pathology

Wang Z, Ke ZF, Lu XF, Luo CJ, Liu YD, Lin ZW, Wang LT

OncoTargets and Therapy 2015, 8:395-400

Published Date: 5 February 2015

XPA A23G polymorphism and risk of digestive system cancers: a meta-analysis

He L, Deng T, Luo H

OncoTargets and Therapy 2015, 8:385-394

Published Date: 5 February 2015

Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787

Parker AR, Petluru PN, Nienaber VL, Zhao M, Ayala PY, Badger J, Chie-Leon B, Sridhar V, Logan C, Kochat H, Hausheer FH

OncoTargets and Therapy 2015, 8:375-383

Published Date: 4 February 2015

The utility of bexarotene in mycosis fungoides and Sézary syndrome

Panchal MR, Scarisbrick JJ

OncoTargets and Therapy 2015, 8:367-373

Published Date: 3 February 2015

MicroRNA-153 acts as a prognostic marker in gastric cancer and its role in cell migration and invasion

Zhang Z, Sun J, Bai Z, Li H, He S, Chen R, Che X

OncoTargets and Therapy 2015, 8:357-364

Published Date: 2 February 2015

Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma

Lee SH, Kim SU, Jang JW, Bae SH, Lee SH, Kim BK, Park JY, Kim DY, Ahn SH, Han KH

OncoTargets and Therapy 2015, 8:347-356

Published Date: 2 February 2015

Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines

Fumagalli I, Dugue D, Bibault JE, Clémenson C, Vozenin MC, Mondini M, Deutsch E

OncoTargets and Therapy 2015, 8:335-345

Published Date: 2 February 2015

Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations

Nguyen ST, Nguyen HL, Pham VQ, Nguyen GT, Tran CD, Phan NK, Pham PV

OncoTargets and Therapy 2015, 8:323-334

Published Date: 30 January 2015

Targeted therapies for renal cell carcinoma in Chinese patients: focus on everolimus

Tan X, Liu Y, Hou J, Cao G

OncoTargets and Therapy 2015, 8:313-321

Published Date: 29 January 2015

Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway

Jia G, Wang Q, Wang R, Deng D, Xue L, Shao N, Zhang Y, Xia X, Zhi F, Yang Y

OncoTargets and Therapy 2015, 8:303-311

Published Date: 30 January 2015

In vivo DNA damaging and apoptotic potential of silver nanoparticles in Swiss albino mice

Al Gurabi MA, Ali D, Alkahtani S, Alarifi S

OncoTargets and Therapy 2015, 8:295-302

Published Date: 29 January 2015

Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases

Ricciardi GRR, Russo A, Franchina T, Ferraro G, Adamo V

OncoTargets and Therapy 2015, 8:289-294

Published Date: 2 February 2015

The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis

Yan S, Jiao X, Li K, Li W, Zou H

OncoTargets and Therapy 2015, 8:279-287

Published Date: 29 January 2015

NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOR phosphorylation

Sun ZH, Li QH, Zhang S, Chen J, Huang LL, Ren JH, Chang Y, Liang YC, Wu G

OncoTargets and Therapy 2015, 8:269-277

Published Date: 29 January 2015

Primary malignant lymphoma of the uterus and broad ligament: a case report and review of literature

Chen R, Yu Z, Zhang H, Ding J, Chen B

OncoTargets and Therapy 2015, 8:265-268

Published Date: 29 January 2015

Changes in sebum levels and the development of acneiform rash in patients with non–small cell lung cancer after treatment with EGFR inhibitors

Nakahara T, Moroi Y, Takayama K, Itoh E, Kido-Nakahara M, Nakanishi Y, Furue M

OncoTargets and Therapy 2015, 8:259-263

Published Date: 28 January 2015

Anticoagulant therapy for venous thromboembolism detected by Doppler ultrasound in patients with metastatic colorectal cancer receiving bevacizumab

Suenaga M, Mizunuma N, Shinozaki E, Matsusaka S, Ozaka M, Ogura M, Chin K, Yamaguchi T

OncoTargets and Therapy 2015, 8:243-249

Published Date: 27 January 2015

Tumor deposit is a poor prognostic indicator in patients who underwent simultaneous resection for synchronous colorectal liver metastases

Lin Q, Wei Y, Ren L, Zhong Y, Qin C, Zheng P, Xu P, Zhu D, Ji M, Xu J

OncoTargets and Therapy 2015, 8:233-240

Published Date: 22 January 2015

Impact on growth and invasion of gastric cancer cell lines by silencing NEDD9

Zhang SS, Wu LH, Liu Q, Chen KS, Zhang XF

OncoTargets and Therapy 2015, 8:223-231

Published Date: 20 January 2015

Meta-analysis of the association between APC promoter methylation and colorectal cancer

Ding ZY, Jiang T, Piao Y, Han T, Han YL, Xie XD

OncoTargets and Therapy 2015, 8:211-222

Published Date: 19 January 2015

Oncogenic mutation profiling in new lung cancer and mesothelioma cell lines

Lam DC, Luo SY, Deng W, Kwan JS, Rodriguez-Canales J, Cheung AL, Cheng GH, Lin CH, Wistuba II, Sham PC, Wan TS, Tsao SW

OncoTargets and Therapy 2015, 8:195-209

Published Date: 16 January 2015

Triple-negative breast cancer: new perspectives for targeted therapies

Tomao F, Papa A, Zaccarelli E, Rossi L, Caruso D, Minozzi M, Vici P, Frati L, Tomao S

OncoTargets and Therapy 2015, 8:177-193

Published Date: 16 January 2015

HMGA2 is associated with epithelial–mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma

Xia YY, Yin L, Tian H, Guo WJ, Jiang N, Jiang XS, Wu J, Chen M, Wu JZ, He X

OncoTargets and Therapy 2015, 8:169-176

Published Date: 17 January 2015

BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies

Spagnolo F, Ghiorzo P, Orgiano L, Pastorino L, Picasso V, Tornari E, Ottaviano V, Queirolo P

OncoTargets and Therapy 2015, 8:157-168

Published Date: 16 January 2015

Prognostic role of apoptosis-related gene functional variants in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy

Tao KY, Li XX, Xu WZ, Wang Y, Zhu SM, Xie HX, Luo WH, Xu YJ, Xu XL

OncoTargets and Therapy 2015, 8:147-155

Published Date: 14 January 2015

Advances in the targeted therapy of liposarcoma

Guan Z, Yu X, Wang H, Wang H, Zhang J, Li G, Cao J, Teng L

OncoTargets and Therapy 2015, 8:125-136

Published Date: 5 January 2015

Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung

Doval DC, Prabhash K, Patil S, Chaturvedi H, Goswami C, Vaid AK, Desai S, Dutt S, Veldore VH, Jambhekar N, Mehta A, Hazarika D, Azam S, Gawande S, Gupta S

OncoTargets and Therapy 2015, 8:117-123

Published Date: 5 January 2015

Ethanol extracts of Cinnamomum kanehirai Hayata leaves induce apoptosis in human hepatoma cell through caspase-3 cascade

Liu YK, Chen KH, Leu YL, Way TD, Wang LW, Chen YJ, Liu YM

OncoTargets and Therapy 2015, 8:99-109

Published Date: 31 December 2014

Breast metastases of gastric signet-ring cell carcinoma: a report of two cases and review of the literature

Iesato A, Oba T, Ono M, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ishizaka K, Kitabatake H, Takeuchi D, Suzuki A, Nakayama J, Ito K

OncoTargets and Therapy 2015, 8:91-97

Published Date: 29 December 2014

Decreased expression of APAF-1 and increased expression of cathepsin B in invasive pituitary adenoma

Tanase C, Albulescu R, Codrici E, Calenic B, Popescu ID, Mihai S, Necula L, Cruceru ML, Hinescu ME

OncoTargets and Therapy 2015, 8:81-90

Published Date: 22 December 2014

The landscape of alternative splicing in cervical squamous cell carcinoma

Guo P, Wang D, Wu J, Yang J, Ren T, Zhu B, Xiang Y

OncoTargets and Therapy 2015, 8:73-79

Published Date: 22 December 2014

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells

Yu L, Wang XL, Zhu D, Ding WC, Wang LM, Zhang CL, Jiang XH, Shen H, Liao SJ, Ma D, Hu Z, Wang H

OncoTargets and Therapy 2015, 8:37-44

Published Date: 22 December 2014

Lumbosacral plexus delineation, dose distribution, and its correlation with radiation-induced lumbosacral plexopathy in cervical cancer patients

Tunio M, Al Asiri M, Bayoumi Y, Abdullah O Balbaid A, AlHameed M, Gabriela SL, Amir O Ali A

OncoTargets and Therapy 2015, 8:21-27

Published Date: 23 December 2014

Neoadjuvant hormone therapy following treatment with robotic-assisted radical prostatectomy achieved favorable in high-risk prostate cancer

Hou CP, Lee WC, Lin YH, Chen SM, Chen CL, Chang PL, Juang HH, Tsui KH

OncoTargets and Therapy 2015, 8:15-19

Published Date: 17 December 2014

Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas

Tang D, Liu YJ, Shen D, Fan S, Su X, Ye P, Gavine PR, Yin X

OncoTargets and Therapy 2015, 8:7-14

Published Date: 16 December 2014

Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population

Benekli M, Yalcin S, Ozkan M, Elkiran ET, Sevinc A, Cabuk D, Coskun HS, Oksuzoglu B, Bayar B, Akbulat A, Ozet A

OncoTargets and Therapy 2015, 8:1-5

Published Date: 15 December 2014

Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib

Huang LM, Hu CQ, Di Benedetto M, Varin R, Liu JL, Wang L, Vannier JP, Jin J, Janin A, Lu H, Li H

OncoTargets and Therapy 2014, 7:2249-2255

Published Date: 4 December 2014

Angiogenesis and antiangiogenic agents in cervical cancer

Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, Benedetti Panici P, Tomao S

OncoTargets and Therapy 2014, 7:2237-2248

Published Date: 3 December 2014

Microtubule inhibitor-based antibody–drug conjugates for cancer therapy

Klute K, Nackos E, Tasaki S, Nguyen DP, Bander NH, Tagawa ST

OncoTargets and Therapy 2014, 7:2227-2236

Published Date: 3 December 2014

Multidrug resistance protein 1 localization in lipid raft domains and prostasomes in prostate cancer cell lines

Gomà A, Mir R, Martínez-Soler F, Tortosa A, Vidal A, Condom E, Pérez–Tomás R, Giménez-Bonafé P

OncoTargets and Therapy 2014, 7:2215-2225

Published Date: 5 December 2014

Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer

Witzel I, Milde-Langosch K, Schmidt M, Karn T, Becker S, Wirtz R, Rody A, Laakmann E, Schütze D, Jänicke F, Müller V

OncoTargets and Therapy 2014, 7:2205-2213

Published Date: 28 November 2014

EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy

Su NW, Leu YS, Lee JC, Liu CJ, Cheng CY, Lin JS, Chen YJ, Chen CK, Fang IC, Hsieh RK, Chang YF

OncoTargets and Therapy 2014, 7:2197-2204

Published Date: 28 November 2014

Doxorubicin-conjugated bacteriophages carrying anti-MHC class I chain-related A for targeted cancer therapy in vitro

Phumyen A, Jantasorn S, Jumnainsong A, Leelayuwat C

OncoTargets and Therapy 2014, 7:2183-2195

Published Date: 28 November 2014

Continuation of bevacizumab and addition of hormone therapy following weekly paclitaxel therapy in HER2-negative metastatic breast cancer

Redondo A, Martínez V, Zamora P, Castelo B, Pinto A, Cruz P, Higuera O, Mendiola M, Hardisson D, Espinosa E

OncoTargets and Therapy 2014, 7:2175-2181

Published Date: 27 November 2014

The association of apoptotic protein expressions sensitive to apoptosis gene, p73 and p53 with the prognosis of cervical carcinoma

Mega Tiber P, Baloglu L, Ozden S, Ozgen Z, Ozyurt H, Eren M, Orun O

OncoTargets and Therapy 2014, 7:2161-2168

Published Date: 26 November 2014

Neoadjuvant chemotherapy in locally advanced cervical carcinoma: which is better, intravenous or intra-arterial?

Gui T, Shen K, Xiang Y, Pan LY, Lang JH, Wu M, Huang HF, Cao DY, Yang JX

OncoTargets and Therapy 2014, 7:2155-2160

Published Date: 26 November 2014

Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People’s Republic of China

Ma FJ, Liu ZB, Qu L, Hao S, Liu GY, Wu J, Shao ZM

OncoTargets and Therapy 2014, 7:2147-2154

Published Date: 27 November 2014

Post-nephrectomy foreign-body granuloma in the retroperitoneum mimicking lymph node metastasis of renal cell cancer

Luo J, Mao Y, Cai S, Shen X, Chen S, Xie L

OncoTargets and Therapy 2014, 7:2137-2141

Published Date: 20 November 2014

Long-term complete remission in a patient with intravascular large B-cell lymphoma with central nervous system involvement

Sawada T, Omuro Y, Kobayashi T, Hishima T, Koizumi F, Kanemasa Y, Shimoyama T, Sasaki E, Maeda Y

OncoTargets and Therapy 2014, 7:2133-2136

Published Date: 18 November 2014

Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma

Cai D, Li H, Wang R, Li Y, Pan YJ, Hu HC, Zhang Y, Gong RX, Pan B, Sun YH, Chen HQ

OncoTargets and Therapy 2014, 7:2127-2132

Published Date: 18 November 2014

Large malignant ovarian tumors during pregnancy: two cases

Xu D, Liang C, He J

OncoTargets and Therapy 2014, 7:2121-2125

Published Date: 17 November 2014

Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer

Susini T, Berti B, Carriero C, Tavella K, Nori J, Vanzi E, Molino C, Di Tommaso M, Santini M, Saladino V, Bianchi S

OncoTargets and Therapy 2014, 7:2111-2120

Published Date: 17 November 2014

Pelvis metastasis from primary choroidal melanoma: a case report

Xiong Y, Lang Y, Tu CQ, Duan H

OncoTargets and Therapy 2014, 7:2107-2110

Published Date: 14 November 2014

Natural history of histologically moderate cervical dysplasia in adolescent and young women

Piris S, Bravo V, Álvarez C, Muñoz-Hernando L, Lorenzo-Hernando E, Oliver R, Marqueta-Marques L, Seoane-Ruiz JM, Tejerizo-Garcia A, Jiménez JS

OncoTargets and Therapy 2014, 7:2101-2106

Published Date: 13 November 2014

Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma

Gutierrez A, Rodriguez J, Martinez-Serra J, Gines J, Paredes P, Garcia F, Vercher J, Balanzat J, del Campo R, Galan P, Morey M, Sampol A, Novo A, Bento L, García L, Bargay J, Besalduch J

OncoTargets and Therapy 2014, 7:2093-2100

Published Date: 13 November 2014

Elevation of methylated DNA in KILLIN/PTEN in the plasma of patients with thyroid and/or breast cancer

Ng EK, Shin VY, Leung CP, Chan VW, Law FB, Siu MT, Lang BH, Ma ES, Kwong A

OncoTargets and Therapy 2014, 7:2085-2092

Published Date: 11 November 2014

IL-1α -889 C/T polymorphism and cancer susceptibility: a meta-analysis

Cheng D, Hao Y, Zhou W

OncoTargets and Therapy 2014, 7:2067-2074

Published Date: 10 November 2014

Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analyses

Oezkan F, Khan AM, Zarogoulidis P, Hohenforst-Schmidt W, Theegarten D, Yasufuku K, Nakajima T, Freitag L, Darwiche K

OncoTargets and Therapy 2014, 7:2061-2065

Published Date: 10 November 2014

Clinical outcome of advanced and metastatic renal cell carcinoma treated with targeted therapy: is there a difference between young and old patients?

Zhang G, Zhu Y, Dong D, Gu W, Zhang H, Sun L, Ye D

OncoTargets and Therapy 2014, 7:2043-2052

Published Date: 3 November 2014

Antisense therapeutics in oncology: current status

Farooqi AA, Rehman ZU, Muntane J

OncoTargets and Therapy 2014, 7:2035-2042

Published Date: 3 November 2014

Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells

Cardama GA, Gonzalez N, Ciarlantini M, Gandolfi Donadío L, Comin MJ, Alonso DF, Menna PL, Gomez DE

OncoTargets and Therapy 2014, 7:2021-2033

Published Date: 30 October 2014

The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cells

Zhang J, Zhou Q, Gao G, Wang Y, Fang Z, Li G, Yu M, Kong L, Xing Y, Gao X

OncoTargets and Therapy 2014, 7:2013-2019

Published Date: 30 October 2014

Gli3 silencing enhances cyclopamine suppressive effects on ovarian cancer

Liu HY, Dong Z

OncoTargets and Therapy 2014, 7:2007-2011

Published Date: 30 October 2014

Ramucirumab: preclinical research and clinical development

Aprile G, Rijavec E, Fontanella C, Rihawi K, Grossi F

OncoTargets and Therapy 2014, 7:1997-2006

Published Date: 29 October 2014

Prognostic significance of CDH13 hypermethylation and mRNA in NSCLC

Xue R, Yang C, Zhao F, Li D

OncoTargets and Therapy 2014, 7:1987-1996

Published Date: 31 October 2014

B7-H3 expression in breast cancer and upregulation of VEGF through gene silence

Sun J, Guo YD, Li XN, Zhang YQ, Gu L, Wu PP, Bai GH, Xiao Y

OncoTargets and Therapy 2014, 7:1979-1986

Published Date: 29 October 2014

Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma

Bodiford A, Bodge M, Talbott MS, Reddy NM

OncoTargets and Therapy 2014, 7:1971-1977

Published Date: 24 October 2014

Downregulated Ku70 and ATM associated to poor prognosis in colorectal cancer among Chinese patients

Lu YF, Gao JY, Lu YM

OncoTargets and Therapy 2014, 7:1955-1961

Published Date: 24 October 2014

Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling

Lee JK, Joo KM, Lee J, Yoon Y, Nam DH

OncoTargets and Therapy 2014, 7:1933-1944

Published Date: 20 October 2014

Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives

Bupathi M, Kaseb A, Janku F

OncoTargets and Therapy 2014, 7:1927-1932

Published Date: 20 October 2014

Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature

Bongiovanni A, Riva N, Calpona S, Ricci M, Gunelli E, Liverani C, La Manna F, De Vita A, Monti M, Severi S, Pieri F, Amadori E, Galassi R, Cavaliere D, Zaccaroni A, Tartaglia A, Lunedei V, Gardini A, Mercatali L, Amadori D, Ibrahim T

OncoTargets and Therapy 2014, 7:1919-1926

Published Date: 20 October 2014

More than 9 years of continuous trastuzumab treatment in metastatic breast cancer without cardiac toxicity: a case report and literature review

Badulescu F, Badulescu A, Paul D, Popescu CF, Florescu C

OncoTargets and Therapy 2014, 7:1911-1917

Published Date: 17 October 2014

Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives

Chen GX, Zhang S, He XH, Liu SY, Ma C, Zou XP

OncoTargets and Therapy 2014, 7:1901-1909

Published Date: 21 October 2014

A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histology

Chen M, Jin Y, Bi YL, Yin J, Wang YX, Pan LY

OncoTargets and Therapy 2014, 7:1891-1899

Published Date: 16 October 2014

Inhibition of Mus81 by siRNA enhances sensitivity to 5-FU in breast carcinoma cell lines

Qian Y, Liu YN, Yan QY, Lv J, Ni XY, Wu YL, Dong XJ

OncoTargets and Therapy 2014, 7:1883-1890

Published Date: 21 October 2014

Analysis of exfoliated gastric carcinoma cells attached on surgical supplies

Yu XF, Ma YY, Hu XQ, Zhang QF, Ye ZY

OncoTargets and Therapy 2014, 7:1869-1873

Published Date: 10 October 2014

Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials

Hong SD, Fang WF, Liang WH, Yan Y, Zhou T, Qin T, Wu X, Ma YX, Zhao YY, Yang YP, Hu ZH, Xue C, Hou X, Chen Y, Huang Y, Zhao HY, Zhang L

OncoTargets and Therapy 2014, 7:1851-1867

Published Date: 7 October 2014

Obstructive jaundice caused by intraductal metastasis of lung adenocarcinoma

Ochi N, Goto D, Yamane H, Yamagishi T, Honda Y, Monobe Y, Kawamoto H, Takigawa N

OncoTargets and Therapy 2014, 7:1847-1850

Published Date: 7 October 2014

Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer

Liontos M, Lykka M, Dimopoulos MA, Bamias A

OncoTargets and Therapy 2014, 7:1837-1845

Published Date: 4 October 2014

Colorectal cancer in Chinese patients: current and emerging treatment options

Li L, Ma BBY

OncoTargets and Therapy 2014, 7:1817-1828

Published Date: 4 October 2014

A new inflammation index is useful for patients with esophageal squamous cell carcinoma

Feng JF, Huang Y, Chen QX

OncoTargets and Therapy 2014, 7:1811-1815

Published Date: 30 September 2014

Study of the mechanism of sonodynamic therapy in a rat glioma model

Song D, Yue W, Li Z, Li J, Zhao J, Zhang N

OncoTargets and Therapy 2014, 7:1801-1810

Published Date: 30 September 2014

An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma

Offidani M, Corvatta L, Caraffa P, Gentili S, Maracci L, Leoni P

OncoTargets and Therapy 2014, 7:1793-1800

Published Date: 29 September 2014

Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients' heart?

Fontanella C, Aita M, Cinausero M, Aprile G, Baldin MG, Dusi V, Lestuzzi C, Fasola G, Puglisi F

OncoTargets and Therapy 2014, 7:1783-1791

Published Date: 29 September 2014

The expression sequence tag is an effective method for screening DNA segments that predict urinary bladder transitional cell carcinoma prognosis

Yang PS, Hsu YC, Lin YH, Hou CP, Chen CL, Chang PL, Juang HH, Tsui KH

OncoTargets and Therapy 2014, 7:1777-1781

Published Date: 30 September 2014

Crenolanib, a PDGFR inhibitor, suppresses lung cancer cell proliferation and inhibits tumor growth in vivo

Wang P, Song L, Ge H, Jin P, Jiang Y, Hu W, Geng N

OncoTargets and Therapy 2014, 7:1761-1768

Published Date: 26 September 2014

Expression of YY1 correlates with progression and metastasis in esophageal squamous cell carcinomas

Luo J, Jiang X, Cao L, Dai K, Zhang S, Ge X, Zhou X, Lu X

OncoTargets and Therapy 2014, 7:1753-1759

Published Date: 26 September 2014

Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer

Yao MY, Liu Y, Jin HL, Liu XJ, Lv KZ, Wei HY, Du CY, Wang SQ, Wei BJ, Fu PF

OncoTargets and Therapy 2014, 7:1743-1752

Published Date: 26 September 2014

Overexpression of ETV4 protein in triple-negative breast cancer is associated with a higher risk of distant metastasis

Yuan ZY, Dai T, Wang SS, Peng RJ, Li XH, Qin T, Song LB, Wang X

OncoTargets and Therapy 2014, 7:1733-1742

Published Date: 26 September 2014

PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs

Ataseven B, Gunesch A, Eiermann W, Kates RE, Högel B, Knyazev P, Ullrich A, Harbeck N

OncoTargets and Therapy 2014, 7:1723-1731

Published Date: 6 October 2014

Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia

Yang QM, Hong JY, Ko YH, Lin SY, Au WY, Choi MK, Park S, Kim SJ, Kim WS

OncoTargets and Therapy 2014, 7:1717-1722

Published Date: 26 September 2014

Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins

Gui T, Bai HM, Zeng JF, Zhong ZJ, Cao DY, Cui QC, Chen J, Yang JX, Shen K

OncoTargets and Therapy 2014, 7:1705-1716

Published Date: 25 September 2014

The emerging role of class-3 semaphorins and their neuropilin receptors in oncology

Nasarre P, Gemmill RM, Drabkin HA

OncoTargets and Therapy 2014, 7:1663-1687

Published Date: 24 September 2014

Clinical significance of UGT1A1 gene polymorphisms on irinotecan-based regimens as the treatment in metastatic colorectal cancer

Li MM, Wang ZH, Guo J, Liu J, Li CZ, Liu L, Shi H, Liu LY, Li HH, Xie C, Zhang X, Sun WW, Fang S, Bi X

OncoTargets and Therapy 2014, 7:1653-1661

Published Date: 23 September 2014

The target therapy of ovarian clear cell carcinoma

Jin Y, Li Y, Pan LY

OncoTargets and Therapy 2014, 7:1647-1652

Published Date: 23 September 2014

Cyclophosphamide-induced symptomatic hyponatremia, a rare but severe side effect: a case report

Elazzazy S, Mohamed AE, Gulied A

OncoTargets and Therapy 2014, 7:1641-1645

Published Date: 30 September 2014

Profile of selumetinib and its potential in the treatment of melanoma

Kim DW, Patel SP

OncoTargets and Therapy 2014, 7:1631-1639

Published Date: 19 September 2014

Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer

Ding J, Li D, Gong M, Wang J, Huang X, Wu T, Wang C

OncoTargets and Therapy 2014, 7:1625-1630

Published Date: 18 September 2014

Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis

Davis PJ, Lin HY, Sudha T, Yalcin M, Tang HY, Hercbergs A, Leith JT, Luidens MK, Ashur-Fabian O, Incerpi S, Mousa SA

OncoTargets and Therapy 2014, 7:1619-1624

Published Date: 18 September 2014

Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion

Chinen LTD, Mello CAL, Abdallah EA, Ocea LMM, Buim ME, Breve NM, Gasparini Junior JL, Fanelli MF, Paterlini-Bréchot P

OncoTargets and Therapy 2014, 7:1609-1617

Published Date: 16 September 2014

Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients: a meta-analysis and systematic review

He XP, Yang K, Chen P, Liu B, Zhang Y, Wang F, Guo Z, Liu XD, Lou JX, Chen HR

OncoTargets and Therapy 2014, 7:1593-1599

Published Date: 10 September 2014

MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma

Lin FO, Yao LJ, Xiao J, Liu DF, Ni ZY

OncoTargets and Therapy 2014, 7:1583-1591

Published Date: 11 September 2014

Antiangiogenic cancer drug sunitinib exhibits unexpected proangiogenic effects on endothelial cells

Norton KA, Han ZY, Popel AS, Pandey NB

OncoTargets and Therapy 2014, 7:1571-1582

Published Date: 9 September 2014

HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium

Braicu EI, Luketina H, Richter R, Cacsire Castillo-Tong D, Lambrechts S, Mahner S, Concin N, Mentze M, Zeillinger R, Vergote I, Sehouli J

OncoTargets and Therapy 2014, 7:1563-1569

Published Date: 11 September 2014

Bevacizumab in Japanese patients with malignant glioma: from basic research to clinical trial

Takano S, Ishikawa E, Nakai K, Matsuda M, Masumoto T, Yamamoto T, Matsumura A

OncoTargets and Therapy 2014, 7:1551-1562

Published Date: 5 September 2014

Bupivacaine administered intrathecally versus rectally in the management of intractable rectal cancer pain in palliative care

Zaporowska-Stachowiak I, Kowalski G, Łuczak J, Kosicka K, Kotlinska-Lemieszek A, Sopata M, Główka F

OncoTargets and Therapy 2014, 7:1541-1550

Published Date: 6 October 2014

An individual drug-therapy and genetic testing report of temporal bone verrucous carcinoma

Tan HL, Liu Y, Zhu GC, Pi LM, Huang DH, Zhang X

OncoTargets and Therapy 2014, 7:1535-1540

Published Date: 4 September 2014

ER-α36: a novel biomarker and potential therapeutic target in breast cancer

Su XY, Xu X, Li GL, Lin BY, Cao J, Teng LS

OncoTargets and Therapy 2014, 7:1525-1533

Published Date: 30 August 2014

Long-term outcomes from dose-escalated image-guided intensity-modulated radiotherapy with androgen deprivation: encouraging results for intermediate- and high-risk prostate cancer

Wilcox SW, Aherne NJ, Benjamin LC, Wu B, de Campos Silva T, McLachlan CS, McKay MJ, Last AJ, Shakespeare TP

OncoTargets and Therapy 2014, 7:1519-1523

Published Date: 30 August 2014

Cytoprotection “gone astray’’: Nrf2 and its role in cancer

Geismann C, Arlt A, Sebens S, Schäfer H

OncoTargets and Therapy 2014, 7:1497-1518

Published Date: 26 August 2014

The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis

Ying HQ, Wang F, He BS, Pan YQ, Gao TY, Xu YQ, Li R, Deng QW, Sun HL, Wang SK

OncoTargets and Therapy 2014, 7:1487-1496

Published Date: 25 August 2014

miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer

Fesler A, Zhai H, Ju J

OncoTargets and Therapy 2014, 7:1481-1485

Published Date: 21 August 2014

The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer

Chen Y, Sun J, Zhao H, Zhu DM, Zhi QM, Song SD, Zhang LF, He SB, Kuang YT, Zhang ZX, Li DC

OncoTargets and Therapy 2014, 7:1465-1472

Published Date: 19 August 2014

A simple in vitro method for evaluating dendritic cell-based vaccinations

Pham PV, Nguyen NT, Nguyen HM, Khuat LT, Le PM, Pham VQ, Nguyen ST, Phan NK

OncoTargets and Therapy 2014, 7:1455-1464

Published Date: 18 August 2014

Glucagonoma syndrome: a case report with focus on skin disorders

Fang S, Li S, Cai T

OncoTargets and Therapy 2014, 7:1449-1453

Published Date: 14 August 2014

Isothermal multiple displacement amplification: a methodical approach enhancing molecular routine diagnostics of microcarcinomas and small biopsies

Mairinger FD, Walter RFH, Vollbrecht C, Hager T, Worm K, Ting S, Wohlschläger J, Zarogoulidis P, Zarogoulidis K, Schmid KW

OncoTargets and Therapy 2014, 7:1441-1447

Published Date: 13 August 2014

Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma

Hu H, Pan Y, Li Y, Wang L, Wang R, Zhang Y, Li H, Ye T, Zhang Y, Luo X, Shao L, Sun Z, Cai D, Xu J, Lu Q, Deng Y, Shen L, Ji H, Sun Y, Chen H

OncoTargets and Therapy 2014, 7:1423-1437

Published Date: 13 August 2014

Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer

Yin CX, Jiang C, Liao FX, Rong YM, Cai XY, Guo GF, Qiu HJ, Chen XX, Zhang B, He WZ, Xia LP

OncoTargets and Therapy 2014, 7:1415-1422

Published Date: 11 August 2014

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era

Berger JL, Smith A, Zorn KK, Sukumvanich P, Olawaiye AB, Kelley J, Krivak TC

OncoTargets and Therapy 2014, 7:1409-1413

Published Date: 8 August 2014

PKN1 modulates TGFß and EGF signaling in HEC-1-A endometrial cancer cell line

Attarha S, Saini RK, Andersson S, Mints M, Souchelnytskyi S

OncoTargets and Therapy 2014, 7:1397-1408

Published Date: 4 August 2014

Silencing B7-H1 enhances the anti-tumor effect of bladder cancer antigen-loaded dendritic cell vaccine in vitro

Wang S, Wang YH, Liu J, Shao SX, Li XJ, Gao JN, Niu HT, Wang XS

OncoTargets and Therapy 2014, 7:1389-1396

Published Date: 5 August 2014

Paclitaxel- and/or cisplatin-induced ocular neurotoxicity: a case report and literature review

Li Y, Li YP, Li JY, Pi GL, Tan WY

OncoTargets and Therapy 2014, 7:1361-1366

Published Date: 31 July 2014

PD-1 as an emerging therapeutic target in renal cell carcinoma: current evidence

Tykodi SS

OncoTargets and Therapy 2014, 7:1349-1359

Published Date: 25 July 2014

Comparison of short-term effect of thoracoscopic segmentectomy and thoracoscopic lobectomy for the solitary pulmonary nodule and early-stage lung cancer

Ren MM, Meng QJ, Zhou WY, Kong FY, Yang B, Yuan J, Wu DW, Zhang J, Li QQ, Lin YS, Viswanathan VB, Song X

OncoTargets and Therapy 2014, 7:1343-1347

Published Date: 24 July 2014

External iliac vein – transplant ureteral fistula combined with renal cell carcinoma: an unusual case of hematuria

Luo JD, Liu B, Wang P, Zhou F, Xu XL, Li SQ, Cai SL, Wang YM

OncoTargets and Therapy 2014, 7:1339-1342

Published Date: 23 July 2014

MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer

Salido-Guadarrama I, Romero-Cordoba S, Peralta-Zaragoza O, Hidalgo-Miranda A, Rodríguez-Dorantes M

OncoTargets and Therapy 2014, 7:1327-1338

Published Date: 21 July 2014

High expression of HEF1 is associated with poor prognosis in urinary bladder carcinoma

Zhang Q, Wang HJ, Zhang DH, Ru GQ, He XJ, Ma YY

OncoTargets and Therapy 2014, 7:1319-1326

Published Date: 21 July 2014

Circulating tumor cells in the central and peripheral venous compartment – assessing hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma

Fang ZT, Zhang W, Wang GZ, Zhou B, Yang GW, Qu XD, Liu R, Qian S, Zhu L, Liu LX, Wang JH

OncoTargets and Therapy 2014, 7:1311-1318

Published Date: 18 July 2014

Prognostic significance of thymidylate synthase in postoperative non-small cell lung cancer patients

Zhao HY, Ma GW, Zou BY, Li M, Lin SX, Zhao LP, Guo Y, Huang Y, Tian Y, Xie D, Zhang L

OncoTargets and Therapy 2014, 7:1301-1310

Published Date: 16 July 2014

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer

McFarland DC, Misiukiewicz KJ

OncoTargets and Therapy 2014, 7:1291-1299

Published Date: 15 July 2014

Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status

Laidi F, Bouziane A, Lakhdar A, Khabouze S, Rhrab B, Zaoui F

OncoTargets and Therapy 2014, 7:1285-1289

Published Date: 14 July 2014

Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence

Mascilini F, Amadio G, Di Stefano MG, Ludovisi M, Di Legge A, Conte C, De Vincenzo R, Ricci C, Masciullo V, Salutari V, Scambia G, Ferrandina G

OncoTargets and Therapy 2014, 7:1273-1284

Published Date: 12 July 2014

Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation

Ieni A, Barresi V, Caltabiano R, Cascone AM, Del Sordo R, Cabibi D, Zeppa P, Lanzafame S, Sidoni A, Franco V, Tuccari G

OncoTargets and Therapy 2014, 7:1267-1272

Published Date: 11 July 2014

Randomized double-blind trial of prophylactic topical Evozac® Calming Skin Spray for gefitinib-associated acne-like eruption

Wang Y, Yang Y, Xu J, Yu J, Liu X, Gao R, Zhang L

OncoTargets and Therapy 2014, 7:1261-1266

Published Date: 10 July 2014

Lack of association between the XPD Lys751Gln polymorphism and colorectal cancer risk: a meta-analysis

Zhang T, Zhang DM, Zhao D, Hou XM, Ma SC, Liu XJ

OncoTargets and Therapy 2014, 7:1255-1260

Published Date: 12 July 2014

Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: a meta-analysis

Mu WP, Wang J, Niu Q, Shi N, Lian HF

OncoTargets and Therapy 2014, 7:1237-1245

Published Date: 10 July 2014